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CH.APTER 1 : INTRODUCTION 
While goitres had been recognised since the earliest times, and 
Shakespeare could remark in the "Tenpest", 
"Who would believe that there were mountaineers 
Dew-lapped like bulls, whose throats had hanging at them 
Wallets of flesh; ••••••• " 
it was only in 1825 that the first clinical description of eypertbyroidism 
with exophthal.Joos was recorded by Caleb H. Parry, who wrote: 
"About three months after lying in, while she was suckling her child, a lunp 
about the size of a walnut was perceived in the right side of her neck. This 
continued to enlarge till the period of my attendance, when it occupied both 
sides of her neck, so as to have reached an enonoous size, projecting for-
wards before the margin of the lower jaw. The part swelled was the thyroid 
gland. The carotid artery on each side was greatly distended, the eyes were 
protruded from their sockets and the countenance exhibited an appearance ot 
agitation and distress, especially in any D11SCular exertion, which I have 
rarely seen equalled". <166) 
The physiology ot the thyroid gland, and the regulation of its 
secretion, remained speculative until 1851, when Niepce is credited with 
the first observation of a possible relationship between it and the pituitary 
gland. <165) He reported anterior pituitary eypertrophy in patients and 
animal.a with endemic goitre and cretinism. It was subsequently shown that 
the pituitary gland in the dog and rabbit enlarged and had an altered micro-
scopic appearance following thyroideotomy.( 186) 
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Conversely, Cushing reported ultimate involution of the teyroid gland 
with excess colloid formation and a low epithelial lining following bypo-
physectoll\Y in dogs. (69) This was later noted in humans. (B7) An atrophic 
thyroid was found in all of 34 cases of Simnonds' disease reviewed by 
Graubuer.(109) 
An iDportant link in the understanding of the pituitary-thyroid 
relationship was forged when Allen demonstrated that the anterior pituitary 
secreted a thyroid stimulating substance. He reported that the thyroid 
atropey in tadpoles following the removal of the anterior pituitary could 
be conpletely resolved by anterior-pituitary inplants from trogs.<
21 , 22) 
Later, Smith and Smi. th noted similar observations in tadpoles following the 
injection of bovine anterior pituitary extract. (204-) Similar experiments 
were performed on rats. <202, 23, 203) Atropey was actually prevented after 
bypophysecto~ by starting treatment inmediately. ( 23) Anterior pituitary 
extract was shown to stilll.ilate the thyroid JIX>rphologically and functionally 
in the salamander(21 5) and axolotl larvae(21 3, 216). This was manifested aa 
an increase in height of the epithelial cells of the thyroid follicle and an 
acceleration of met81JK)rphosis. Thus the occurrence of histological changes 
became known for the first time. Since the effect on larval met81JK)rphosis 
was abolished by thyroidecto?l\1, it was concluded that the anterior lobe of 
the pituitary gland contained a factor which activated the thyroid gland. 
Subsequently, byperplaaie. of the thyroid induced by the parenteral admini-
stration of anterior pituitary extracts was reported in a variety of labora-
tory ani ma] s ( 139' 25). Thyroid transplants as well as normal glands were 
found to be stimulated by anterior pituitary administration(148). 
- 3 -
From these experiioontal beginnings, the concept ot a thyroid-
stimulating hormone arose. Many names have been given to this substance. 
These include "metam:>rphic substance" (205), "thyreotropic hormone" (67), 
"thyreoactivator11<21 i..), thyrotropin, thyrotrophin and tlzyroid-stimulating 
hormone (T.S.H.). Throughout this thesis, the name "thyrotrophin" will be 
used, as it appears to be the correct generic term. 
Following the proposal ot a thyroid stimulating hormone(67), indirect 
evidence tor its ,,xistence was adduced when signs ot supposed eyperthyroid 
activity were reported following anterior pituitary administration. These 
included basal metabolic rate ( 194-), emphthalmos ( 191 ) and taceyoardia ( 189). 
The utilisation ot thyrotrophin by the thyroid gland was suggested when it 
was administered intravenously and was shown to disappear more quickly from 
the blood of normal, as opposed to thyroidectomi.sed animals(1.z..2), though it 
did not appear in the urine(193). 
The tmderstanding of the thyroid-pituitary relationship was carried 
further when it was discovered that the resting tlzyroid gland induced by 
thyroid substance in the intact animal could be correlated with a reduced 
pituitary tb¥rotrophin(55, 2). Subsequently, thyroid hormone was shown to 
inhibit the histologio response to siuultaneously administered thyrotrophin 
in hypopey-sectomised ( 66) and intact an; maJ s ( 140, 't37). 
From this latter evidence, the concept of a homeostatic control 
mechanism between the anterior pituitary and thyroid gland was founded (Fig.1 ) • 
By this mechanism, excess thyroxine is thought to danp down the anterior 
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pituitary secretion of thyrotrophin, and this would tend to reduce thyroxine 











FIGURE 1: Concept of pituitary-
thyroid homeostasis. 
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Soon after 19 30, it was reported that exophthalloos could be produced in 
experimental animal.a by the injection of anterior pituitary extract rich in 
tlzyrotrophin( 141 , 147' 191). It was consequently suggested that tlzyrotrophin 
might be responsible for this phenomenon despite the rarity of exophthalloos 
in spontaneous eypoteyroidism, where large amounts of circulating teyro-
trophin would be expected. This concept, however, gained support when tby-
roidectolJ\V' was found to enhance the exophthalmos-produoing effect of anterior A 
pituitary extracts in guinea-pigs(Bo, 146, 147, 196), presumably by a dis-
turbance of the pituitary-teyroid balance and an enhancement of teyrotrophin 
secretion. TeyroidectOlJ\V' alone was claimed to have caused exophthalmos in 
both animals (7S, 108, 220) and man(7B). However, this has been disputed by 
workers using more refined techniques for measuring exophthalmos in experi-
mental enimals(12s, 15°), especially if allowance is made for weight gain 
following this procedure ( 125). Discrepancies between the levels of circu- . 
lating tlzyrotrophin and associated clinical exophthalloos ( 75' 107) have led 
to the theory that a separate exophthalmos producing substance (E.P.S.) 
exists, and this has been given both experinmtal (36, 37, Blt., 126) and 
clinical backing ( 85' 15°). The subject will be discussed at greater length 
in Chapter IV. 
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The presence of a substance in the blood of some hyperthyroid 
patients which has been correlated with the presence of associated exoph-
thalmos, has been reported recently(5, 11 , 43, 13, 155, 162). This factor, 
currently named "long-acting thyroid stimulator" or L.A.T.S~ has been shown 
to have a thyrot1;q,bic aotion on the thyroid gland(43, 144, 158), but has 
both a longer circulating halt-lite than tblrotrophin(6, 156, 160) and a 
different dose response slope(7). 
The association of byperteyroid and exophthalmic states with assqable 
levels of this substance have led to the suggestion that it may be the agent 
responsible for byperthyroidisi13). Others feel it to be identical with 
E.P.s. discussed above(5, 160). 
At least two, and possibly three, hormonal factors appear to be 
involved in the synptom-complex of hyperthyroidism and exophthalmos, but 
their precise importance is obscure. In addition, the status and inter-
relationship of these substances in patients with exophthalmos and induced 
hypothyroid states or pretibial JVX()edema., has not been clarified. 
Th3'rotrophin and exophthalms producing substance (E.P.S.) appear to 
be different; but whether E.P.S. is identical. with the long acting thyroid 
stinulator (L.A.T.S.) found in exophthal.mic states is not lmown. It was 
thought that collaborative biological assays for these three substances in 
the same aliquot of serum from exophthalmic patients might possibly settle 
this point. 
(3') Terminology informally agreed upon at the Fourth International Goitre 
Conference, London, July 1960. 
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The paucity of serial asse;ys of th31rotrophin, L.A.T.S. or E.P.S. in 
patients receiving therapy for exophthaJ.mic or hyperthyroid states is 
striking. Only Dobyns ( 86) and McGill ( 15°) have followed exophthaJ.mic 
patients and have attempted to coITelate clinical change and exophthalloos 
producing activity, while serial estimations of L.A.T.S. have not been 
reported. It was felt worthwhile, therefore, to record serial serum levels 
of all three factors in persons suffering from both hyperthyroid and ex-
ophthalmic states and to look for a correlation between clillical change and 
the hormonal status in these oases. 
Only couparatively recently has the assay of thyrotrophic activity 
in serum been put onto a sound statistical footing. The levels of thyro-
trophin have since been estimated in a variety of end.oorinopathies with 
reasonable reliability. However, discrepancies are still noted, for ex8Dple 
in hyperthyroidism. In some oases, including hyperthyroid, hypothyroid and 
hypopituitary states, assay levels are well documented (see Chapter VII); 
in others, including aoromegaly, siuple goitre and pretibial JIG'Xoedema 
very few results have been reported. Thyrotrophin has not been assayed in 
persons suffering from teyroid carcinoma or thyroiditis (both chronic, 
Hashimto's, or subacute, De Quervain's). It was considered to be of interest, 
therefore, to estimate thyrotrophic activity in these states. 
The interpretation of the tri-iodothyron:ine (T3) suppression test of 
th31roid function baa recently been questioned. The concept postulated by 
Werne/ 224) that failure of T3 to suppress I 131 uptake in lzyperteyroid 
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states i.Dplied autonoioous thyroid activity, has been cri ticisei 100) . As 
only one very brief report of thyrotrophin levels before and after tri-
iodothyronine suppression has appeared(l+B), it was decided to assq such 
activity in thyrotorio and euthyroid subjects with high thyroid uptakes ot 
I 131 in order to test correlation between suppressibility and serum levels 
of th3'rotrophin and occasionally E.P.S., and possibly to throw light on the 
m,chanism involved in, and the interpretation of, this test of tlzyroid 
tunction. 
To sumnarise, it was hoped by m,ans of collaborative biological ass83'8 
of thyrotrophin, L.A.T.S. and E.P.S., or by ass83'8 of thyrotrophin alone, to 
investigate the following problems : -
( i) The status end interrelationships of these hormonal 
substances in the conditions of eyperthyroidism and 
exophthalmos, and in exophthalmic states associated 
with induced ~othyroidism, euthyroidism and pretibial 
nuxoedema. 
(ii) The single or separate identities of the three substances 
mentioned, with special regard to L.A.T.S. and E.P.S. 
(iii) The correlation between the clinical and honoonal. status 
in patients suffering from hyperthyroidism or exophthalioos 
during and after therapy. 
(iv) The thyrotrophin level in a variety of thyroid disorders, 
with emphasis on those which have received scant or no 
attention in published reports. 
(v) The mechanism and interpretation of the tri-iodothyronine 
suppression test of thyroid function. 
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The Biological Assay of Th.yrotrophin - A Review 
lwzy" years before the concept of a pituitary-tbyroid interrelationship 
had been evaluated, Renon and Delille reported vaiat was probably the first 
assay of teyrotrophin when they noted after anterior pituitary injections 
into rabbits that "la thyroide est le siege de modifications tres 
remarquables" (183, 1Blt-). The first unit of tbyrotrophic activity waa 
assayed quantitatively only in 1932 by J1mJcmann and Schoeller by a subjective 
grading of histologica1 changes induced in the guinea-pig thyroid following 
anterior pi~ tary injections ( 128). Since then, numerous assq methods have 
been described(52), based on virtually every known teyrotrophic effect on the 
tbyroid gland, as well as the end organ effects of' secondarily released thyroid 
hornxme. 
That assay methods have not been directly couparable, has been due not 
only to the Dill tiplici ty of techniques based on dif'f'eren t parameters of thyro-
trophic ef:f ect, but, until recently, to the lack of a standardised reference 
substance. In 1955, a stock of standard known as u.s.P. Thyrotropin Reference 
Standard was released; 13.5 D¥J• being equal to 1 U.S.P. unit(
157). The same 
year, an "International Standard for TbT,rotrophin" was established under the 
World Health Organisation Expert Conmittee on Biological Standardisation(164.). 
Both U. s. P. and International Standards are equipotent, and the uni ts are 
identical. Since 1955, it has been possible to conpare the sensitivities of 
all assays in which these reference standards have been used. These conpari-
sons have been further facilitated by the relatively recent application of 
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statistical analyses to bio-ass~ results. 
Earlier Units of Sensitivity: 
Sensitivity of earlier assqs was reported in terms of various 
arbitrary units. As these were based on subjective histological techniques, 
accurate standardisation was inpossible, as was cooparison between ass83"8. 
For this reason, only approximate figures for sensitivity could be reported. 
The earliest unit to gain popularity was the Junkmann-Schoeller Unit (J.s.uH128) 
defined as the smallest daily dose of anterior pituitary extract which, when 
injected subcutaneously into guinea-pigs daily for three dqs, would by the 
fourth~ cause histological evidence of tl\Yl'Oid activity (colloid and 
follicular epithelial change) in one out of two animals. A slight refineirent 
was the unit of Heyl and Laquem (H.L. U. / 122) who, in 19~, defined in 
guinea-pigs six categories of t~oid epithelial response to anterior pituitary 
extracts injected daily for two successive ~s. The teyroid gland was 
examined twenty-four homs after the second injection. An H.L.U. was one-
quarter of this total injected dose which yielded a response (the 4th histo-
logical category) in two out of three animals. It has been estimated that both 
J.S. and H.L. units are roughly equiva1ent(208). Their relationship to the 
U. S.P. unit cannot be precisely estimated because of the subjectiveness of 
these earlier units; but it is generally accepted that one U.S.P. unit equals 
10 - 12 J.s.u. (178, 117). Soire conparison (albeit a rather unsatisfactory 
one) of sensitivities of earlier and zoore recent assqs is thus possible. 
In this thesis, teyrotrophin levels will be referred to only in terms of 
international units and milliunits (m.u. ). 
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Contusion was caused by the use of a provisional U.S.P. reference 
substance in the first standardised ass~ (47, 177, 179). This was twenty 
times as potent as the final reference material which · was diluted 1 part to 
19 parts lactose. 
The combination of technical refinements, caretul statistical analyses 
and the use of an international standard material for reference, has led to 
a degree of uniformity in teyrotrophin assay methods, whereas, until recently, 
a chaotic state existed. 
ASSAY lW.rHODS: 
Earlier techniques are of historical interest only end have been 
reviewed cri ticall.;r and in great detail ( 19 ' 52, 133). These will be 
described briefly but consideration will be given mainly to those methods 
in which the sensitivity has been of an order to warrant reasonable conclusions 
regarding teyrotrophio activity in human serum. This review will follow a 
classification of assa_y methods based on the various para:aeters of teyro-
trophio effect, both indirect and direct. 
INDIROOT METHODS: 
lletabolic effects: 
Anderson and Collip devised a method based on the response of the basal 
metabolic rate in eypophysectomised rats to anterior pituitary extracts(24-). 
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Tadpole Method: 
D'.Angelo and his co-workers(73) showed that the metaIOOrphosis in 
tadpoles which was inhibited by starving, could be stinw.ated rapidly by 
intraperitoneal anterior pituitary extract, with ensuing weight loss, increase 
in hind limb length, and histological evidence of thyroid gland activity. 
When these latter two :f'unctions were used as combined criteria, a sensitivity 
of 60 to 120 tines that of previous histological methods was claimed. (See 
page 13) . Subsequently, elegant m:i.cro-histometrio methods for the measurement 
of acinar oel.l height added objectivity and a log-dose response curve, suitable 
for assay purposes, was obtalhneaC71 ' 74). 
DIREJT METHODS: 
Gravimetric Methods: 
As the ~ertropey ot the thyroid ind.med by thyrotrophin was found 
to be reflected by weight increase of the gland, this was, for a time, used 
as an index of thyrotrophic activity in guinea-pigs(188), yo\.U'lg chicks(lt-t,
65,197) 
and young d.uo;ks ( 190) • 
Reoently, an in vitro method involving thyroid weight increase has 
been described(31). Slices of beef tl:zyroid are incubated in Krebs-Ringer 
phosphate buffer, thyrotrophin having been added to the :nedia in graded doses. 
A linear weight increase of the slices related to the logarithm of the dose 
waa recorded. The mechanism of this effect is obscure. Thyrotrophic 
activity in untreated blood could not be measured by this method; but, when 
this was separated by means of ion exchange chromatograpey-(
118), satisfactory 
ass ays were obtained. 
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General Histological Methods: 
The pioneer work concerning histological evidence of thyroid activity 
and its relationship to anterior pituitary stimulation, has been referred to 
( 122 128) . . ( 127 151 ) earlier ' . These methods and subsequent md:if1cat1ons ' were 
abandoned because of insensitivity and great subjectiveness. 
Miorohiatamtric method: 
The use of an ocular micrometer to measure epithelial cell height 
directly(BS, 181 , 182), enabled mre objective histological evidence of thyro-
trophic activity to be used for assq purposes. One cell was measured in each 
of a number of f'ollieles and a mean cell height was obtained. The technique 
was, however, laborious and subjective influemes might have governed the 
selection of cells to be measured. Griesbach and Purves used a modification 
of this assq in pretreated animals<113). A similar technique was subsequently 
used with stasis tadpoles and combined with observations of' hind limb length 
(73, 74) 
• The sensitivity of this uethod (0.05 m.u. of the international 
standard, with an injection volume of 0.25 to 0.35 ml.. serum) enabled measure-
m.mts to be made in untreated blood sanples in various endocrine disorders. 
Other workers have used this uethod with varying success (27' 195). 
Histoquantitative linear measurement methods: 
A sinpler and more objective method f'or histological evaluation of 
thyroid stiDJJl.ation in guinea-pigs was subsequently described and elabo-
rateaC 208, 218). This involved determination of the relative proportions of 
epithelium, colloid and stroma in the thyroid. Percentage of epithelium ( E%) 
was regarded as the best index of thyroid activity and a direct relationship 
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between the difference of E % in untreated and treated anj ma) s ( dE % ) and the 
logarithm of the dose ot thyrotrophin was discovered. An .assay method was 
developed with a sensitivity of 1.0 1111. ( 211 ) which was used tor the assay ot 
thyrotrophin in human serum ( 21 O). A discovery by Ludwig ( 143) of changes in 
nuclear volune of thyroid epithelial cells was later adapted for assay 
purposes(209), but, though sensitive, it was extremely tedious. 
Intracellular colloid droplet nethod: 
De Robertis, using guinea-pigs, measured the nu.ni>er of intracellular 
colloid droplets in the thyroids after intracardiac injection of thyrotrophic 
extract ( 185) • He used the ratio between this nunber and the mean diameter of 
corresponding follicles to establish a "cytological coefi"icient". He claimed 
a sensitivity of 0.02 D11. using a Fellillger(95) extract of blood, with a log-
dose response relationship, but this sensitivity has been criticised for a lack 
of preoision(208) and specificity(B9, 90). 
:Measurement of ~oid I2 depletion: 
Following the discovery that thyrotrophin depleted the thyroid of' 
iodine(6o, 97), a chemical method(206) for the estimation of blood and tbyroid 
iodine was used to study these efi"ects in animals(70, 207). A daily injection 
of pituitary extract for 5 da,ys C811Sed significant depletion of thyroid iodine 
as early as 2li- hours after comnencement and, on this basis, an assay nethod 
was detined(2o7) and later elaborated(20, 98 , 169). A linear log-dose response 
was obtained in non-pretreated chicks, but with poor sensitivity (5 - 20 Dll. ) ( 169) 
However, as cheml.cal estimation of iodine is laborious, the method was abandoned. 
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In spite of the diversity of the thyrotrophic effects used. in assq 
techniquesbefore radio-isotopes became the tools of choice, the correlation 
between many of the methods was often remarkably good.(2o, 209). The sensi-
tivity was usually p~or, the exceptions being the"stasis tadpole" method of 
D'Angelo(73, 74), the histoquantitative technique of Tala(208) and the 
in vitro assay using thyroid slices, developed by Bakke ( 118). 
Measurement of thyroid P32 increase: 
Borell reported that the phosphorus content of guinea-pig tlzyroid 
increased after th3rotrophic stimulation(45), and he later elaborated a 
method of assay based on radio-phosphorus uptake(46). A fairly linear log-
dose response to thyrotrophin was obtained over a wide range; but, though 
his method was easy and objective, the sensitivity was poor. This was later 
increased, firstly when 2 day-old chicks were used.(42, 68) and, later, (but 
at the expense of the range - 0.5 to 5.0 DU.) by Scandinavian workers (133, 
134, 221 ), who also clained specificity of this method after noting an 
excel.lent coITelation with the epithelial percentage (Efo) assq( 133). 
Greenspan and his colleagues noted a similar sensitivity and specificity of 
response ( 11 O) • Assays were attenpted in both blood and urine, but subsequent 
dift'icul ty was encounterei 111 ) and it was tel t that non-pituitary factors 
might have been influencing the assay by stim.ilating P 32 uptake. This lack 
of specificity DllSt weigh very heavily against the usefulness of the method. 
The mechanism of this unusual action of thyrotrophin is obscure, but 
is thought to be a non-specific result of increased metabolism leading to an 
increasing turnover of phosphorylated conpounds ( 134), as occurs in an;y growing 
tissue. 
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The use of I 
131 in thyrotrophin assays: 
There seems clearly a three-fold effect of thyrotrophin on the meta-
bolism of thyroid iodine ( 58) , nam::ly : -
(i) Release of organically bound I2 from the thyroid. 
(ii) Conversion of inorganic I2 to protein bound conpounds. 
(iii) Trapping of inorganic I2 from the blood stream. 
These effects were used by various "WOrkers as end-points in the development 
of thyrotrophin assays. The availability of radio-active iodine made these 
end points both objective and easily definable. 
The sequence of these effects has been iuestigated. Keating and his 
co-workers(129) showed that the first change to occur in thyrotrophin treated 
chicks was loss of' thyroid I 2 and. that this occUITed pari passu with histo-
logies+ evidence of activity. An increased I 2 uptake, noted only 24 hours 
later, was thought to be a passive result of the "iodine containing horoonal 
purge" induced by thyrotrophin, and not a direct effect at all. This was 
later confirmed by others(180, 221 ). 
Thus, if radio-iodine is given without carrier, for exuple, 24 hours 
before thyrotrophin, release of 1131 from the thyroid (as P.B.I131 ) begins 
after a few hours. This may be measured either by reduction in thyroid radio-
activity or its increase in the plasma. 
When radio-iodine is given after thyrotrophin stiuw.a.tion, increased 
trapping ability is noted in the form of increased I 131 uptake by the thyroid 
gland. This oontinues until iodine stores in the thyroid are loaded, when 
the trapping ability returns to normal. 
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Thyroid r131 uptake methods: 
Hertz and his colleagues< 120, 121 ) first showed an increased r131 
thyroid uptake following thyrotrophin, and an assay method was later 
suggested(104) and confirmed(51, 136) in hypophysectomised rats where linear 
dose responses were obtained. Others repeated thi s work using tadpoles(53), 
mice(17B) and chicks(171) as test animals. Lack of sensitivity precluded the 





) were able to concentrate serum and therefore thyrotrophic activity, 
using the Cohn method(61 ), and, by this means, were able to record. serum 
thyrotrophin levels. Endogenous thyrotrophic activity was suppressed in the 
test animal (mouse) by feeding with iodo-casein. Sensitivity of this method 
was reported as 2 mu. 
131 In vitro preparations of thyroid slices were shown to take up I 
when thyrotrophin was added to the incubating med.iui30, 47); but, though __-
used for studies in the rabbit(1+7), it was found unreliable. 
Thyroid r131 discharge - measured as depletion of thyroid iodine: 
Following the cumbersome chemical estimations of iodine discussed 
earlier, by which means a linear effect of thyrotrophin in depleting the 
thyroid of r2 was elaborated into an assay method, r
131 was used to measure 
this effect. 
Gilliland and his colleagues used t he thyroxine-treated baby chick as 
test animal 1°5, 106, 107). Activity of t he t hyroid was determined in vivo 
before and 24 hours after the second of 2 thyrotrophin injections. A drop 
in thyroid radioactivity conforming to a linear dose response relationship 
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was found between 2.5 and 40 mu. thyrotrophin. 
Bates modified the method by pretreating the chicles with propylthiou-
racil in addition to thyroxine (3B, 63). This was claimed to prevent re-
utilization of released r131 by the thyroid. However, the sensitivity of 
the method was little changed in their hands(! 2 mu . ). Others, too, have 
used this method(9G, 102). 
Thyroid r131 discharge - measured as increase in blood iodine: 
Amongst the most sensitive of recent methods have been those measuring 
r131 discharge as an increase in blood r131 in the test animals. This 
followed earlier experiments showing the appearance of r127 in the blood 
following injections of anterior pituitary extract in guinea-pigs(Go). Later, 
r127 and r131 release were coITelated (40) and used as an assay prooedure(104). 
A linear dose response relationship was obtained. 
The first workers to develop this principle into a method of sensitive 
Adam d Purv . th . . t t . 1(9, 10, 12) assay were s an es usl.Ilg e gu1nea-pig as es anima • 
Young animals were pre-treated with thyroxine, and then given carrier-free 
r131 intraperitoneally. 72 hours later, the animals' plasma r131 was shown 
to have been largely cleared by the kidneys and thyroid, and this was ad-
judged the optimum time for assay. The animals were bled initially and again 
3 hours after thyrotrophin injection. The percentage increase in plasma 
radio-activity 3 hours following thyrotrophin was the recorded response. 
Linear dose responses were obtained over a range of 0.1 to 0.6 mu. 
McKenzie (153,154) used an almost identical technique with thyroxine 
pretreated mice and improved the sensitivity to 0.025 mu., linearity in the 
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log-dose response being maintained to 1 • 6 Dll.. This method will be considered 
in greater detail in the following chapter. The great sensitivity makes it 
an admirable choice for the assay ot thyrotrophin in the plasma of man and, 
tor this reason, after slight mdifioations, it was used in this st~. 
Others have been able to repeat McKenzie's technique and confirm the reproduci-
bility of the method.(4, 162 , 227) 
In vitro preparations of guinea-pig tl\Yroid slices were used by 
Bottari and Donovan in the development of an assay based on I 131 discharge (49). 
They obtained a linear log dose response w.i. th a remarkable sensitivity 
(0.001 JDJ..) and wide range (to 10 Dll..). An extensive investigation of 
thyrotrophic activity in human serum was reported in 1960 using this method ( 48). 
Conclusions: 
A brief review of past and current methods used in the biological 
assay of thyrotrophin has been presented. Results have to be interpreted 
with great caution and, even in the best hands, are often unpredictable and 
wisatisfactory. Technique and attention to detail has to be meticulous to 
avoid discrepancies and, even then, inexplicable biological variations in 
the responses of the test animals occur. These limit the usefulness of 
biological methods; but, to date, no chemical techniques for the identi-
fication of thyrotrophin have been developed. 
Albert(19) and Segalof/192) have stressed the prerequisites for the 
ideal bio-assay. The method should be (1) specific, (2) reproducible from 
laboratory to laboratory, (3) sensitive, (4) statistically sound, (5) siuple, 
(6) rapid, and (7) objective. 
- 20 -
The application of these criteria to the DX>re sensitive assay 
techniques will be considered. 
Specificity inplies the use of an ass83' end point, the effect on 
which JDJ.St be attributable to thyrotrophin and to no other substance. Thus 
assays enploying indirect effects of' thyrotrophin are suspect, as are those 
in which other substances with similar properties are not assayed for a 
non-specific "thyrotrophic" effect in control experiments. The assay 
methods involving I 131 uptake or discharge, the histoquantitative techniques 
and the "stasis tadpole" method of D'Angelo are all clearly specific. Doubt 
has been cast on the colloid droplet method(s9, 9o), and DX>re recently-, the 
increase in P32 uptake which follows thyrotrophin, has been shown to be a 
non-specific effect of growing tissue and therefore possibly influenced also 
by non-pituitary factors ( 111 ) • The in vitro m:ithod euploying thyroid weight 
increase is also clearly non-specific; but this point has not, as yet, been 
critically e:xp+ored. 
The methods enploying P32 and I 131 have all been reproducible to 
a greater or lesser degree, though minor differences in technique are found 
in various laboratories. In some, used only by one or two groups of 
workers, reproducibility can only be assumed. The good correlation of 
results (for exanple, the normal level of tbyrotrcphin in plasma) using 
these varying methods, makes the above assunptionprobably valid. 
Sensitivity of various irethods has already been mentioned. In 
summary, however, a few techniques only are capable of demonstrating 
thyrotrophic activity in human serum, and IJl8Ili1 of these can do so only 
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in blood whioh has been treated ohemioally to concentrate or extract thyro-
trophin. While no definite evidence exists that such measures distort or 
alter thyrotrophic activity, a further source of confusion should be 
avoided in e:xperimental work alreac\Y so prone to pitfalls. 
For teyrotrophic activity to be detectable in plasma, an assay 
sensitivity of 1.0 to 2.0 mu. is essential. Only 11 different techniques 
. (71 and 74; 118, 208 and 211; 110, 134, 177, 179, 185 and221) 
f'all into this range 
(105, 106 and 107; 38 and 63; 9, 10 and 12; 153 and 154; 49) . 
In a nuni>er of these, preliminary extraction of thyrotrophin is neoessary(
118
' 
177, 179, 185) The most sensitive ass83"8 currently in use ere the stasis 
tadpole technique of D'Angelo(71, 74) (0.05 D11.), the 1131 discharge method 
of McKenzie ( 15 3 ' 154) ( 0. 025 Dll. ) and that of' Bottari ( 49 ) ( 0. 001 'm.1. ) 
One of the great ad.vantages in the use of radio-isotopes as markers 
in assays, is the great objectivity obtained - an objectivity difficult to 
claim in methods involving gravimetry and histologio assessment in its 
various forms. 
McKenzie's technique incorporating 1131 discharge trom mouse tlzyroids 
(153, 154) fulfils the criteria discussed above, and is, in addition, 
relatively sinple and statistically sound.. For these reasons it was developed 
and used as an assay prooedure for this study, and this will be considered in 
detail in the following chapter. 
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CHAPl'ER III 
Tl;\yrotrophin assay based on the discharge of radio-iodine 
from the thyroid gland of the Mouse. 
A: MATERIAIS AND Ml!.'THOOO 
Theoretical basis tor the assa.y: 
In the previous chapter, the evolution of a thyrotrophin ass83' 
dependent on I 131 discharge from the thyroid gland was discussed. 
Following thyrotrophin stim.il.ation, organically bound iodine is released 
from the thyroid. This appears to be the first and probably the mst 
specific effect of this hormone. If measured as an increase in plasma. 
i PBI 131, this occurs within hours of stim.il.ation in rats <226), mi.ce ( 1 Slt-) and 
guinea-pigs(1o), and within twenty-four hours if noted as a decrease in 
tlzyroid I 131 <129, 180, 221 ). Both paraneters roughly parallel tcyroid 
hyperplasia(129, 180, 221 ) and this seems strong evidence for a specificity 
of these end points when used to neasure teyrotrophic effect. 
The reasons for the choice of an ass83' method involving increase in 
plasma. PBI 131 have been alluded to in the previous chapter. To these may 
be added .the convenience of an early demonstrable thyrotrophic effect and 
the clear specificity of the mechanism involved, as outlined. above. 
The assay animal: 
A variety of test animals has been used in thyrotrophin ass83's. 
Earlier workers used the guinea-pig and chick. These were shown to have 
3 PBI refers to protein-bound iodine. 
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the lowest endogenous thyrotrophin secretion(1, 91, 138 ) and therefore were ,--------, 
ideally suitable for accurate estimations. However, really sensitive methods 
are not available using these animals. Conversely, large auounts of thyro-
trophin have been de100nstrated in the anterior pituitaries of rats and 
mice(1 , 91 , 138 ) and the use of these animals is precluded unless measures 
are taken to suppress endogenous thyrotrophin secretion, which would spon-
taneously release the administered radio-iodine from the thyroid and negate 
the asSSJ'• Such measures include hypophysectoD\1(51 , 1'6) and pretreatment 
with either iodo-casein(177, 178 , 179), thyroxine or dry thyroid powder(1o, 
153, 1.54) . Because of their rea.d.Y availability, inexpensiveness and the 
efficacy. of pretreatment, mice are particularly suited as test animals and 
hav~ been used in the method to be discussed. 
It has been shown in chicks that differences in strain may lead to 
large discrepancies when the same techniques are used in different, or even 
the same, laboratorie/20, 133). Similarly, sex differences may influence 
the response in chick/41 ), and mice(208). In addition, variations in 
tenperature(34, 21 7) and light(173) ma;y- influence thyroid fuootion in test --
animals. 
The state of lUltri tion may be inportant. D' Angelo (71 ) dem::>nstrated 
a low thyrotrophin level in the b1ood of starved male rats and mice, while 
the effects of goitrogenic diets in increasing anterior pituitary thyro-
trophin are well known. Finally, a seasonal variation in the functional 
activity of guinea-pig thyroid has been shown(208). 
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The existence of so many variables makes careful choice and control 
of the test animal imperative. For the assay in this study, weanling mice 
of a single strain, inbred in the animal house, University of Cape Town 
Medical School, were consistently used. They were all pretrested to suppress 
endogenous thyrotrophin. All were in the same weight range ( 13 - 19 G) ; 
were of the same sex (female) and were kept under strict basal conditions, 
at a thermostatically controlled temperature in an animal room adjoining the 
laboratory. Variations in light were reduced to a m:i,.nimum. The diet was 
consistent and mice were never starved prior to assay. 
Development of the Method: 
Pretreatment: 
The reasonable suggestion( 1o, 154) that a period on a low iodine 
intake would increas.e the avidity of the thyroid of the test animal for 
radio-iodine, and thus lead to a more significant response to injected 
thyrotrophin, was followed. All mice used in this assay were kept on 
powdered mouse-biscuit (Vereeniging Milling Co., Cape Town) of a low iodine 
content (70 p.g./kg.) and distilled water for ten days. 
Suppression of endogenous thyrotrophin secretion is imperative in 
mice. McKenzie(154) investigated the efficacy of exogenous thyroid hormone 
in this respect by means of thyroidal r131 uptake tests. He found optimal 
suppress ion of I 131 uptake with a single subcutaneous injection of 1 0 pg. 
Ir-thyroxine coupled with thyroid powder added to the food at O.O~ concen-
tration. He also investigated the maximal permissible thyroid content of 
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131 
I and fol.lll.d 2f!J• to be the critical level above which rad.ionecrosis occurred. 
He concluded that, as the I 131 uptake averaged 20)& after one week on a low iodine 
diet, a suitable iose would be 8 /JC· I 131 , which ~ould lead to a thyroid content 
of 1.6 Po• This was given intraperitoneally. It was also shown that subcutaneous 
thyroxine, given immediately after I 131, did not significantly affect the uptake. 
These recommendations were carried out in the present assay and, on the 
eleventh day of low iodine intake, 8 pc· of carrier-free I 131 in 0.2 ml. of 
normal saline (obtained from Airersham, U.K.) was injected intraperitoneally 
under light ether anaesthesia. This was followed imnediately by 10 ~· L-thyroxine 
in 0.2 ml. saline, injected subcutaneously into the dorsal neck region, and 
thyroid sicca (Burroughs-Wellcome) powder was added to the diet - 1 gr. (66 mg.) 
per 100 G. The thyroxine powder was dissolved in a small volume (! 1 ml. ) of 
0.1 NaOH, before being diluted with saline. The solution was freshly prepared () 
before each assay. 
Four days were allowed for the ad.equate excretion of I 131 not taken up 
by the thyroid. On the fifth day, the mice were considered ready for assay, 
with an optimum aJOOunt of radio-iodine in their thyroid glands and a minimum 
of circulating radioactivity. 
With this scheme of pretreatment, unsatisfactory responses to thyro-
trophin were obtained; possibly a result of inadequate suppression of en-
dogenous thyrotrophin. Accordingly, a second dose of 10 pg· L-thyroxine was 
administered subcutaneously two days after the initial injection and thyroid 
sicca was replaced by thyroxine powder B.P., which is synthetic and regarded 
as a nuch rore stable preparation. 
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On this regimen, blood radioactivity dropped to consistent levels 
and the responses to ad.ministered thyrotrophin became regular and predictable. 
Summary of pretreatment: 




Low iodine diet, including distilled water. 
8 pc. carrier-free r131 by intraperitoneal injection, 
followed by 10 pg. L.-thyroxine by subcutaneous 
injection and 0.1 mg. thyroxine.powder per 100 G. food. 
10 pg. L-thyroxine by subcutaneous injection. 
Mice ready for assay. 
This scheme was followed in all assays included in this thesis. 
Bleeding of Mice: 
0.1 ml. blood was obtained from the cavernous sinuses of the mice 
under light ether anaesthesia by means of an angled glass pipette, suitably 
graduated. (Fig. 2). 
FIGURE 2: Technique of bleeding :from cavernous sinus o:f the mouse. 
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The pipette was cleaned with normal saline and acetone and was 
primed with heparin to prevent coagulation of the aspirated blood. This 
routine was repeated after each bleeding . Aspiration from the cavernous 
sinus was achieved largely by capillarity; but more definitive control 
was obtained by attaching the pipette by snugly-fitting thick pressure 
tubing to a closed plastic cylindrical case, compressed by the jaws of a 
micrometer screw. By manipulating the screw and thus increasing or 
decreasing the column of the plastic cylinder, blood was either sucked 
into or expelled from the pipette with accurate control. (Fig. 3). 
On completion of the procedure, the eyeball resumed its place in 
its orbit and effectively sealed off :f'urther bleeding. The mice emerged 
none the worse for this experience and only very occasional deaths were 
encountered, as a result of the anaesthetic and not the bleeding procedure. 
Exactly 0.1 ml. of blood was expelled into a test tube containing 
1.9 ml. of tap water. Immediate haemolysis occurred and therefore an 
even dispersion of radioactivity was obtained. 
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Intravenous injections: 
FIGURE 3: Apparatus for bleeding 
from cavernous sinus. 
The mouse has five conveniently situated veins, accessible for intra-
venous injection, running longitudinally down the tail. Adams and Purves( 1o) 
showed that intravenously administered thyrotrophin resulted in a sensitivity 
five to ten times that of thyrotrophin given subcutaneously or intraperi-
toneally, and all substances to be tested were therefore given intravenously. 
Mice were immobilized in a perspex container and, after preliminary 
immersion of the tails in warm water, a 26 gauge needle was easily inserted 
into a dilated tail vein and the injection given slowly over two to three 
minutes. (Figs. 4 and 5). 
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FIGURE 5: Technique of intravenous injection. 
FIGURE 4: Mouse inunobilized 
in perspex cylinder. 
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Substances injected intravenously: 
Three classes of material were injected intravenously to elicit an 
1131 discharge effect:-
(i) Normal saline. 
(ii) u.s.P. Thyrotropin Reference Standard. 
(iii) The plasma or tissue hom:>genate assayed for thyrotrophic 
activity. 
Volume, nature and dilutions of injected material: 
The volune injected throughout all e:xperiments was 0.5 ml. This 
allowed an injectable range of 0.2 to 0.5 ml. plasma., essential for testing 
parallelism with standard reference substance. (See(lii) below). 
(i) Normal (0.9%) saline was the obvious choice as a control solution 
to test non.;.specific responses and haem:> dilution effect. 
(ii) U.S.P. Thyrotropin Reference Standard • was used asreferenoe 
substance. 13.5 ~· of the powdered standard is equal to 1 U.S.P. 
and International m'lit of thyrotrophin(157) and, by sinple weighing, 
standard solutions in normal saline were prepared freshly before assay. 
The dilutions were ma.de to correspond to concentrations of 0.025, 
0.05, 0.15 and 0.45 milliunits (n12.) in 0.5 ml. For the DX>St part, 
0.05, 0.15 and 0.45 were used as the three dose levels in any one 
e:xperiment; but on various occasiona, lower concentrations were 
used so that the sensitivity of the assay could be eJCplored. 
(iii) Plasma was occasionally injected undiluted, but, in the majority 
of assays, 0.3 ml. was found convenient, in which case 0.2 ml. of 
normal saline was added to make up the bulk and the necessary 0.5 ml. 
Plasma was alwe;ys freshly obtained by venipuncture on the morning of 
the assay, heparinized, separated and used within a few hours of 
bleeding. 
• Kindly donated by Armour Laboratories, Ltd. 
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Radioactive counting: 
Mouse blood I 131 was assqed in a well-type scintillation counter 
(lEHO Electronics) using a thallium-activated sodium iodide crystal (93). 
Two counters were used, but both initial and final blood sanples in each 
animal were assayed on the same counter. Counts were recorded over 300 
seconds. 
On the morning of each assay, a 3,000 second background count was 
performed. These ranged between 4--2 - 4--4 counts per second (ops.) and 
4--9 - 5.1 ops. on the two counters used. Blood radio-activity was recorded 
in cps. above background. Initial counts below 1.28 cps. above background 
were regarded as not significant and discarded, as were those over 7.36 cps. 
which fell above the statistical limits set for the range ot initial counts. 










Statistics ot Counting: 





(As rx is usually small coupared to x, the error involved in assuming 
that standard deviation = ../x , instead of the square root of the mean 
count, is usually negligible, and the "true" count is therefore x ! .Ix 
with one chance in three that these limits of error will be exceeded). 
It can be deduced trom Table I that the random error (R.E.) when 
activity between 1.28 and 7.36 cps. is counted for 300 seconds, is 2 - 5% 
at one standard deviation. 
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Measurement of the assay response: 
At a fixed tine after injection of thyrotrophin standard, saline or 
the unknown plasma, the mice were re-bled in exactly the same way as initially. 
McKenzie< 154) suggested that the imrease in blood I 131 be noted in 
two ways; (i) as an absolute increase in counts per minute /0.1 ml. blood 
over the initial oount end (ii) as a percentage imrease on initial activity, 
the latter being regarded as 100)6. He conpared the dose response relation-
ship in fourways, by plotting (i) and (ii) against the dose of thyrotrophin 
on both a logarithmic and arithnetic scale. 
Initially, both methods of measuring response were plotted; but it 
was soon fo\Dld that the percentage i:oorease in activity was D11Ch oore satis-
factory and consistent, and it was adopted as the parameter of choice, 
being plotted against the logarithm of the dose. 
Maximal thyrotrophic effect; optimal bleeding time: 
McKenzie ( 154) also reported a gradual i:oorease of eirculating plasma. 
radioactivity following intravenous (I.V.) thyrotrophin in his mice, reaching 
a maxi m1m at two hours, with a slow decline. He felt that the optimal 
bleeding time was therefore two hours after the injection. 
This was confirmed in an experiment (Figure 6.) which shows a 
levelling off of activity two hours after I.V. thyrotrophin, and this time 
was found convenient and adopted routinely for the second bleeding except in 
assays for the "long-acting teyroid stimulator" substance (See Chapter VI). 
300 
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Hours after Intravenous Injection 
FIGURE 6: The release of r131 af'ter intravenous thyrotrophin reaches a 
maxinrum at 1t to 2t hours. Each point represents the mean of 
seven assay responses. 
Specificity of r131 discharge in this assay: 
The theoretical. arguments favouring this reaction as being a highly 
specific response to thyrotrophin have al.ready been noted (page 22) • This 
supposition was put to the test and other substances were injected and 
ass ayed for possible thyrotrophin-like activity. 
(1) SaJ.ine: Physiological saline was injected in a volume of 0.5 ml. on 
184 occasions. The mean response was 87% (a drop in radioactivity occurred) 
with a standard deviation (S.D.) of 28% and a standard error (S.E.) of 2.06%. 
Thus no effect from saline was observed, confirming McKenzie's observations ( 154). 
The consistent fall is probably due to haeDX>dilution, as smaller volumes of saline 
caused a significantly smaller drop in radioactivity (see page 41 ). 
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This is not surprising, as the blood volume of a 15 - 20 G. mouse is in 
the neighbourhood. of 1.5 to 2.0 ml. This is deduced by analogy with the 
rat, in which the average blood voluue has been found to be 4.0 to 5.3 ml. 
per 100 G; the sma1ler animals having larger blood volumes relative to 
their bo<zy weight(114). At these levels, the rapid addition of 0.5 ml. could 
alter the blood voluue appreciably and lead to haemodilution. 
(2) H.ydrooortisone: McKenzie(
154) and others(227) have investigated the 
e:f"fect of stressful. handling of mice by injecting hyd.rooortisone and adrenalin, 
and reported no change in plasma radioactivity. In the present study, 0.01 mg. 
hydrocortisone hemisuccinate, diluted in saline caused a response not signi-
ficantly dif'f'erent from saline alone. (Table 2). This, and the lack of 
correlation between the "toxic" effects to mice of certain plasma sanples 
and subsequent r131 release, suggests that the effect of stress on the 
specificity of this ass83" is negligible. 
(3) Gelatin: To exclude the possibilicy of non-specific responses to 
protein material, a !j}b solution of gelatin in normal saline was injected 
into six mice. The results, again not significantly different from saline 
(Table 2) suggest that an innocuous protein will have no false-positive 
"thyrotrophic" effect. This con.firmed Wahl.berg's observations in chick/
221 ) 
and those of McKenzie in mice under similar experimental condition/
160) 
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SALINE HYDROOORTisrnE GELATJN 
92: 6 91 .± 6 94- ± 5 
T.Am,E 2: Percentage change in radioactivity two hours after ad.ministration 
of saline, 0.01 mg. hydrocortisone in saline and 5% gelatin in 
saline. Mean, ! S.E. of six responses are shown in each case. 
(4-) Pla.sma with no detectable thyrotrophic activity: In a number of plasma 
sanples no detectable thyrotrophic activity was noted, the radioactivity 
dropping to saline levels. One was from a patient with proven lzypopituitary 
function (See Chapter IX) and this is probably the strongest evidence that 
the assay method is specific in detecting teyrotrophic effect. 
(5) "Recovery" experiments: Yamazaki and his colleagues<221) added a known 
am:>unt of thyrotrophin to pooled serum from euteyroid and hyperthyroid 
patients and assayed the mixture using an alDDst identical. technique to that 
used in this study. A recovery of 115% and from 81 - 98% was noted in the 
eutlzyroid and hyperthyroid sera respectively. 
The validity of the method, therefore, seems clearly established. 
Difficulties encountered during the development of the 
Assa.y method used in this study: 
The bleeding and injection techniques used in this assay called for 
a degree of proficiency which came only after DUCh practice. In the early 
stages of this work, nuch difficulty was encountered because of this. 
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It has been reoonmend.ed ( 
154-) that both the thyroxine used in the 
pretreatment and the thyrotrophin reference standard be prepared freshly ~ 
before each assq, as denaturation of the proteins occurs in solution wi. th 
loss of effectiveness. This was confirmed in this study when a solution of 
reference standard was inadvertently used five dqs after preparation. A 
loss of potency of about 50}6 was noted. 
Occasionally, sal.ine or thyrotrophin standard was injected too 
rapidly. The mice became cyanosed and obviously ey-spnoeic and died al.m:>st 
iDIOOdiately. These effects seemed due to pulDDnary oedema following acute 
circulatory overload, though autopsies were not performed to confirm this. 
This effect was avoided coupletely when Dl)re time (one minute) was taken 
over this procedure. 
Finally, a marked ''toxic" effect of certain plasma saDples was 
encountered in some ass~s. The mice appeared well immediately f'ollowing 
the injection, but 5 - 10 minutes later became hyperexoitable, developed 
twitchings and died rapidly in a "d.ecerebrate" posture with hyperextension 
of all limbs and arching of the back. Autopsies revealed Dl)derate pulm:mary 
oedema only, and no evidence of intraoranial or other haeDl)rrhage, or a 
state of a.naphylaxis. (Autopsies were kindly performed and interpreted by 
Dr. C. Campbell, Senior Lecturer, Dept. Pathology, University of Cape Town). 
The precise mechanism remains obscure. Similar "toxicity" of' intravenously 
injected serum has been noted by Adams(S, 1
2) in guinea-pigs and MoKenzie(159) 
in mice. Adams felt that toxicity was due to haeDl)lysis and broncho-
constriction and suggested serotonin release as the cause. A possible 
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underlying genetic predisposition was also nx>0tei8). He had the iupression 
that toxicity was removed by diluting with saline and then reconcentrating 
by dialysis against a dextran-saline mixture. McKenzie(159) passed "toxic" 
serum down a short column of Sephadex G-25 ( a dextran conplex marketed by 
Pharmacia of Uppsala, Sweden) in distilled water. The effluent serum was 
found acceptable to animals. 
These measures were not found necessary in this study. Greater caution 
with intravenous injections (given over three minutes), coupled with a maJrlllllm 
voll..llle of' 0.3 ml. (with 0.2 ml. saline to conplete the required bulk) in all 
instances where reactions occurred, led to the reduction of animal. deaths to -
a mini mim. When these did occur, extra mice were utilised to bring the 
couplement up to the required number for assq purposes. The inpression was 
gained that mice appeared to tolerate plasma better, irrespective of speed 
or volune of injection, in the summer months. Strain susceptibility seems 
most unlikely as all mice used were a single inbred strain obtained from the 
Animal Laboratories, Medical School, University of Cape Town. 
Final experimental design: 
Bliss (4.4) suggests that biological assa,ys based on log-dose response 
relationships should adhere to a synmetrioal design with a group of animals 
being used for each assay point and with equal. numbers of animals in ea.oh 
group. He adds that statistical analysis is facilitated by using dose levels 
at equal log-intervals apart. 
The following e:xperimental design was therefore adhered to : -
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Groups ot six mice were used to determine each assay point. Each 
group was placed in a separate cage, distinctively lettered. In each cage, 
the mice were marked with Indian ink to enable easy individual. identification. 
In each experim!nt, six mice received saline and six received each 
of 3 dose levels of th;yrotrophin reference standard. Usually, 0.05, 0.15 
and 0.45 1111. in 0.5 ml. were injected; but, on occasions, 0.025 llll• was 
given to test the sensitivity of the assay. Thus twenty-four mice were used 
in each assay to construct a log-dose response line. As a definite end 
consistent drop was noted after saline administration, the percentage 
increase in radioactivity following the 3 dose levels of reference standard 
was plotted as a function of the saline response, which was regarded as 100%. 
All. the individual results at each dose level were collated and a 
mean log-dose response line was constructed tor the entire study. In 95% 
cit ell experiments, two or all three points corresponded closely to the 
final mean result and lay within the fiducial limits decided on ( one standard 
deviation). It many individual readings fell outside the limits, the experi-
ment was declared invalid and not used. 
In those experiments in which only two of' the three points of the 
log-dose line were acceptable, the result was still considered to be val.id 
i:t' the resultant slope corresponded to the final mean slope. The few assays 
in 11hich only one point fell into the required limits were discarded, and 
were used only to construct the final mean figure. 
~ 
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Tests for Parallelism: 
Plasma at one dose level, either o. 3 or o. 5 ml. , but always in a 
voluae of o. 5 ml. , was injected into eaoh of six mice, grouped as described. 
Three plasma sanples were injected at two dose levels into similar groups 
and the slopes were compared to those obtained with the three point line 
using standard reference substance. 




















FIGURE 7: The response to three plasma. sanples assayed at two dose levels , 
compared to a three point dose response to thyrotrophin standard. 
Each point represents the mean of six readings. Two standard 
errors are shown. 
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The results show a good degree of parallelism. The inportant question of 
parallelism between plasma and standard has been more extensively investigated 
and confirned by .McKenzie, using the same methoaC154). It was therefore 
considered that plasma had comparable tlzyro't1'9Phic effects to the standard, 
and that it would be valid to assay plasma at one dose level only. A sur-
prising degree of' consistency was noted and those sanples which produced 
marked variations in activity from mouse to mouse were not used in this study. 
The nean (± S.E.) of' plasma responses was plotted in relation to the 
standard and, by extrapolation, values were obtained in 'IIJJ../o. 3 ml. or 
'IIJJ../0.5 ml.. plasma. These values were finally eJCpressed as mu. tlzyrotrophin/ 
100 ml.. plasma. A range which included the 95% confidence limits of' the 
result was calculated in each case. 
Batches of' 54 or 60 mice were used in each assay experiment and it 
was thus possible on each occasion to assay 5 or 6 unknown samples at one dose 
level, thyrotrophin standard at three levels and a saline control. 
B RESULTS 
Dose Response Relationship: 
(1) The initial blood radioactivity: 
The m,an of the initial blood radioactivity in all experiments 
included in this stu~ was f'ound to be 3.61 cps. above background, with a 
S.D. of' 1.80 cps and S.E. of' 0.048 cps. This was based on a total of 
1,381 observations. In order to reduce marked fluctuations, and exclude 
the occasional count which differed greatly f'rom the mean, those more than 
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2 S.D. on either side of the nean were discarded. This limit however would 
include counts in the lower range statistically insignificant above back-
ground. Final limits of 1.25 S.D. below the mean to 2 S.D. above, were used, _,-
and counts which .fall outside this range were discarded. 
(2) Saline responses: 
Initially responses following the injection of 0.2 ml. saline intra-
venously were calculated. 35 such responses were obtained, with a mean 
result of 96% (that is, a slight drop in radioactivity) and S.D. of ~, 
S.E. of 3.3%. This matches McKenzie's findings closely(154-). 
During subsequent assays, volumes of plasma up to 0.5 ml. were 
injected, and control volumes of saline were correspondingly increased. 
Following 0.5 ml. saline, a decrease in radioactivity to 87% was noted 
(S.D. 28.0'}&, S.E. 2.06%) for 184 observations. This is significantly lower 
than the result following 0.2 ml. (t = 2.308; 0.05 < p < 0.02) and must 
be attributed to a haemodilution effect associated with the rapid injection 
of a large quantity of fluid relative to the very small blood volume. 
All readings resulting from injection volumes of O. 5 ml.. were then 
corrected for the haemodilution factor by expressing them as a function of 
the saline response, where such a response was regarded as 100)&. 
M::Kenzie(152, 153, 154-) makes no nention of the effects of haemo-
dilution. He uses volumes ranging from 0.2 to 0.5 ml., and it is not clear 
whether he keeps these volumes constant for SIJY one experiment. Comparison 
of responses is not val.Dl when they result from different volwnes of injected 
material. 
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( 3) Responses to thyrotrophin reference standard: 
The responses to doses of thyrotrophin ranging from 0. 025 to 0.45 mu. a.re 
tabulated below. The bulk of the assays were done at 0.05, 0.15, 0 . 45 mu. 
dose levels. 
DOSE LEVEL ( IIJ.lo) No. observations + MEAN - S.E. 
Saline 184 100 :t 2. 06 
0.025 28 122 :t 6.2 
0.05 161 + 151 - 5.5 
0.15 133 227 :t 7.8 
0.45 135 + 280 - 9.9 
From these results, the following overall response line, plotted against the 
loga.ri thm of the dose, was derived. 
300 
250 






0 -025 0 -05 0 ·15 0-45 
Thy rotrophin Standard (mu ) 
FIGURE 8: Thyroidal I 131 release expressed as a linear repponse to 
the logari thrn of graded doses of thyrotrophin. 
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A clear linearity in response is denxmstrated. The correct regression line / 
was determined by the method of ''least squares". 
Precision of the Assay: 
Using the method described by Gaddum(103), both McKenzie(154) and 
Yama.zaki(227) have investigated fully the average index of precision of a 
virtually identical assay to that used in this study. As their results 
matched alJOOst exactly, the preision of this technique seemed established 
and it was not considered necessary to repeat their v.ork. 
Sensitivity and Range of the Assay: 
A highly sie'J].ificant increase in radioactivity was noted at a dose 
level of thyrotrophin of 0.025 IID.l. ( t= 3.4 p < 0.01). As the amunt of 
human plasma injected ranged from o. 3 to O. 5 ml. ( the total volume was always 
made up to 0.5 ml.), thyrotrophin levels of 0.05 to 0.10 m.i./ml. are detec-
table using this assa,y. 
No more than two plasma sanples assayed in this study elicited 
thyrotrophic activity in excess of 0.45 mu., so that linearity was not 
explored beyond this limit. McKenzie has, however, reported linearity of 
rel:i>onse to 1.6 IID.l. using an identical method( 154) 
Although responses greatly in excess of these were obtained from 
plasma with L.A.T.S. activity, these results are not directly conparable 




An assay teclmique, outlined in some detail, has been used for the 
bio-assq of thyrotrophin in human plasma. It 111JSt be stressed, however, 
that what in fact has been assayed and called tlzyrotrophin, is merely a 
substance which discharges I 131 from the tlzyroid gland two hours after 
injection. Though this is probably the mst important parameter of thyro-
trophin tunction, other types of thyrotrophin may be active, and antihormnes 
or antagonists may block this action . and negate a particular assay. What 
is being measured, then, is the sum of positive and negative effects -
effects better termed thyrotrophin-like activity. All results must be 
interpreted in this light. 
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CHAPrER IV 
Exophthalm:>s Producing Substance (E.P.S.) : 
Its nature and biological assq. 
Exophthalm:>s producing substance of the anterior pituitary: 
In 1931, exophthalm:,s was induced in duoks(191 ) and guinea-pigs(BO, 
141 , 146, 147) by the administration of anterior pituitary extracts. 
Histologic evidence of associated thyroid }zyperplasia was noted(
191 ) and a 
pituitary thyrotrophic factor was incriminated as the causal agent of both 
effects. This concept gained further support when thyroidectoll\Y' was found 
to enhance the exophthalm:,s producing effects of anterior pituitery extracts 
in guinea-pigs(BO, 146, 147, 196), by a presumed disturbance in pituitary-
teyroid balance and resultant increase in th,yrotrophin secretion. Thyroid('c-
toll\Y alone was reported to have caused exophthalm:>s in rabbits<
108), 
a puppy(108), foxes< 22o) and guinea-pigs(7S), while Dobyns made serial 
examinations of eye protrusion in 233 patients before and after thyroidectOJllY' 
and noted an increase in prominence in 9.5% of cases(7B). Finally, when 
anterior pituitery extracts richest in thyrotrophin were found to contain 
m:,st exophthalm:>s producing activity(16, ·17, 18, SO, 167), the single 
identity of th,yrotrophin and the exophthal.Joos producing factor seemed certain. 
This view, however, could not account for the rerity of exophthalms 
in spontaneous myxoedema, where lerge amounts of circul.ating t}zyrotrophin 
would be expected. Subsequently, Jef'teries, using a ioore refined method of 
measurement, failed to confirm the exophthal.Joos stim.llating effect of 
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thyroidectont1 alone, or following anterior pituitary extract in guinea-
pigs ( 125). Patients suff'ering from acromegaly and Jl\YX()ed.ema, in whose blood 
a high level of thyrotrophin had been assayed, showed no clinical evidence 
of exophthalmos ( 75). Conversely, the serum of only two out of eleven 
severely exophthalmic patients contained an increased thyrotrophin level ( 75' 
107) 
• Recently, McGill found no exophthalmos producing substance (E.P.S.) 
in the serum of three patients after thyroidectont1 for hyperthyroidism and 
three cases of JJO'Xoedema, where high levels of thyrotrophin are usually 
present ( 15°) • 
Jefferies, by iodination at pH 4,.2, was able to destroy thyrotrophic 
activity and retain the exophthalmic factor in anterior pituitary extracts(
126\ 
while Dobyns and Steelman noticed that some com:nercial thyrotrophin pre-
parations had marked thyrotrophic and little exophthalm:>s producing activity 
when each substance was separately assayed ( B4) • The discrepancy was brought 
out by the differing solubility of these two factors in 8% trichloracetic 
acid, the exophthalmio factor being precipitated. Bl'\ll'lish showed that the 
activity of thyrotrophic pituitary extracts decreased to between one fifth 
and one tenth of the original after peptic digestion, whereas the exoph- -
thalJOOS producing activity remained (54.). Bates and Condli:ffe recently assayed 
both thyrotrophin and exophthalmst producing substance (E.P.S.) in trans-
plantable thyrotrophin producing tumours in mice and found enormous levels 
of thyrotrophin (1,500 Dl.l./~.) but no exophthalmos producing factor, even 
after the administration of 4.,500 Dl.1. to the test animal. (36, 37) When 
-
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they ran tumour extracts through a carboJcymethylcellulose column at pH 6, 
E.P.S. was found in the unadsorbed fraction, whereas thyrotrophin was 
adsorbed en the column ( 37). 
Unequivoca1 evidence of' the separate identity of thyrotrophin and 
a :f'actor possibly responsible for exophthalmos, therefore exists. 
The nature of the exophtha1mos producing substance: 
McGill, with f'ish as test animals, assayed exophthal.mos producing 
activity in serum under a variety of e:xperimenta1 conditions(
150). He noted 
that if serum was filtered through a collddion meni>rane, no E.P.S. was 
present in the protein-tree filtrate, but a1l occurred in the protein-rich 
material. He concluded that E.P.s. has a protein structure, like a1l 
hormones. Its presence in anterior pituitary extracts has been mentioned 
and it has not been detected in sera of persons with b;ypopituitary tunotion(150). 
E.P.S. levels a1so dropped sharply in a patient with severe exophtha1mos, 
following anterior pituitary irradiation(1SO). Therefore, the anterior 
pituitary appears to be the site of' origin of this hormone. 
E.P.S. is rapidly destroyed when plasma is stored at 37°0. but at 
4 °c. potency is relatively stable ( 15°) and at -22°0. ~kedly so ( 86 ). Others 
have noted a maintainance of potency for about a week at room teuperature(SS). 
The action of E.P.S. 
The action of' E.P.S. is widespread, affecting tissues throughout 
the body. Smelser first demonstrated the orbita1 f'ibro-f'atty oedematous 
int'il tration in exophthalmos ( 198 ' 199' 201 ) • Albert confi:nned the presence 
-
- 48 -
of orbital lynphocyte-laden fat, infiltrating and stretohing the local 
muscles(1B). He noted a curious gel-like substance in addition and assqed -----
E.P.S. from this fluid, and also showed that exophthalmos was purely the 
mechanical effect of accumulation of material in the retrobulbar area. 
SympathectoJey" and bypopbyseotoley' had no effect. Dobyns indicated the more 
generalized nature of the fatty disturbance following anterior pituitary 
injections in animals, demonstrating fatty, polyioorphonuolear and round-cell 
infiltration in skeletal' and cardiac muscle, connective tissue, liver and 
kidney(79). An increase in plasma fat and acetone was mentioned and cir-
ow.ating leucocytes were foum. to contain fat globules ( 81 ) • These findings 
. (~) 
were later conf'irmed by others • They showed an inorease in ma.st cells 
and also demonstrated a replacement of' the retrobulbar fatty infiltration by 
a muoo-polysaccharide. The presence of mast cells was related to cyaluronic 
acid production. 
Following current understanding, it appears that in patients who 
are clinically exophthalmic, an exophthalmos producing substance is secreted 
by the anterior pituitary. This mq only be one of several horm:mes secreted 
in excess in this state. E.P.S. appears to cause a disturbance of fat 
metabolism with generalized. f'ibro-f'atty infiltration. This process then 
localizes in the orbit far obscure reasons, but can occur elsewhere, as in 
''pretibial JJO'XOedema". A muoo-polysaccharide replacement of the local fibro-
f atty change then ensues, and exophthal.m:>s develops for mechanical reasons. 
ACTH and cortisone Jn83 have an enhancing effect on this process (2B, 57). 
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The biological assay of E.P.S. 
The assay methods fall into two groups:-
(i) Those using direct measurement of ocular protrusion in test animals, 
following injection of material with exophthalmos producing activity. 
(ii) That based on the sensitivity of the Harderian gland to the exophthalmos 
producing substance. 
(i) Assays based on measurement of ocular protrusion: 
The experimental production of exophthalmos in test animals has 
already been discussed. For assay purposes, guinea-pigs were preferred by 
earlier workers because of their ease of handling and ready availability(7S, 
80, 125, 201) Albert reported exophthalmos in the Atlantic Minnow 
(Fundulus heteroclitus, Linn.) following the intracoelomic injection of 
anterior pituitary extracts(1s). He used twenty fish to assay each dose 
level of pituitary extract and measured the percentage of fish at each dose 
level which developed "significant'' exophthalmos at six hours ( the time of 
maxirnal response). He was able to construct a dose response curve by this 
means and detected exophthalm:>s prodwing activity in as little as 12.5 mg. 
equivalents of anterior pituitary. He also noted that the degree of exoph-
thalm:>s in individual fish increased directly with the n.uui>er of positive ....-
results. He finally defined a unit of e:xophthalmic activity as that 8Jll0unt 
of a substance causing exophthalIOOS in 2.5% of fish, six hours e:fter intra- _.-
peri toneeJ. injection. Fish were chosen as a suitable test animal because 
the lateral position of their eyes enabled the measurement of intercorneal 
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distance, rather than that of each eye, to be used as a criterion of exoph-
thalmos. Subsequent to these experiments, fish have been exclusively used 
for the bioassS3" of E.P.s.(54, 57, 84-, 85, 86, 130, 150) 
The method was inproved by Dobyns and his associates who, for the 
first tine, demonstrated exophthal.Jros producing activity in the sera of 
patients with progressive exophthalmos(B4, B5). They al.so used Fundulus 
as test animals in groups of eight to twelve to assess responses at each 
dose +evel. An elaborate apparatus with a veznier slide rule allowed .--
intercorneal distance to be measured in duplicate to 0.1 mn. A 3% error 
was noted. 0.25 ml.. material, often repeated twice, was injected into the 
coelomic cavity via the cloaca. Percentage increase in the intercorneal 
distance (I.C.D.) over saline controls was used as an imex of exophthalmos 
producing activity. A meximal effect was noted within two d83's following 
anterior pituitary extracts and seven d83's after the injection of serum 
from exophthalmic patients. They therefore correlated E. P. S. with quanti-
tative• measurement of I.C. distance, rather than with a percentage of fish 
show.i.ng a significant response, as had Albert. However, they reported then, 
and since, a considerable variation in the responses of' individual fish to 
a single dose level, so that an accurate dose response line could not be 
produced. Nevertheless, an acceptable dose response trend was shown(B6) 
Canad.ell and Barraquer confirmed the exophthalmos producing capacity 
of sera from patients with endocrine exophthalmos, using gold:f'ish (Carassius _____.. 
a.uratus)(.56), while mre recently, MoGi11(
150) and der Kinderen and his 
co-workers(130) used a virtually identical assS3" technique with Shubunkins 
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(Carassius auratus, Linn.) and carp respectively. Both obtained linear log-
dose responses and the latter workers demnstrated parallelism between the 
saline pituitary extract responses and those of human serum. This has not 
been repeated by others. Brunish, using the same method in Fundulus, produced 
a curved dose response line(54). 
Maximal exophthaJ.mic effect; optimal time for measurement: 
The time of maximal exophthalmic effect in response to saline extracts 
ot beef anterior pituitary and serum has varied considerably in the hands of 
various workers. In the minnow, pituitary extract was found to cause maximal 
exophthalmos at 4 - 24 hours depending on the dose ( 18' 86 ) ; in the carp this 
was noted at 48 hours(130), and in a variety of goldfish at 18 hours(150). 
Following the injection of human serum, maximal exophthalmos was 
present at 4 - 10 d.a3"s in the minn.ow(B6), 72 hours in the carp(1JO), and at 
3 hours in the goldfish ( 150) • Dobyns coDlllellted on the prolonged length of 
time ocular protrusion persisted ( 85) , while McGill found it to return to 
normal in 24 hours(150). A mixture of anterior pituitary extract and serum 
retarded the effect slightly in the carp, although it was still maximal at 
72 hours(1JO); while a 3 hour peak was reported in goldfish(150). The 
differences appear to relate to the species of fish used, and claims for the 
presence of a serum accelerator substance ( 15°) or a serum factor inhibiting ,_...-
E. P. S. (S5) have no real validity. 
Specificity: 
The question of the specificity of exophthalmos as an ind.ex of E.P.S. 
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activity has to be answered. Albert, in his original. investigations, tested 
various endocrine extracts, including sheep pituitary extracts in various 
degrees of purification, in the minnow(
1B). Exophthalmos producing activity 
was found only in those extracts rieh in thyrotrophin. Subsequently, Dobyns 
and Steelman confirmed these findings, but reported a great fluctuation in 
E.P.S. activity in thyrotrophin extracts, related to the use of trichlor-
acetic acid in the preparation thereof ( 84). They were then able to separate 
E.P.S. and thyrotrophin by their differential solubility in trichloracetic 
acid, and sh~d them to be different substances, even though often present 
in the same extract and possibly related. It would thus appear that other 
hornxmal substances, including purified thyrotrophin, dQ not cause protrusion 
in test fish, and that this response is specific to an unknown exophthalmos 
producing factor. Aterman has claimed that cortisone alone will precipitate 
exophthalmos in rats(29), and will increase exophthalmos induced by thyro-
trophin in guinea-pigs ( 28). This effect was not noted however, when a group 
of eight rats was given cortisone 1.5 mg. a day subcutaneously for 4 - 6 
weeks in this laboratory. 
As pooled(SS, 86) and individualsera(130, 150) from normal persons 
have general.l.y failed to elicit a significant proptotic response, a non-
specific action of' serum proteins in this respect may be ruled out. This 
was confirmed in this study. (See Chapter VII). 
]urther evidence supporting specificity of the reaction may be drawn 
from the correlation between proptotic responses of fish to serum from 
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patients suffering from exophthalmos, and. the degree and progression of the 
disease in those patients(BG, 130, 15°). 
ponse 
Normal saline injections have tailed to elicit an exophthalmic res-
in fish(B5, 150), although recently a slight increase in I.C.D. over 
tour days in the minnow has been reported(BG). Hypotonic saline has led to 
weight gain, but no exophthalioos ( 150). This confirms that the pathogenesis 
is not related to siuple fluid retention and weight gain, but to the more 
specific effect of an injected hormone. 
It ma,y be concluded, therefore, that the increase in ocular protrusion 
in goldfish following injections of serum or anterior pituitary extract, is 
a specific effect of a substance associated with, if not partly responsible 
for, clinical exophthalmos, and this may be used as a valid method of bio-
logical assay for this substance 
The various assay methods differ in minor technicalities which include 
the volume of injected material, number of injections, the standard preparation, 
method of measuring I.C.D., optimum time for such measurement and species of 
fish used. This fact precludes strict oouparison of results which, in addition, 
is made difficult by the crudeness of the methods, poor sensitivity, lack of 
uniformity of response and inability to apply statistical analyses to the 
results. Finally, as no reference standard of E.P.S. activity exists, either 
for saline pituitary extracts or serum (which appears to behave differently), 
quantitative estimations are not possible. 
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The limitations of such results must be clearly recognised. The 
assey does, however, serve as a crude ind.ex of exophthalmos producing activity 
and has been shown to correlate fairly well with the degree and clinical 
course of exophthalmos(BG, 130, 150). 
With mi.nor modifications, this technique haa been adopted in this study. 
(ii) Assay based on Harderian gland sensitivity: 
This assay is currently being investigated, but has not yet been 
applied to the detection of exophthal.mos producing activity in serum. 
Early investigators noted an increase in weight of the Harderian 
gland in experimental. animals after the administration of anterior pituitary 
extract rich in tbyrotrophin(170, 200). It was al.so claimed that tbyroidec-
toey al.one caused eypertrophy of this gland in the guinea-pig and that this 
prooedure enhanced the lzy:pertrophy induced by anterior pituitary extract/
200). 
A recent report showed that thyrotrophic pituitary preparations 
significantly increased the uptake of 335 la.belled sulphate by the Harderian 
gland and retrobulbar connective tissue within 24 hours of' hormonal stimu-
lation ( 135). 335 autoradiography of the Harderian and v:en~al lachrymal 
glands has shown the radioactivity to be in the parenchymal cells of both 
glands but in the secretions of the latter glands onJ.y( 222). 
Following this "WOrk, Wegelius and his colleagues developed an assay 
method for the detection of "ophthalnx:>trophic" activity in thyrotrophin 
preparations< 223). Using guinea-pigs, they inject_ed varying doses of thyro-
trophin and saline controls sillll1.taneously with 150 pc.s35-labelled N82 so4 
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and carrier. 24 hours later, the animals were sacrificed, the Harderian and 
ventral lachrymal glands dissected out, weighed, ashed and finally counted in 
an end-wind.ow Geiger-Milller tube. Radioactivity was expressed as counts per 
minute per 100 mg. wet weight for Harderian gland, and as counts per minute 
per mg. wet weight for ventral lachrymal gland. Data were statistically 
analysed (but no details were included in the paper) by the analysis of 
variance technique. An increase in s35 uptake was noted following thyrotrophin. 
That · this effect was due to E.P.S. was suggested by its enhancement following 
peptic digestion of the pituitary extract, which has been shown to destroy 
thyrotrophin but has no effect on E.P.s.(54-). 
This assay has detected E.P.S. in 3.0 mg. and 5.0 mg. thyrotrophin (1.62 and 
2. 7 U.S.P. units); but no details of dose response and range are available. 
The sensitivity is probably less than the bioassay using fish and, until it 
is carefully investigated as regards specificity and dose responsiveness, 
DI.1st remain an interesting experimental observation. only. 
Conclusions: 
That the present concepts regarding the aetiology and nature of 
endocrine exophthalmos are somewhat vague, and often contradictory, is to an 
extent due to a lack of a suitable assay ror the detection of exophtha1100s 
producing substance or substances in human serum. Such methods as are 
available have been discussed. Great caution JillSt be exercised in the inter-
pretation of the results of these methods which are lacking in many of the 
f"IUldamenta1 prerequisites for a valid biologica1 assay. At the most, only 
- 56 -
a crude assessment of E.P.S. activity can be made, and attenpts to quantitate 
such levels are inpossible because of the difficulties mentioned and the la.ck 
of a reference standard. 
The only available assay relies on the estimation of proptosis in 
fish following the ad:m:injstration of the test substances. An alternative 
technique., based on the effects of E.P.S. on the s35 uptake by the Hard.erian 
gland, is as yet experimental. 
As a crude but definite correlation has been found between the 
clinieal degree and progression of exopbthalms and the "level" of E.P.S. 
as defined in this chapter and as assayed in fish, this technique was used 
for such estimations in this study. 
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OHAPrER V 
Assay of E.P.S. based on the increase in intercorneal distance 
of the goldfish (Carassius auratus). 
A: MATERIALS AND METHODS 
The Assay Animal: 
Species: The Atlantic Minnow (Fundulus) has been used by .An:erican workers 
in this f'iel.d( 181 54-, 84, 85, 86) but marked seasonal fluctuations have been 
reported with this species ( 86) • Better responses were obtained during the 
winter m:mths, as opposed to the responses of the carp ( 130) and goldfish ( 150), 
where a m:>re consistent result was noted throughout the year. In addition, 
gol.dfish did not become refractory to E.P.S. :following repeated assays(150). 
For these reasons, and because of their inexpensiveness and availability, 
goldfish were used as the test animal in this stuiy. 
Batches of 50 - 100 :fish were periodically procured from the Jonkers-
hoek Hatcheries. The weight was kept as constant as possible and fish between 
4,. 0 and 8. 0 G. only were used. 
Care: As susceptibility to exophthalros has been shown to vary directly with 
the environmental teuperature ( 15°), this was kept constant at 25°0. by means 
of theroostaticall.y controlled electric heaters. Fish were kept in batohes 
of' 40 in three large glass storage tanks(! 20 gall.on capacity), adeq1l!,tely 
aerated by m:>tor punp. On the day of ea.ch experiment, groups of six fish 
were transferred to each of' seven glass assay tanks, 25 cm. in diameter, where 
they remained until the assay was coilpleted. 
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In the earlier experiments, fish could be individually identified by 
means of coloured cottons threaded through the oouth, or by their natural 
markings. Later this was not pursued. 
The diet was constant throughout the study, a locally manufactured 
goldfish food being used with the occasional addition of live daphnia. The 
:f'ish were starved for eighteen hours before each assay. 
Fish were handled only during injecting and then, in thoroughly wet 
hands. They were c8llght in a small fish net and otherwise manipulated by a 
specially constructed perspex holder with sponge-rubber lining. Care was 
thus taken to avoid the introduction of superficial fungal infection, an 
inportant cause of fish oorbidity. 
The anaesthetic: 
Adequate anaesthesia, essential for the required manipulations, was 
accouplished by the imDersion of_ the fish in a 1 : 3,500 solution of MS 222 
SANDOZ(x), an isomer of benzocaine. No adverse effects have been reported 
in this concentration. 
Fish became anaesthetised in two to three minutes and remained so 
from two to ten minutes, during which time, the necessary procedures were 
carried out. Morbidity attributable to the anaesthetic was low. 
Measurement of the intercorneal distance: 
The anaesthetised fish were steadied in a perspex holder and inter-
corneal distance was measured by two independent observers using a micrometer 
screw. The head of the fish was placed between the limbs of the apparatus 
(x) MS 222 - Information bulletin, published by Sandoz, Ltd., Basle, 
Switzerland. 
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which were carefully screwed together until each just touched the laterally 
placed cornea.e, without damaging them in any way. (Figure 9). Readings to 
the nearest 1/1000 inch (0.025 mm.) were possible and the two observers were 
found to correlate with a great degree of accuracy, usually to within 3/1000 
to 5/1000 inch ( 0.1 to 0.15 mm.) The mean of the two observed readings 
was taken as the intercorneal distance (I.C.D.). This very sinple procedure 
was found to be eminently satisfactory. As the usual I.C.D. was about 
0.450 inch, an error of about 1% was present. The use of duplicate readings 
greatly increased the objectivity of the technique. 
FIGURE 9: Measurement of intercorneal. distance. 
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Injecting the substances to be assayed: 
Technique: A 26 gauge needle attached to a tuberculin syringe was inserted 
into the cloaca. The barrel of the syringe was swung caudally and the needle 
pushed forward 5 nm. to pierce the gut and enter the coelomic cavity into 
which the contents were injected. During the procedure, which took about 
30 seconds, the anaesthetised fish was held in the wet hand, the ventral 
aspect facing the injector. 
FIGURE 10: Technique of intracoelomic injection. 
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The volume of any material injected was 0.5 ml. Fish varied a great 
deal in their tolerance to such a volume and, on occasions, when the injec-
tions were more hurried, a considerable mortality was noted about 48 - 72 hours 
afterwards. Injections were therefore perfor~d very slowly in the smaller 
fish. McGill, using a radioactive tracer, has shown that excellent retention 
of the injected material occurs using this technique ( 150). When this is not 
retained, the leak is quite obvious. 
Nature of injected substances: Fish were divided into groups of six. In 
each e:xperinent, a group received (i) physiological. saline as a control, 
(ii) "Thytropar" (x), a beef anterior pituitary extract rich in E.P.S. in 
a fixed dose of 0.2 u. thyrotrophin, or 50 mg. equivalents of beef anterior 
pituitary and (iii) the "unknown" undiluted plasma or tissue hom:>genate 
assayed. Up to seven groups of fish were used in any one experinent, in 
which the assay of five unknown substances was therefore possible. A:fter 
each experinent, the fish were not used again for two weeks. 
Solutions of "Thytropar" were made, just prior to assay, in normal 
saline. 0 Plasma or hoIIDgenates were stored at -15 C. for up to two months 
before assay, al.though the majority of estimations were done within four 
weeks of storage. This lengthy storage does not affect assay results, as 
0 Dobyns has shown that E.P.S. does not lose its potency when stored at -22 C. 
for up to twenty month/BG), and at room teuperature for up to one week(B5). 
McGill confirmed the relative stability at 4°c., but reported rapid decay 
over 24, hours at 37°c.(150) 
(x) Thyrotrophin "Anoour". 
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Measurement of the assay response: 
I.C.D. was measured before and at an optimal tine after the injection. 
The percentage increase was then calculated individually for each fish and 
the mean of the six results in each group was taken as the overall response 
to each substance injected. In later experiments, the intercorneal distances 
were measured for each group, without special note being made of the individual 
increases of each fish, as it becane clear that great fluctuations within a 
group prevented aizy" great statistical accuracy. Therefore, the assay response 
to each injected substance was the mean I.C.D. following intracoelomic 
injection of that substance into six fish. 
FIGURE 11: ExophthaJ.mos in goldfish following the injection 
of plasma from an exophthalmic subject. A fish 
injected wi. th saline serves as a control. 
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Maximal exophthalmi.c effect: Optimal time for ireasurement: 
The tremendous variability reported in the time responses to the 
various materials injected has been discussed. These JIil.St be attributed 
to differences in species and the relationships were therefore investigated 
in this study. 
(i) Anterior pituitary extract: "Thytropar", 1 unit (2.50 mg. equivalent 
anterior pituitary) was injected into the coelomic cavities of 
twelve goldfish. The result (Figure 12) confirms McGill's obser-
vations ( 150). A maximal response was noted between 3 and 21 hours 
while at 27 hours, the response was declining. 
°lo lncrQOSQ 
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FIGURE 12: Time relationships in the exophthalmic responses to two 
doses of "Thytropar". Each point represents the mean of 
six responses. 
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In addition, the responses appeared to vary according to the injected 
dose, those in the lower dose range declining more rapidly. This confirms 
Dobyns' statement that the peak of response to anterior pituitary extracts 
occurs later and is sustained longer if the dose level is increased(BG). 
(ii) Plasma: 0.5 ml.. undiluted plasma was administered in a single injec-
tion, to each of six :f'ish. Three typical results are shown below. 
A peak effect at three hours was found wi. th every plasma in which 
E.P.S. was assayed, confirming McGill's report with the same species 
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FIGURE 13: Time relationships in the exophthalmic responses to 
three plasma. sa.nples. Each point represents the mean 
of six responses. 
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For convenience, the 2 hour reading was chosen as optimal for both 
· the plasma and the anterior pituitary extract used as a standard. This 
represents the time of peak response to plasma and, probably, the near-peak 
response to the standard extract in the dose used in this study. 
Difficulties encountered during the development of the technique: 
The method is technically very sinple. No difficulties were encoun-
tered with the intracoelomic injections and the excellent correlation between 
the independent observations of the I.C.D. has been mentioned. The mrbidity 
im:ned.iately following the procedures was usually very slight. 
Intermittently, a heavy mortality was noted. Two "epidemics" of an 
unknown infection occurred and these spread rapidly to all three storage 
tanks with a heavy toll. The causal agent was never discovered; autopsies 
proving non-informative with no obvious fungal infection present. On rare 
occasions, up to one-third of fish used in a particular experiment would 
succuni> 48 to 72 hours later. This mrtality seemed to be related to the 
speed of, and the care taken over, the injections. Any trauma or bleeding 
related to this procedure was badly tolerated. 
Final experimental design: 
As no accurate quantitation of E.P.S. activity was possible, a dose 
response line was not attenpted in every assay. Once a reasonable dose 
.response relationship had been established, a single dose level of the 
standard was used for conparison in each assay. Groups of fish, of equal 
number ( 44), were used for each unknown or standard. 
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In swmar,y, the :following experimental design was followed:-
Groups o:f six fish were used. Each group was kept in a separate 
tank and in the earlier eJq>erimsnts fish were individually ~ked. 
In each experinent, one group received 0~5 ml. normal saline, one, 
50 mg. equivalent of' beef anterior pituitary (0.2 u. "Thytropar") in 0.5 ml.. 
saline and the remaining two to five groups received 0.5 ml. of the 
undiluted plasma. or tissue homgenate to be assayed, so that a total of 
24 to 42 fish were used. 
At the beginning of the study, the contents of ten vials of' "Thytropar" 
were pooled and used as a standard throughout. "Thytropar", in common with 
every other known E.P.S.-rich pituitary extract, has not been standardized 
f'or this substance. It was felt that a comoon ~ool" of the standard 
powder would minimize possible unknown fluctuations occurring from batch to 
batch and provide a degree of consistency in the level of E.P.S. used as a 
standard f'or conparison. 
The I.C.D. was measured in each fish before and 3 hours after each 
preparation injected and the mean of the six readings on each group was 
calculated and used to find the increase in I.C.D. The responses to saline 
were subtracted from those following the anterior pituitary standard and 
the unknown substances to provide an absolute value. The three hour response 
following the unknown was then expressed as a percentage of that response 
following the standard - thus, mean increase I.C.D. (unknown) X 100 
mean increase I.C.D. (standard) 
An atte:npt at standardization was therefore ma.de to emmter possible seasonal 
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and. other fluctuations. Dobyns has recently published a similar scheme of 
expressing resul.ts(S6). 
A crude system of quanti tation was adopted, the responses being 
graded as follows:-
0 . No increase in I.C.D. . 
+ . Increase in I.C.D • 0-25% of standard . 
+ . Increase in I.C.D • 25-5o% of standard . 
++ . " II " 50-100'fa " " . 
+++ . " II " 100-200% " It . 
++++ . " II It over 200% " " . 
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B: RESULTS: 
( 1 ) The basal intercorneal distance: The man of all the measurements of 
basal I.C.D. used in this study was 0.452 inch with a standard deviation 
of 0.020 inch. 500 measurements were used to coupile these figures. 
As the range of these basal readings is narrow, it was not found neces-
sar.r to discard any. 
(2) The saline response: A total of 140 fish received 0.5 ml. normal 
saline, six in each experiment. A three hour increase in I.C.D. of 
1.45% was noted (s.D. o. 71%; S.E. o.06%). On occasions when the 
fish were found to be exceptional.ly responsive, increases as much as 
3.l$ and 3.6% were recorded. During these experiments, this responsive-
ness was mirrored by a correspondingly larger increase in response to 
the anterior pituitary standard. 
(3) Response to anterior pituitary standard: An arbitrary fixed dose of' 
50 mg. equivalent of ~ef' anterior pi tui ta.ry was used as a standard in 
each experinent. A mean response of' 6.5% increase in I.C.D. was found 
in 20 experiments (S.D. 1.9%; S.E. 0.40)&). This represents a f'air 
degree of consistency, but occasional unpredictable fluctuations 
occurred, which did not appear to be a seasonal effect, although this 
has been reported ( 86) • 
(4) Dose response relationship: Three groups of six fish were injected with 
"Thytropar", in doses of 125, 250 and 375 mg. equivalents of been anterior 
















FIGURE 14: Increase in I.C.D. as a function of the log-dose of "Thytropar" 
standard. Ea.ch point represents the mean and standard error in 
six fish. I.C.D. was measured at three hours. 
At the time this experiment was recorded, the fish were 
passing through a phase of very poor responsiveness and the 
readings are much lower than those usually obtained. Note the 
very large standard error of the response to 250 mg. equivalent 
of an anterior pituitary which nust cast some doubt on the 
validity of the line. Dobyns had similar difficulty in ob-
taining good linearity of the log-dose responses; although, 
as in this study, an undoubted dose response trend was 
apparent(B6). 
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Sensitivity and range ot the Assay: · 
As no fixed assay technique exists for the estimation of E.P.S. 
activity, sensitivity cannot be conpared to that noted by other workers. 
In addition, there appeared to be fluctuations in the responsiveness of 
the fish tor reasons at present obscure. Seasonal tactors could not be 
incriminated. 
During periods when the fish were reacting well, as little as 25 mg. 
equivalent of beef anterior pituitary caused a three hour increase in I.C.D. 
ot 4.8)& over saline (S.D. 1.2%j S.E. 0.5%). This response is highly 
significant ( t = 6. 2264 p < o. 01). 
The upper limits of responsiveness were not explored as plasma 
sanples with such gross E.P.S. activity were not found. 
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CHAPTER VI 
The Long Acting Thyroid Stimil.ator - Its Nature and Assa:y. 
The nature of' the long-acting thyroid stiIIlll.ator: 
In 1956, Adams noted abnormal responses in his guinea-pig thyrotrophin 
assey while testing various human sera for thyrotrophic activity(3, 11 ). 
Instead of the. usual maxima] discharge of I 131 three hours following thyro-
trophin injection, . a peak was found sixteen hours after injection in certain 
cases of hyperthyroidism. This abnormal thyrotrophic response was confirmed 
in a similar assay using mice as test ani ma] s, when the usual two hour peak 
was displaced to seven to twelve hours after thyrotrophin administration(l+-, 
155, 162) Once again it was noted that this response was virtually confined 
to serum :f'.rom hyperthyroid subjects and especially those with significant 
exophthalloos, although blood :f'.rom euthyroid or hypothyroid exophthal.mic patients 
was found to elicit this abnormal reaction(155, 162). 
These efi'ects have recently been tested on human volunteers ( 4-3) • Blood _-
from eight exophthelmic patients and two controls was transfused into normal 
recipients. In other subjects, thyrotrophin was injected intravenously at 
two dose levels. The protein bound iodine (P.B.I.) was estimated before and 
twelve hourly after the transfusion for 72 hours. A maximal increase in 
P.B.I. was found 30 hours after thyrotrophin, and 40 to 65 hours after blood 
transfusion from six out of eight exophthalmic patients. 
The discharge of' I 131 is specific and appears to represent actual 
stiDlllation of thyroid function in animals(141+, 158 ) and man(43). Serum 
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from appropriate subjects has been shown to cause elevation of the P.B.I. (43, 158) 
and to stiDlllate an increased thyroidal uptake of' I 131 with histologic evidence 
of' thyroid hyperplasia in thyroxine treated mice<144, 1.58). This aubstanoe 
then, has thyrotrophic properties. It has been given a number of' nanes 
including "'1mormal teyroid stiDlllating hormoru,"(5), "Abnormal thyroid sti.m.1-
lator"(5) and "Thyroid aotivator11 ( 156 , 158). It is by agreement currently 
termed "Long-aoting thyroid stimulator" or L.A.T.s.'il 
L.A.T.S. appears to aot directly on the teyroid gland as typical 
"delayed" responses are still obtainable in hypopbysectoml.sed ml.ce(15, 162). 
The more sustained and delqed eff'ects are probably due to a longer half' life 
in the circulating blood, conpared to normal th_yrotrophin. This difference 
has been clearly shown in mice(160) and rats(6 ) after intravenous injection 
of' appropriate sera. 
Further dif't'erences between L.A.T.S. and normal thyrotrophin have been 
reported. ~trophic aotivity in the sera of patients with 11\YXoedema is 
assooiated with the guma-globulin f'raotion on a starch-block electro-
phoresis(1521 160, 162). Using the same procedure, L.A.T.S. was not found 
in association with ~ specific f'raotion of the serum proteins ( 160' 162) • 
When serum was f'raotionated by means of' chromatography using a column of' 
diethylaminoethyl cellulose (DEAE) ( 160), a similar laok of' specific associ-
ation with a serum protein was noted, as opposed to normal thyrotrophin which -
again was found in the g&DID8.-globulin f'raotion. 
L.A.T.S. is poorly recovered after exposure to aoetone as opposed to 
thyrotrop~(7) and, following Bates• alcohol percolation method.(37), McKenzie 
~ Terminology informally agreed upon at the Fourth International Goitre 
Conf'erenoe, London, July 1960. 
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found very little of the original L.A.T.S. activity in the four fractions 
assa,yed., whereas thyrotrophic activity was easily concentrated ( 160). .Ad.ans 
has investigated the dose response relationship of' L.A.T.S. and found a 
steeper slope and a higher maximal linear response(7). 
Heat has been shown to destroy thyrotrophin JD.1Ch more readily than 
L.A.T.s.<162) which is, in addition, very atable when stored at 4°0., no 
change in activity being noted after 176 days ( 162) • Thyrotrophin loses its 
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Decrease in Thyrotrophic Activity in 
Plasma stored at -10°C 
6 
FIGURE 15: Rapid decline in t~otrophic activity in 
plasma stored at -10 C. Weekly assays were 
done on a single large aliquot of plasma 
from a JI\YXOedematous subject. Each point 
represents the mean of six observations. 
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Finally, L.A. T.S. does not appear to originate from the anterior 
pituitary. Four patients who developed Graves' disease after surgical 
ablation of the pituitary for various reasons, bad serum L.A.T.S. activity(
160). 
Similarly, the anterior pituitary glands removed at necropsy from three cases 
of active or recent hyperthyroidism showed no L.A.T.S. <160, 163), although 
this had been present in the blood of one patient during life ( 
160). 
It is clearly apparent therefore that at least two subst8.11Ces with 
thyrotrophic activity appear to exist. 
The association between levels of L.A.T.S. and the clinical states 
mentioned abOV'e has naturally led to speculation as to whether this is the 
causal agent in Graves' disease(13) and a remarkable case has been cited in 
this context ( 144). An exophthalmic person, euteyroid following thyroidectoiqy -
for hyperteyroidism seven years previously, was found to have enor100us levels 
of L.A.T.S. She gave birth to two live infants who were considered to be 
suffering from congenital thyrotoxicosis. The aetiological connection between 
maternal L.A.T.S. and the hyperthyroid state of the offspring has been seri-
ously considered. 
( 5, 160) · Other authors have suggested that L.A.T.S. may be the E.P.S. 
assayed in fish by earlier workers; again, because of similar clinical 
associations. Like L.A.T.S., E.P.S. is stable 'f'or long periods at 4°0. (1so) 
or -22°0. (BG) 
The site of origin and mode of action of L.A.T.S. remains speculative. 
It does not appear to originate in the anterior pituitary, nor is the action 
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mediated via that gland(15, 162). It has been found in equal. concentration 
in the internal jugular and ante-cubi tal veins of hyperthyroid subjects ( 16 3). 
L.A.T.S. may represent normal thyrotroplµ.n DX>dified by an unknown 
factor present in patients with the hyperthyroid-exophthalmos oonplex, as 
the incubation of thyrotrophin with thyrotoxic serum appears to alter the 
. (163) normal character of thyrotrophin in the direction of L.A.T.S. 
Assay of L.A.T.S. 
L.A.T.S. was initieJ.ly reported, and is still conveniently assayed, 
using 1131 discharge as a criterion of activity(4, 155, 162), the increase in 
plasma radioactivity being noted seven to twelve hours after the serum injec-
tion, instead of the usual two to three hours. 
In this study L.A.T.S. was assayed using precisely the technique for 
normal thyrotrophin assay as outlined in Chapter III. In addition to the 
two hour bleeding, aspiration of 0.1 ml. of blood was carried out seven hours 
after injection of plasma with suspected L.A.T.S. activity and after occasional 
controls. Batches of six pretreated mice were used and radioactive counting 
was performed as described earlier. Once again, the assay response was 
recorded as the percentage of the initial blood radioactivity. 
As opposed to thyrotrophin ass~s, no L.A.T.S. reference standard 
exists, so that no attenpt has been made to quantitate this substance in terms 
of 8l\Y form of unit. All values, therefore, have been expressed directly in --
terms of the percentages referred to above, at two and seven hours. 
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Results: 
Figure 16 illustrates a. typical delayed response elicited from an 
appropriate plasma.. This is contrasted with the responses both from plasma 
of an acromegalic subject, and from 0.05 and 0.15 Dl.l. of tl\}'rotrophin 
reference standard. 
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131 Two and seven hour rel ease of I from the tl\}'roid glands 
of mice following the injection of thyrotrophin standard 
and plasma. from both an a.cromegeJ.ic subject and a. patient 
with severe exophthalm::>s and pretibial myxoedema.. 
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This assay, in conjunction with that described for E.P.S. was 
performed on plasma of patients su:t'f ering f'rom exophthalmos and other 




Activity of Thyrotrophin and E::x:ophthaloos Producina Subst&llCe 
in the Serum and Plasma of normal subjects. 
( 1 ) TBYROTROPKIC ACTIVITY IN THE SERUM OF NORMAL StJBJIDTS: 
Although a few of the earlier workers had reported arbitrary levels 
of thyrotrophic activity in treated(G4, 95) and untreated serum(2J+, 119), 
the techniques used were insensitive, usuell.y lacking in statistical precision 
and were seldom reproducible. As recently as 1949, Albert expressed doubts as 
to whether thyrotrophin had been convincingly assayed in fractionated or un-
fractionated seruJJl and he stressed the couplete lack of uniformity of results 
at that time(19). 
Assay methods, though still subject to much criticism, have inproved 
to the extent of having provided a reasonably consistent overall. picture of 
the thyrotrophin level in normal serum, although very recent work has re-
openedex>ntroversy(J2). 
A range of 5 to 20 mu./100 ml. has been noted by some worker/74, 75, 
107, 179, 227), although the majority report levels somewhat higher, averaging 
between 20 and 50 mu./100 ml. (12, 35, 37, 39, 48, 64, 77, 154, 185) 
The most extensive survey of thyrotrophic activity in serum yet 
reported is that of Bottari (4.8). He found a range of 7 - 80 mu./100 ml. 
(mean 25 mu.) in 110 normal ma1es; 30 - 100 JJll./100 ml. (mean 60 mu.) in 
36 pre-menopausal fema1es; 8 - 45 mu./100 ml. (mean 23 JIil.) in 28 post-
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menopausal females and levels of from O - 8 Dll. (with oceasional exceptions) 
in 20 persons of both sexes over 60. The general range of results corresponds 
with those reported above, though significantly higher values occur in pre-
menopausal females and a. definite decline with age is noted, as has been 
reported in the rat(157). 
In 1961, Bakke and his colleagues reduced 1,000 ml. pooled fresh 
plasma to a 50 ml. clear sanple by an extraction ~thod and on assqing this 
fraction using thyroid slices in vitro, found a thyrotrophin concentration 
of 0.2 D11./100 ml.(32) This was repeated once, with the same result. Bates 
is quoted as having revised his previously reported levels down fifty-told 
to 1.0 Dl.1./100 ml. (35) This work remains to be repeated and confir~d by 
others. 
Thyrotrophic activity as assqed in the present study: 
Thyrotrophin levels were assqed ( as outlined in Chapter III) in 
plasma. from 15 normal subjects, all of whom were clinically euthyroid and 
had no evidence of goitre. Thyroid function was not otherwise tested. 
Results are summarised in Table III:-
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Patient Age Sex 
Thyrotrophic Activity 
mi./100 ml. 
1. R.H. 39 M 26 (13 - 4-7) 
2. R.C. 24- M 22 (11 - 28} 
2· E.B. 22 F 21 (16 - 22} 
~· G.B. 22 F 12 ( 8 - 21} 
2· R.K. 62 F 20 ( 12 - 21} 
6. G.E. 4.8 F 21 (.~o - 4.8} 
1· B.P. 28 M 20 (11 - 2,2} 
a. B.L. 26 M 4-0 ( 21 - 54-} 
2· E.G.W. 22 F 11 (12 - 22} 
10. R.G. 4D F 11 ( 11 - 21} 
11. M.F. 21 F 10 ( 8 - 14-} 
12. W.G. 22 M 0 ( O - 1 } 
1J. R.M. 21 F 28 (20 - 4-1} 
14-. J.L. 22 F 26 (24- - 22} 
15. M.N. 4D M 21 (18 - 26) 
TABLE III. Plasma thyrotrophic activity in 15 normal subjects. 
Each value represents the mean of six assay responses. 
95% confidence limits are in parenthesis. 
CoDll'.lent: The mean activity of 22 mi./100 "1· plasma in the six males and 
24- mu. /100 ml. in the nine females "is in close agreement with many current 
reports(12,35,37,39,4.8,64,77,154-,185), and especially with that of McKenzie 
who uses a similar method.( 154-). It is difficult to understand the failure 
of' Munro to find significant levels of thyrotrophin in 8 of 9 normal sera, 
using the same technique(162). 
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The much higher mean level (60 mu./100 ml.) reported in pre-menopausal 
females by Bottari ( 48) has not been confirmed by other workers, nor do the de.ta 
derived from the 7 pre-menopausal females in this smaJ.l study lend support to 
his report. 
Serial estimations of thyrotrgphic activity: 
These were performed on a normal subject (R.H.) to study the fluctuation 








R.H. aged 39 
Thyrotraphic Activity 
(mu./100 ml.) 
26 ( 13 - 4-7) 
22 (17 - 30) 
22 (16 - 32) 
32 (21+ - 4-5) 
27 (22 - 35) 
TABLE IV. 
Serial assays of thyrotrophic 
activity in a normal subject. Ea.ch 
value represents the mean of six assays. 
95% confidence limits are in parenthesis. 
( 1) Only minor fluctuations occurred in this normal subject over 
the three xoonths during which the assays were perf'orm,d. 
(2) The consistency in results during this period confirms the 
reproducibility of the method. 
A similar study in which the same results were obtained has recently 
been reported on four healthy subjects over a five day period(227). 
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( 2) THE LEVEL OF E. P. S. IN THE SERUM OF NORMAL StJBJ1XJTS: 
ExophthaJ.mos producing activity has not been unequivocally demonstrated 
in the serum of normal subjeots. McGi11(150) reported "slight" exophthal.Joos 
in fish three hours after injection of serum from 60 normal persons, but it is 
doubtful whether the 1 - 2% increase in intercorneal distance he noted is 
significant. Others have failed to record significant activity(S5, 
86, 13°), 
except in occasional serum san:ples. Dobyns found pooled normal serum to give 
consistently negative results(S6). 
E.P.S. activity as assayed in the present study: 
Plasma from 10 normal subjects was assa,yed for exophthalmos producing 
activity as described in Chapter V. Results are graded from Oto++++ and 
summarised below:-
Patient Age Sex E.P. Activity 
1. B.P. 28 }4 + 
2. M.R. 19 F 0 
3. W.M. 4£, F + 
4. D.P. 62 F + 
5. L.W. 35 F 0 
6. E.J. 39 F 0 
7. D.M. 30 F 0 
8. J.G. 39 M + 
9 R.H. 39 M 0 
10. J.E. 48 F 0 
TABLE V. E~ P. S. ACTIVITY lN PLASMA OF 10 NORMAL SUBJIDTS 
Comxoont: ExophtheJmos producing activity has been formd in the plasma of one 
out of ten normal subjeots, confirming other reports. If E.P.S. is present in 




Activity of Thyrotrophin, L.A.T.S. 8.I_ld E.P.S. in the plasma of 
patients with hypothyroid and hypertl\Yi:9id :f\motion. 
(1) THYROTROPHIC .ACTIVITY IN HYPOTHYROID ST~: 
In 1936, Hertz and Oastler reported the qualitative determination of 
thyrotrophic activity from the sera of nine nzyxoedematous subjects<
11 9) and 
others subsequently confirmed tbia(62, 92, 175, 182, 195). It was noted that 
sera :from lzypoth,yroid persons gave positive assq responses far more coD1100nl.y 
than those :from patients suffering from other thyroid disorders. 
When quantitative estimations became possible, th,yrotrophin levels 
were found to vary a great deal. De Robertis reported very high levels ( one 
over 5 u./100 m.1..) in two cases, and negligible aJOOunts in two others(
1B5). 
D'Angelo noted elevated anx:>unts (20, 30, 40 nu./100 m.1..), normal levels 
( 7, 8 JD1. /100 m.1.. ) and absent activity ( 5 cas~s) in ten sera ( 75). Gilliland 
and Strudwick had the same experience; 72 - 126 nu./100 m.1.. in eight out of 
ten sera and no activity in two others. Sera from two cretins were found 
to have levels of 160 and 282 w./100 m.1..<
107). Bowers and his colleagues 
reported increased activity in three cretins (37, 74, 407 w./100 m1../50), 
as did Ad.ams in four cases ( 100 - 250 Dll../100 m.1..) (5\ while Di George and 
his co-workers reported variable levels (0, 80, 120, 360 nu./100 ml.)(77) 
Others have confirmed elevated thyrotrophin levels in JIO'XOedema, 
including McKenzie (34 - 70 Dll../100 ml.)(
154) and Bakke (1 - 7 nu./100 ml., 
which is ten times the normal value with this assq) (3
2), while Bottari 
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noted either very high (200 - 450 Illl./100 ml.) or negligible anx,unts 
(o - 4 Illl./100 m.1..) in his series(48). 
· In general, thyrotrophic. activity may either be grossly elevated or 
trivial in 11.YPothyroid states, though normal activity is occasionally 
reported(75). The ioost elevated levels appear to be associated with induced 
reyxoedema (107), or cretinism (SO, 77, 107). 
Thyrotrophic activity investigated in the present study: 
Plasma f'rom eight patients was assayed. Two patients were suffering 
from spontaneous IeyXoed.ema, three from juvenile }zypotbyroidism, two had 
had total thyroidectomies (:for thyroid carcinoma) followed by 1131 therapy 
and one, a partial thyroideotolJ\Y' for a single nodule. All patients were 
definitely hypothyroid clinically and subse"19ntly responded to thyroxine. 
The results are summarised in Table VI. 
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Patient Age Sex Thyrotrophin level Remarks 
(years) (Dl.l. /100 ml.) 
1. L.W. 76 5 ( O - 20) 131 7% % I uptakes 12, 1 • PBI 2.1 pg. • 
Spontaneous nwxoedema. 
2. S.B. 60 F 150 (70 - 250) 
131 I uptakes 6,4fo. RID uptakes 
8.i.%. Spontaneous icyxoedema. 
3. A.A. lt-9 F O ( O - 6 ) I 
131 uptakes 1 lt-, 16%. RID uptakes 
9. O'fa. Hypotlzyroid following par-
tial thyroidectoiqy for tlzyroid 
nodule. 
q.. P.Z. 32 310 (200 - 460) I 
131 uptakes 1 • 5%; q.8 Hour urines 
- 90}l; of dose. Total thyroidec-
toiqy for carcinoma 6 months pre-
viously. Followed by 13q. m. I1 31 
5. M.K. F 21 ( 1lt- - 32) I
131 uptakes 6%. Total teyroideo-
toJllY for carcinoma 3 years pre-
viously. Thyroxine stopped 3 weeks 
before ass~. 
6. HduP. 15 F 72 (52 - 105) I 
131 uptake 5, 21,. RBC uptake 1 O)l;. 
PBII+;.O pg.%· Juvenile hypothyroid. 
7. B.C. 5/12 F 135 (90 - 204) 
131 I uptake not done. Cretin. 
a. B.F. 7 l,{ 68 (40 - 114) 131 I uptakes 7($. KOOB discharge 
negative. PBI 1.5 pg.%. Goitrous 
cretin. 
TABLE VI. Th.vrotroEhiC activitz in hzeoth..vroidism. 
I 131 uptake figures refer to 6 and 24 hour teyroidal uptakes 
following 25 pc. 1131 given orally. 
131 RBC uptake refers to the percentage uptakes of I by the red 
cells af'ter incubation for two hours with 1131 labelled tri-
iodotlzyronine. 
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TABLE VI (contd.) 
P.B.I. (X) is the protein bound iodine estimation and measures the 
amJunt of circulating organic iodine loosely bound to the serum 
proteins, i.e. the iodine of circulating thyroid honnone. 
Each assay result represents the mean of six observations, the 
95% confidence limits of which are in parenthesis. 
These explanatory remarks apply to all subsequent tables. 
Comments: All three patients suffering from juvenile hypothyroidism or 
cretinism show plasma thyrotrophic activity greatly elevated, three to five 
times the normal value obtained by this assay. This confirms the general 
experience in this f'orm of' hypothyroidism. 
One of the ho subjects studied with spontaneous uzy'XOedema shows 
activity six times the normal value, while the other shows trivial levels. 
This, too, accords with comments in the literature. 
Finally, of the two patients after total thyroidectoll\Y, one has tre-
mendous values (twelve to thirteen times normal) and one, normal levels, 
while no activity was noted in the plasma of one patient after -partial 
thyroidectoll\Y. The patient in whom norml results are obtained, had only 
been off thyroxine therapy for three. weeks and this may have mdified the 
final thyrotrophin level. 
(X) Estimated by Dr. A. van Zyl, Department of Peysiology. 
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The interpretation of an increased thyrotrophic activity is easily 
ma.de according to the concept of a pituitary-thyroid homeostatic state out-
lined in earlier chapters. The failure of thyroxine production, whatever the 
mechanism concerned, is attended by a reciprocal increase in thyrotrophic out-
put by the anterior pituitary, presumably in an attempt to stiIIlllate the 
thyroid to produce thyroxine and restore the balance. As secretion cannot 
be "stepped-up", homeostasis is never r.eached and the thyrotrophin levels 
remain permanent:J.y high. 
Those cases in which diminished thyrotrophic activity has been denon-
strated remain puzzling. D'Angelo(75), Di George(77) and Gilliland and 
Strudwick( 107) have reported such cases in which thyrotrophin levels were 
subsequently raised consider~ly (50 mu./100 ml. 200 J111./100 ml. and 
99 Illl./100 ml. respectively) e.:f'ter treatnent with thyroxine. These results 
may be interpreted as indicating that the nzyxoedematous process may affect the 
pituitary gland resulting in a diminished metabolic and secretory capaoity(99). 
This may concern not only the output of thyrotrophin but other horioones as 
well, as urinary gonadotrophin has been shown in one case to rise after thy-
roxine(99). 
(2) THYROTROPHIC AND L.A.T.S. ACTIVITY IN HYPERTHYROID STATES: 
Hertz and Oastler were llllable to detect thyrotrophic activity in the 
blood of eight thyrotoxic patients, using an assey which detected activity in 
:ieyxoedema.(119). This was noted by other workers(64, 175, 185), who found 
detectable levels after treatnent of the condition(175, 
185). 
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DI Angelo and his colleagues reported a wide range in ten cases ( 7S). 
In three, no activity was found; in six, activity was normal (6 - 10 Illl./100 ml.) 
and in one case, the thyrotrophin level was a little raised (20 Illl./100 ml..). 
Others have also reported variable results ( 27' 179' 195) • Adams and Purves 
reviewed this subject in 1957'13). In 17 of 41 eases they collected from the 
literature, thyrotrophin levels were found to be raised, while in the rest, the 
levels were normal or diminished. Recently, Bottari reported a series of 45 
cases, in which thyrotrophic activity was normal in nine, moderately elevated 
in 23 (100 - 800 II11./100 ml.) and grossly raised in thirteen (over 1 u./100 ml.) 
(48). No association was found between the s~ty of h,yperthyroidism and the 
level ot thyrotrophin. 
Gilliland and Strudwick attempted to correlate the wide range of results 
with the degree of associated eye signs(107). They found increased activity in 
ten of fourteen patients, with the greatest increases confined to those cases 
with severe eye signs. 
This great discrepancy in results has been a source of discussion and 
speculation. On the basis of the pituitary-thyroid homeostatic concept, high 
levels of circulating thyroxine should lead to low or absent thyrotrophic 
activity in al1 cases. It has been suggested that high values ma;, be due to 
some artifact, which is noxious to thyroid tissue and causes iodine release in 
the assq experiments en:ploying this end-point ( 48). Another view is that the 
h.YPerplastic thyroid inactivates thyrotrophin and this accounts for low 
levels(B2); but this has not been shown to occur in vivo(72). 
--
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The long acting thyroid stiuw.ator: The presence of inexplicably high values 
for thyrotrophin in hyperthyroidism may be DX)re effectively explained in terms 
of L.A.T.S. The nature of this substance and the marked correlation between 
its presence and hyperthyroid states associated with severe exophthalllX)s has 
been fully discussed. It is not unreasonable to postulate that the activity 
attributed to thyrotrophin in the assays quoted, resulted in fact from the 
thyrotrophin-like properties of L.A.T.S. These earlier assays failed to dis-
tinguish between this substance and normal thyrotrophin. 
Adams, using an assay enploying thyroid I 131 discharge reported delayed 
activity suggestive of a L.A.i.s. effect in three of five untreated thyrotoxic 
patients with exophthalloos and none of three patients without exophthalm:>s(5). 
McKenzie found delayed activity in the sera of thirteen of fifteen thyrotoxic 
subjects, two euthyroid exophthalmic patients and in one normal person(155, 158); 
while Munro noted L.A.T.S. in six of eleven hyperthyroid patients, two of three 
euthyroid persons with exophthalmos and one of nine normal sera tested(162). 
Recently, Yamazaki reported L.A.T.S. activity in three of nine sera from 
thyrotoxic patients <227) and Bjorkman noted this in six of eight cases, using 
human voiunteers as test subjects(43). 
Thyrotrophic and L.A.T.S. activity investigated in the present study: 
Initial.ly thyrotrophic activity was estimated in ten hyperthyroid 
subjects. .All patients had definite clinical and laboratory evidence of this 
state and respon:ied to subsequent antithyroid therapy. The results are shown 
in Table VII. 
-
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Patient Sex Age (years) 
Thyrotrophin level 
(llll./100 ml.) Remarks 
9. F.F. F 37 5 ( O - 17) Slight exophthal.JOOs. r131 uptakes 
69,69 ~ 97, Tl% after T3. 
I ROO uptake 23.5% 
10. G.D. F 40 (27 - 61) 131 Marked exophthaJ.oos. I uptakes 
70,69 ~ 81,68% after T3. 
ROO uptake 23.8')&. PBI 9.0 pg-% 
11. R.B. F 27 (17 - 43) 131 No exophthaJ.oos. I uptakes 
86,83 ~ 78,71% after T3. 
ROO uptake 21. 5%. PBI 9. 5 pg.% 
12. J.H. F 43 (37 - 53) Mild exophthaJ.mos. I 131 uptakes 
82,55 ~ 85,68% after TJ. 
ROO uptake 22.8% 
13. J.T. F 25 33 (18 - 57) 131 No exophthalioos. I uptakes 
76,60 ~ 71,61% after T3. 
RID uptake 21. 7% 
14. M.G. F 27 (20 - 38) 131 No exophthal.Joos. I uptakes 
75,57 ~ 79,58% after T3. 
ROO uptake 17.6% 
15. P. O'K. JI 8 ( O - 15) 131 No exophthalmos. I uptakes 
80, 7fJ1/,. ROO uptake 31 • 8%• 
PBI 13. 7 pg.% 
16. M.N. F 49 20 ( 4 - 46) 131 No exophthalmos. I uptakes 
76,68 ~ 71, 7'11/o after T3. 
17. L.G. F 31 18 (11 - 29) Slight exophthaloos. r131 uptakes 
73,804 73,85% after T3. I RID uptake 22.6% 
18. D.M. F 54 10 ( 0 - 29) 131 No exophthal:n:os. I uptakes 81, 
80 ~ 79,81% after TJ. ROO uptake 
25. 3%• PBI 14 pg.% 
TABLE VII. Thyrotrophic activity in Hyperthyroidism. 
In this, and in subsequent tables, T3 refers to tri-iodothyronine, which is given 




Comment: The mean thyrotrophin level of 23 llll./100 ml. is almost identical 
. 
with the levels in normal subjects reported in the previous chapter. One 
patient with severe exophthalmos had a level of 40 mu./100 ml.. A range from 
5 mu. to 4-3 Dl.l./100 ml. is present and this corresponds to that repor1;ed in 
the literature. 
These results, however, may have a limited significance as they possibly 
represent part of L.A.T.S. activity, which in many oases appears to produce a 
response as early as two hours after the injection of plasma. 
L.A.T.S. activity was then investigated in nine clinically thyrotoxic 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































TABLE VIII. L.A. T. S. Activity in HyPerthyroidism. 
Each recorded result is the mean of six observations
! the standard error. 
When the 7 hour reading is significantly increased as 
con:pared to that at 2 hours, 
the assa;y is regarded as conclusive for L.A.T.S. W
here the increase is 
definitely present, but not statistically significant
, L.A.T.S. activity is 
"suggestive"; and where a trivial increase or decrea
se, occurs, activity is 
regarded as being absent. A "response ratio" was cal
culated, being the ratio 
of the 7 hour to the 2 hour response. This scheme wil
l be followed in all sub-
sequent relevant tables. 
The evaluation of the significance of a 7 hour respons
e is difficult. 
As has been mentioned, .this has been calculated as co
npared to the 2 hour reading, 
but as this reading is already extremely elevated in 
some cases, this does not 
seem a rational method. Unfortunately, no other stan
dard for conparison exists. 
It does not seem logical to con:pare the plasma 7 hour 
response with the response 
to saline at that time, though it ma,y be valid to con
pare it with a standard 
thyrotrophin solution or a plasma sanple with a high 
"normal" thyrotrophin con-
tent, as did Adams(s). 
It was finally decided to determine the significance 
of the 7 hour 
response conpared to that at 2 hours as outlined abov
e. It should be noted 
however, that though a response ratio of 1.10 or over
 may be insignificant 
statistically, L.A.T.S. activity ma,y still be present
 (as a negative ratio is 
virtually the rul.e with "normal thyrotrophin). The t
erm "suggestive" was 




Comment: The highest L.A. T.S. level is present in the
 only patient clinically 
"hyperophthalroopathic", which accords with current rep
orts. Four of the nine 
patients had significant activity, while a further thr
ee had a distinct increase 
at seven hours, but of doubtful significance. A signi
ficant rise in 100use 
plasma radioactivity at two hours was present in seven
 cases. 
This small study suggests the presence of L.A.T.S. in 
a high proportion 
of thyrotoxic patients, whether true exophthal100s is a
ssociated or not. 
(3) THE ACTIVITY OF E.P.S. IN HYPOTHIROID AND HYPERTHYROID ST
ATES: 
The nature and significance of the exophthaloos produc
ing substance 
has been fully discussed. In summary, significant lev
els of this substance 
are associated alrost exclusively with marked degrees 
of clinical exophthalroos, 
irrespective of thyroid :function(
86 , 150), Tlzy'rotoxio patients without exoph-
thalm:>s usually show no E.P.S. activity(
86 ,1SO), though Dobyns has noted three 
oases with significant levels which have antedated the
 develop:rrent of exoph-
thalmos by weeks or months ( 
86 ). McGill found that serum from three hypothyroid 
subjects and from three patients after thyroid.ectoII\Y' f
or hyperthyroidism failed 
to show E.P.S. activity(
15°), but no other studies on similar patients h~e been 
reported. 
E.P.S. activity investigated in the present study: 
E.P.S. was assayed in two patients with spontaneous Iey
Xoed.ema, two 
oretins, two patients following total th.yroidectoII\Y' fo
r carcinoma of the thyroid 
and eleven hyperthyroid subjects. 
The results are tabulated in Table IX. 
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1. L.W. 76 F Spontaneous Jl\YX()edema 
0 T. 5 mu./100 ml. 
2. S.B. 6o F Spontaneous JitYXOedema 
0 T. 150 IIll./100 ml. 
4. P.Z. 32 F Total thyroidectonv 
++ T. 310 mu. /100 ml. 
for CA. 
5. M.K. 36 F Total thyroidectonv 
+ T. 21 mu./100 ml. 
for CA. 
6.HduP. 15 F Juvenile hypothyroidism 
0 T. 70 nu./100 ml. 
7. B.C. 5/12 F Cretin + 
T. 135 IIll./100 ml. 
9. F.F. 37 F Hyperthyroid. Slight 
+++ T. 5 llll• /100 ml. 
exo:ehthalIOOs. 
10. G.D. 42 F Hyperthyroid. Severe ++++ 
T. 40 mu./100 ml. 
exophthalloos. L. 245% R.R. 1. 
11. R.B. l+4 F Hyperthyroid. No ++ 
T. 27 IIl.l./100 ml. 
exo:ehthalm:,s. 
12. J.H. 36 F Hyperthyroid. Mild 0 
T. 43 nu./100 ml. 
exo:ehthali:oos. 
1J. J. T. 25 F Hyperthyroid. No 
0 T. 33 mu./100 ml. 
exophthali:oos L. 149% R.R. 1.0 
14. M.G. l+4 F Hyperthyroid. No 
+ T. 27 IIll./100 ml. 
exo:ehthalroos 
17. L.G. 31 F Hyperthyroid. Slight 
0 T. 18 mu./100 ml. 
exophthali:oos. L. 16.1% R.R. 1. 8 
16. M.N. 49 F Hyperthyroid. No exoph- ++ 
T. 20 mu./100 ml. 
thaJ.mos. Periorbi tal L. 167% 
oedema. R.R. 1.,2J 
19. L.A. F Hyperthyroid. No ++ 
T. 9 mu./100 ml. 
exophthali:oos. L. 152}& R.R. 1.21 
20. J.P. 26 F Hyperthyroid. Marked +++ 
T. 0 
lid lag,ahd retrac- L. 140% 
tion. R.R. 1.2:z 
21. M.M. 51 F Hyperthyroid. Marked + 
T. 40 II11./100 ml. 




TABLE IX. E.P.S. Activitz in Hypothyroid
 and llvPerth.vroid States. 
T., L. and R.R. refer to thyrotrophin, L.A.T.S. a
nd respmise-ratio 
respectively. Relevant laboratory data has alread
Jr been included in 
Tables VI, VII and VIII. 
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Comment: (a) E.P.S. activity: In hypothyroid
ism, trivial or no E.P.S. 
activity was found, the single exception being a pati
ent assayed after total 
thyroidectOD\Y• The other thyroidectomised subject ha
d elicitable, though slight, 
activity. Neither patient had exophthaltoos. Though 
the results in general 
accord with those published by others, E.P.S. has not
 been reported in serum 
from patients after total thyroidectoDO"• 
The significance of these observations is obscure, bu
t they may bear 
a relationship to the early reports of exophthalioos f
ollowing total thyroidec-
toD\Y in animals(7S, 
108, 220) imd man(7S). Such a conplication is extremely rare 
in hypothyroidism arising spontaneously nor is E.P.S.
 present(150). The 
mechanism of' this discrepancy is puzzling, and it is 
possible that in D\Y'Xoedema 
the thyroid, though failing in its output of thyroxin
e, may still be producing 
a substance controlling E.P.S. secretion by the anter
ior pituitary gland and 
preserving homeostasis. After total thyroidectoD\Y, b
oth this factor and 
thyroxine would be absent, and accelerated release of
 E.P.S., in addition to 
thyrotrophin, might ensue. This speculation can only
 be clarified by the col-
lection of data from more cases similar to the ones s
tudied. 
Though McGill reports an absence of' E.P.S. in three p
atients following 
thyroidectonzy- for hyperthyroidism<
15o), these operations are likely to have 
been sub-total however, and the above suggestion is n
ot invalidated. 
In hyperthyroidism, E.P.S. was assayed ioore often and
 at high.er levels, 
as would be expected. The greatest response was asso
ciated with exophthalmos, 
and this has been the experience of others(SG,
15o); but fout" patients in whom 
this conplication was not present had increased activ






marked lid lag and retraction, with perior
bi tal oedema in one instance. This 
has been reported by Dobyns(BG), who found
 that such cases ultimately tended to 
develop exophthalm:>s. 
(b) The non-identity of thyrotrophin and 
E.P.S. In spite of greatly increased 
levels of thyrotrophin in the plasma. of ca
ses 2 and 6, no E.P.S. activity was 
assayed. This strongly favours the differ
ent identities of these two substances 
and confirms the other evidence for this d
iscussed in Chapter IV. 
Figure 17 shows the results of E.P.S. on t
hyrotrophin assays discussed 
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FIGURE 17: · Activity of thyrotrophin and E
. P. S. in plasma from normal 





Activity of Thyrotrophin and E.P.S. in the Pla
sma of 
Patients with various Endocrine disorders 
( 1) .ACTIVITY OF THIROTROPiilN AND E~P. S. m EUTHYROID PATIENTS
 WITH GOITRE 
The assay of thyrotrophic and E.P.S. activity
 in patients with goitre 
has not been the subject ot many reports. Mtmro
 found no significant thyro-
trophin levels in three oases of si:aple goitre
(162), and Fregola and Ferrara 
reported no activity in oases of endemic goit
re although the sensitivity of 
their method was not statea.<
101 ). 
As the neohanism underlying the development ot n
on-toxic goitre remains 
obscure, thyrotrophic activity was assqed in
 this study in 14 persons with 
diffuse goitre, 6 with nw..tinodular goitre, o
ne with a solitary nodule and 
one with a huge goitre, possibly associated w
ith an enzymic block. All sub-
jects were eut}zyroid as assessed clinically a
nd by the usual laboratory 
investigations. The results are tabulated in
 Table X. 
I 




2 . N.C. I F 
J. J .If. p 
4. L.S. p 
I 
5. E.P. I F 
! 
I I 6. S.J. i p 
1. D.lf. I p 
8. D.G. F I 
i 
9. P.P. p 
1 o. M.A. F 
11 . J.A. F 
12. L.V. II 
13 J.K, F 
14. J.E. F 
/ 
l 
15. E.Z. F 
16. R.H. F 
17. c.c. F 
18. A.C. F 
19. E.P. F 
20, S.L. F 






Goitre (mu./100 Ill.) E. P. S . I 
41 Diffu.se 56 (45 - 72) I 
30 Dirt'uae 
I 28 (23 - 36) 0 
39 Dift'uae 18 (14 - 26) 





 17 (12 - 25) +++ 
I 
I 
39 ; DiN'use ' .}4. (28 - 44) 
30 ' Diff'uae 17 (13 - 21.) 0 
.}4. Diffuse 0 
I 
27 Diffuse 16 (11 - 24) 
29 Diffuse 25 (20 - .}4.) 
27 : Diffuse 13 (10 - 18)
 
32 ' Diffuse ! 20 (15 - 27) 
- - - -----l- --- .. 
31 Diffuse 25 (21 - 32) 
33 Diffuse 18 (16 - 23) 
d 
29 Multinod. · 31 (27 - 37) 
!: 
59 Multinod. 20 ( 17 - 25) 
0 
73 Multinod. ' 23 (20 - 29) 
42 Multinod. 14 (12 - 18) 
61 Multinod. 16 ( 11 - 23) 
48 Multinod 21 (17 - 29) 
40 Single 8(0-21) 
nodule 
16 ? Enzymic 16 (11 - 24) 
defect I . I 
Reu.rkB 
I 131 uptakes 32, 51 %. RBC uptake 19.6:f. 
1131 uptakes 36, 50%. RBC uptake 13.4% 
r131 uptakes 41, 61%. RBC uptake 18. 9% 
131 
I uptakes 60, 64 - 21 , 25% after T3 
RBC uptake 12.5% 
131 
I uptakes 58, 36 --+ 25, 28% after T3 
RBC uptake 13.7% 
I 131
 uptakes .}4., 44% • RBC µptake 20.1% 
I 
131 uptakes 57, 68 - 28, .}4.% after T3 
RBC uptake 13.4% 
I 
131 uptakes 58, 72 ~ 33, 40!, after T3 
RBC uptake 15. 8% 
131 
I uptakes 41, 52 - 16, 14% after TJ 
RBC 14.3~ 
1
131 uptakes 26 , 42%. RBC uptake 17.5% 
113
1 uptakes 19, 21 %. RBC uptake 21 • 7% 
I 13
1 
uptakes 50, 60 ~ 15, 24% 
RBC uptake 17 .1% 
- ------
I 1 3
1 uptakes 39, 57 ~ 2o% after T3 
RBC uptake 16 . 3% 
I 1 3
1 uptakes 27, 38%, RBC uptake 14, 9% 
I 131 uptakes 40, 50%. Clinically eutbyroid 
I 131 uptakes 33, 43% 
I 131 uptakes 19, 31 % Retrosternal extension 
I 1 3
1 uptakes 43, 56 ~ 23, 23% after T3 
RBC uptake 17 . 3% 
r131 uptakes 37, 56%. RBC uptake 10.2% 
Retrosternal extension 
I 131 uptakes 37, 41 %. RBC uptake 1 5. <JI, 
I 131 uptakes 18, 32%. RBC uptake 14.6% 
r131 uptakes 67, 78-+ 30, 45% after T3 
RBC uptake 14.4%. PBI 1.5 pg./100 Ill. 
Alb .4.4G. Glob .3,1G. Liver :f\motion teata1 
normal, 
TABLE x. Thyrotrophin activity in eutbyroid 
subjects with goitre, 
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Comment: In 14 subjects with diffuse thyroid enlargement, the
 mean tlzyro-
trophin level is 23 Dll./100 ml. and only one shows tlzyrotrop
hic activity 
outside the normal range (56 JID.l./100 ml.). One has greatly in
creased E.P.S. 
activity, while in three others, E.P.S. is insignificantly inc
reased or absent. 
The mean thyrotrophin level in six patients with multin
odular goitre 
is 21 mu./100 ml. All readings are within the normal range. 
Plasma from two 
cases has been ass~ed for E.P.S., which is not present at sig
nificant levels. 
Both the patient with a single thyroid nodule and the 
one with a 
probable thyroid enzymic defect have normal levels of 
thyrotrophin. 
Euteyroid goitrous states do not appear to be associate
d with increased 
thyrotrophic activity therefore and this suggests that 
an increased secretion 
of teyrotrophin is unlikely to be directly linked in th
e pathogenesis of 
these condi tion.s. It must be stressed once mre that w
hat has been assayed 
is teyrotrophin-like activity, and that the presence o
f antagonists or anti-
horDX>nes in the plasma of such subjects cannot be exclu
ded. 
The presence of E.P.S. activity in one euteyroid patient with 
a diffuse 
goitre is not lightly explained. That this IllSS' be the 
first indication of the 
inpending development of hyperteyroidism and. exophthaJ.
ms, is very remte. 
Dobyns, in his extensive experience, has occasionally n
oted exophthal.mio 
activity in the individ.ua1 serum from a normal subject
, and feels that this 
~ represent a lack of specificity on the part of the 
assay as pooled sera 
invariably failed to elicit such responses ( 
86). The latter reason is mre 




The relationship of the thyrotraphin level to r
131 uptake in euthyroid 
goitrous subjects: 
Amongst the 22 cases summarised in Table X are 9 in which an increased 
thyroidal uptake of I 
131 was found. In each case, this was suppressed by tri-
iodotlzyronine. The conparison between thyrotrophin levels in
 the high and normal 
I 
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Normal Inc r<2as<2d 
131 
I Uptakes (24 hr.) 
R<2lationship betw<2<2n 
Thyrotrophin L<2vel and 1
131 Uptake 
in Euthyroid Subjects with Goitre 
FIGURE 18: The relationship of the thyrotrophin 
level to r131 uptake in euthyroid 
subjects with goitre. 
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CoI11Dent: In both groups, results adhere fairly 
closely to the mean normal 
level. The tend.ency of the results to be slightl
y lower in the group with 
raised I 
131 
uptakes is not significant. The presence of a ra
ised I 131 uptake 
in certain euthyroid patients with goitre does no
t appear to be associated 
with an increased thyrotrophic activity as measur
ed by this assay. 
(2) ACTIVITY OF THYROTROPfilN .AND E.P.s. m PATIF
NTS WITH HYPOPITUITARY 
FUNCTIC!i: 
Gilliland and StrudwickCJ,07) and D'Angelo(75) hav
e reported negative 
assS37s for thyrotrophin in b,ypopi tui trism, as wou
ld be expected. Two such 
cases were assayed in this study and another assa
y was per:f ormed on the plasma 
f'rom a patient after partial b,ypoplzy"sectorqy :for a
 chroIIX)phobe adenoma.. 






Sex Age Thyrotrophin Remarks 
(mu./100 ml.) 
F 70 0 Classical b,ypopitui
tarism f'ollowing post-
partum haeIIX)rrhage years before. Grossly 
JJ\YXOedematous. Death from intercurrent 
pneUIIX)nia, before I131 studies perforned. 
Autopsy: Atrophied pituitary and 
:fibrosed thyroid. 
F 50 0 Hypopi tui tarism follo
wing post-partum 
haeIIX)rrhage. Classical clinical features. 
I131 uptakes 6, ~- ROO uptake 12}6. 
F 38 17 (3 -40) Chrom:>phobe a.denoma. rerooved
 six weeks 
before assay. Considered to be hypo-
pituitary clinically but thyroid and 
adrenal function normal. I131 uptakes 
I : 34, 23%. ROO uptake 15.2% 
Teyrotrophic activity in patients with definite a
nd suspected 
b,ypopi tui tary function. 
I 
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Comment: In the two cases with undoubted hypopi tui tary function, no thyrotrophin 
was assayed, in keeping with the clinical findings. The third patient was very 
doubtfully hypopituitary, as normal I
131 uptakes, urinary ketosteroid, hydroxy-
corticosteroid and gonadotrophin excretion were found. It is therefore not sur-
prising that a normal. thyrotrophin level was assayed from the plasma. 
(3) ACTIVITY OF THYROTROPHm, L.A.T.S. AND E.P.S. IN ACRO:M:00.ALY: 
Only one report on thyrotrophic activity in acromegaly has appeared in 
the literature. D' Angelo found levels up to ·eight times the normal value in three 
untreated cases(75). It is surprising that these results have never been confirmed, 
as the association between acromegaly and goitre is well documented(7G), while cases 
of hyperthyroidism co-existing with acromegaly are known.(7
6, 149). 
For this reason, plasma from three untreated cases of acromegaly was 
assayed for thyrotrophin, L.A.T.S. and E.P.S. The results are tabulated below: -
Mean% Increase 
' 
Patient Age Sex Response E.P.S. I Thyrotrophin Remarks 
Radioactivity Ratio Assay Level (mu./ 
2 Hr. 7 Hr. 1100 Dil.. at 2Hr. 
1. K.B. 35 M 135±16 156±25 1.16 0 16(0 -4.2) Classical ae
ro-
Imoncl\Bhre I megaly.I131 up-
t = 0.70 I take 26%. RID p not sig- uptake 11.5% 
nificant 
2. D.A. 17 M 174,!10 197:!:12 1.13 + I 20(14-30) Gigantism. I131 
aJgges t:b,,e uptakes 35, 61% 
(t:1.497 ROO uptake 22.2)& 
0.1 < ~) < 
0.2 
3.KvV. 39 M 16o!24 146!22 0.91 0 17(6 - 35) Active aero-
Absent megaly. I131 
I 
uptakes 17,3J% 









Comment: As would be expected, no E.P.S. is demmstrable in two oases
 nor are 
the thyrotrophin levels excessive. However, L.A.T.S. and E.P.S. are prob
ably 
present in one case (D.A.) This very interesting finding suggests
 that L.A.T.S. 
activity (and not thyrotrophin) may have been assayed in this condi
tion by D'Angelo. 
A possible aetiological connection between L.A.T.S. and Graves' disease 
has already been discussed. It is tempting to invoke that theory to
 link this 
result and the clinical. association of aoromegaly and lzyperthyroidis
m just 
mentioned. Patient D.A. fits rather neatly into the concept, as the
 I
131 uptakes 
are at high normal. levels, the RBC uptake of I 
131 is distinctly raised ( 22. 2)&) , 
and E.P.S. is present. The thyrotrophin-like action of L.A.T.S. ma.
y be respon-
sible for the raised r131 uptake in this case. L.A.T.S. activity is unlikely 
to be a non-specific effect of growth hormone, as crude extracts of
 human, rat 
and bovine pituitaries containing this honnone have not been shown to give ris
e 
to the "delayed" response characteristic of L.A.T.S. (5). 
The source of the L.A.T.S. in acromegaly is as obscure as in lzyper-
thyroidism. It is logical to incriminate an anterior pituitary adenoma in
 this 
respect, but L.A.T.S. has never been isolated from beef pituitary o
r that of 
the human in hyperthyroidism, even when found in the blood at high l
evels(160,
163). 
(4) THYROTROPHIC ACTIVITY m THYROID CARClliOMA .AND SUBACUTE THYROIDITIS: 
No reports have appeared in the literature regarding thyrotrophin le
vels 
in thyroid carcinoma.. As metastasising thyroid twoours in rats hav
e been 
found to be thyrotrophin-dependent oocasionally(
174·, 176) and a therapeutic 
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effect has been reported from the administration of thyroid h
orm::>ne to 
patients with thyroid carcinoma.(
14,33, 145, 212), information regarding thyro-
trophic activity would be of great interest. Two patients w
ith untreated 
thyroid carcinoma nre seen during the period of this st~ a
nd assS3s were 
undertaken. 
Acute thyroidi tis has also received no mention in the literat
ure. 
One such case was studied; and the result, together with those
 found in the 
patients with carcinoma., is shown in the following table. 
Patient Age Sex Thyrotrophin 
(nu./100 ml.) 
Remarks 
1. J.H. 62 F 20 ( 8 - 39) Hurthle cell tumo
ur with cervical 
metastases. 
131 I uptakes 9, 17% 
2. R.H. 63 I M 17 (12 - 25) Adenocarcinoma. No metastases. 131 
I 
I I uptakes 31, 27% 
3. c.w. I 48 M 75 {60 - 99) Acute thyroidi tis, responding well t 
corticosteriods subsequent to the 
8SS83'0 
131 I uptakes 39, 4£,%. 
ROO uptake 19.8% 
TABLE XIII. Thyrotrophic activity in thyroid carcinoma. and t
byroiditis. 
0 
Comment: (1) In cases 1 and 2, thyrotrophic activity is in 
the normal range 
and a quantitative disturbance of thyrotrophin secretion has 
not been de~n-
strated in the two patients with thyroid carcinoma.. 
(2) Thyrotrophic activity is increased in case 3. Thyroiditis was 
acute and systemic synptoms were present at the time of ass83
'. Naturally, no 
conclusion can be drawn from one case. Circulating antibodi
es which are lmown 
to occur in the disease may have interfered in sone W83 with
 the ass83' and the 




(5) THYROTROPHIC .AND E.P.S • .ACTIVITY IN HASHIMOTO'S DISEASE: 
No data is available regarding the activity of these two substances
 in 
Hashim:>to • s disease. These were assayed in three patients and the 
results 
follow in Table XIV: 
Patient Sex Age Thyrotr.Ahic Activity E.P.S. 
Remarks 
(m.i. 100 ml.) Assay 
1. J.S. F 47 14 (10 - 21) 0 
Thyroid clinically typical 
of Hashim:>to•s disease. 
PBI 5.0 f&•% 
I131 uptakes 54, 92 ~ 15,1~ 
after T3. 
Normal flocculation tests 
I and serum proteins. 
2. L.M. F 36 0 0 Clini
cal diagnosis only. [ 
PBI 8.0 pg.% 
I131 uptakes 44,58 ~ 38,41$ 
after T3. 
ROO uptake 24$& 
Normal flocculation tests 
and serum proteins. 
3. W.N. M 63 0 ( O - 3 ) 0 Diagnosis confirm
ed histo-
lo~ically. 
I 1 1 uptakes 9.0, 12.9% 
RBd uptake 16.6% 
TABLE XIV. Thyrotrophic activity in Hashim:>to's disease. 
Comment: Two patients have no thyrotrophic activity, and the remai
ning patient 
shows low normal. levels of thyrotrophin. None of the three patient
s was 
clinically hypothyroid, although the r
131 uptakes were low in case 3. 
The results are difficult to interpret, especially as the series of
 
cases is very small. These may just be chance findings. Alternativ
ely, they 
may be related in some way to the auto-iIIl!Illile process which occurs i





Apart from the presence of thyroid auto-antibodies, a 
serum thyroid cytotoxic 
factor has been dem:>nstrated(
172, 187). This substance may be interfering 
with the assay by causing necrosis of the mouse thyroi
d gland resulting in 
haphazard and perhaps rapid release of radio-iodine wh
ich may be excreted 
before the two hour blood sanpling. 
No E.P.S. activity was found in the three cases. 
(6) ACTIVITY OF L.A.T.S. AND E.P.S. IN PROBABLE EUTHYROID PA
TIENTS 
WITH EYE SIGNS OF THYROTOXICOSIS: 
Three patients were seen at the Endocrine Clinic, Groo
te Schuur Hospital, 
with synptoms slightly suggestive of hyperthyroidism.
 .All had marked lid-lag 
and lid retraction and slight exophthalm:>s, but. invest
igations, follow up or 
therapeutic tria1 failed to confirm the suspected lzyp
erthyroid state. E.P.S. 
and. L.A.T.S. were assayed and the results are tabulate
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Conment: All 3 patients had a positive response-ratio, although only Case 
1 
elicited a 7 hour response significantly different to the 2 hour reading. 
The status of these patients is \lllCertain. They have the eye signs 
of hyperthyroidism but other clinical features only partly suggest t
he diagnosis. 
Laboratory tests were not confirmatory and Cases 1 and 3, followed up over ye
ars, 
did not develop this state, nor did Case 1 respond. to an adequate c
ourse of 
methimazole. 
Evidence of L.A.T.S. activity is interesting in view of the promine
nce 
of the eye signs and lends support to the theory that a closer relat
ionship 
exists between this substance and exophthe.l.Joos than between it and h
yper-
thyroidism. Alternatively, this could be evidence for an aetiologi
cal connec-
tion with Graves' disease, either anteceding the onset of the illnes
s by IOOnths 
or years or not. Such a concept has been put forward by Werner(
22~) who cited 
ten similar cases. Only prolonged follow up of these patients will
 confirm or 
reflute this interesting possibility. 
(7) ACTIVITY OF L.A.T.S. AND E.P.S. IN THE SYNDROME OF PRETIBIAL 
MYXOEDEMA .AND EXOPHTHALMOS: 
L.A.T.S. has been found consistently in sera of euth;yroid patients w
ith 
maJ.ignant exophthalDX>s(5, 
160, 162), even without antecedent hyperthyroidism 
( 160, 162) • This is a possible explanation for the high levels of "thyrotrophi
n" 
assayed in this condition by earlier workers(75, 
107, 175, 185). In pretibial 
iey:xoed.ema, greatly increased thyrotrophic activity has been found in
 serum(1B5) 
and urine(2
19 >, but no reports of L.A.T.S. assays have appeared. As L.A.T.S. 
activity seemed likely, assays were undertaken on plasma samples fro
m three 
subjects for this study. E.P.S. was concurrently estimated. 
- 110 -
Albert found E.P.S. activity in the Illlco-polysaccharide subs
tance which 
accumulates in the retro-orbital. space in exophthalloos(
1S). In view of this, 
L.A.T.S. and E.P.S. activity was assayed in homogenised sanp
les of pretibial. 
JIO'XC)edematous tissue. 
Such tissue was biopsied, washed clean of blood, dried as much as 
was possible, weighed and homogenised in sal.ine by a hand ho
oogeniser, to 
give a final. concentration of 5 ~- tissue/ ml.. sal.ine. Hom::>genate
s were 
centrifuged and the supernatant assayed. The results were a r
esponse to 
0.5 ml.. of the supernatant fluid i.e. 2.5 ~- tissue. 
After the responses of the first case, it was real.ised that c
ontrol 
hom:,genates should be used. This was done subsequently with sub
cutaneous 
fat reJOOved from a site distant from the pretibial. nzyxoedema and 
homogenised 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 -..... • I I I 
- 112 -
Comment: Enormus levels of L.A.T.S. are present in the plasma of two
 of 
the three patients, and some late activity is possibly present in the third. 
It appears that concentrations of L.A.T.S. of this degree are associated 
strongly with the development of pretibial II\YXC)edema. 
Late activity was likewise found in two of these sa.nples of pretibial 
nzyxoedema, but to a considerably lesser degree than in the plasma. A positiv
e 
response, but of no significance, was obtained in the third case. In view of
 
the very high plasma figures, the possibility of trapped plasma nust be con-
sidered as a cause of this high response, but the significantly lesser 
response from the apparently equally vascular subcutaneous fat would invali-
date this suggestion. 
The finding of such L.A.T.S. activity in pretibial nzyxoedema. raises 
interesting speculation as to its aetiology. 
E.P.S. levels were inconsistent and in the first two cases did not 
parallel L.A.T.S., though some activity was present in the pretibial nzyxoe-
dematous tissue in each case. Case 3 had+++ activity in the serum, and 
sonewhat less in the tissues, but its presence in the otherwise inert fat 
raises a possibility of a false positive reaction. 
(8) ASSAY OF L.A.T.S • .AND E.P.S. IN MALIGNANT EXOPHTHALMOS 
FOLLOWING THIROIDEJTOMY: 
The presence of large am:>unts of L.A.T.S. in malignant exophthalmos 
is well documented(5, 
160, 162). The majority O'f patients either suf'fered 
from a mild degree of lzyperthyroidism or had been treated for this con.di tion,
 
al.though occasional cases without such a preceding history have been 
reported(160, 162). 
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E.P.S., too, has been assayed in exophthalmic patients with great 
frequency, irrespective of thyroid function(
86 , 15°). 
L.A.T.S. and E.P.S. a.ssa,ys were performed on two euthyroid patients 
each of whom had undergone two thyroidectomies for recurrent thyrotoxicosis 
during the preceding 15 years. The resw.ts are shown in Table XVII. 
Patient Sex , Age I Mean % Increase Response E.P.S. Remarks I I in Radioactivity Ratio Assa,y 
2 hr. 7 hr. 
' 
1. J.M. F 53 ! 195±23 278±32 1.43 ++ Thyroidectoll\Y twice ill 
? Significant 16 years for recurrent 
(t =2.1298 hyperthyroidism. Gross 
I 0.05 < ) exophthalm:>s with 
l < 0.1 visual i:apairment, static for 6 years. 
I 
2. A.L. F 54 146±20 1a5±25 1.27 0 Thyroidecto!J\Y' twice in 
? Absent 10 years for recurrent 
(t = 1.279 hyperthyroidism. 
p not sig- Euthyroid at present, 
nificant.) with severe exophthal-
JIX)Se I131 uptakes 25, 
3(1fo. RBJ uptake 22. 01),. 
' 
TABLE XVII. E.P.S. and L.A.T.S. in malignant exophthaJ.nx>s. 
Comment: In both cases, L.A.T.S. activity is deioonstrated although this ma:y 
not be significant in Case 2, and this conforms to the reported incidence. 
The type of clinical backgr01.m.d present wow.d appear to provide the ideal 
setting for the development of exophthalioos, and certainly the highest levels 
of L.A.T.S. appear to have been found under these conditions(5, 
160, 163). 
E.P.S. was found in the subject with the greatest L.A.T.S. activity only. 
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THE RELATIONSHIP BETWEEN L.A. T. S. AND E. P. S. 
The association between the presence of L.A.T.S. and clinical 
exophthalm:,s already discussed and shown in this study ( Chapters VIII and IX) 
has led to speculation as to whether L.A.T.S. mas- be identical with E.P.S., 
and whether two entirely different assay techniques are, in fact, measuring 
the same substance. Unlike thyrotrophin, both L.A.T.S. and E.P.S. are 
stable if stored in a frozen state(SG, 
15°, 162). 
Undoubted differences exist however. E.P.S. is always found in the 
thyrotrophin fraction of anterior pituitary extracts(
16, 17, 18, 80, 167), 
whereas the anterior pituitary glands of three patients with the h;yper-
thyroidism-exophthalm:>s conplex have been found to contain no L.A.T.S. (
160, 163), 
although this had been present in the serum of one patient during life(
160). 
Furtherm:>re, four patients who developed Graves' disease after surgical 
ablation of the pituitary for various reasons had L.A.T.S. activity in their 
serum(1
60). The site of origin of these two substances is therefore 
dissimilar. 
To settle this issue, collaborative bioassays for both these sub-
stances, perforned on a single aliquot of plasma and reported in this and 
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Comment: On 21 occasions, collaborative bioassa,ys were performed. All except 
one of the eleven plasma or hoIIX)genate speci:rrens which yielded a positive 
( + to ++++) E.P.S. assa,y had significant L.A. T.S. activity. In fact, higher 
levels of E.P.S. tended to correlate with increased amounts of L.A.T.S. (cases 
1 , 9, 11 and plasma of Case 8) • Of the remaining ten specimens without 
significant E.P.S. activity, seven actually contained significant L.A.T.S. 
levels (Cases 3, 5, 10, plasma and fat hoxoogenate of Case 6 and plasma and 
hoioogenate of pretibial IeyXC>edema of Case 7). The plasma of H.F. (Case 6) 
which 'had tre:rrendous L.A.T.S. activity was strikingly lacld..ng in E.P.S. 
Three SSIIples contained neither L.A.T.S. nor E.P.S., while an hoIOO-
genate of fat of Case 8, used as a control, showed no L.A.T.S. or thyrotrophic 
activity, yet had ++ E.P.S. As has been mentioned, this last observation is 
of doubtful significance as occasional false positive E.P.S. assa,ys are reported. 
Six patients were severely exophthalmi.c. The plasma of all contained 
greatly increased amounts of L.A.T.S. (in five instances, roadings of± 25(1}& 
or higher are present - Cases 1, 6, 7, 8 and 9). In only three of these was 
E.P.S. found, but on each of these occasions, at high levels. 
At tines, therefore, a correlation between E.P.S. and L.A.T.S. appears 
to exist; but at others, a marked discrepancy was d.eIOOnstrated (at a time when 
the fish used in the E.P.S. assays were responding well). This suggests that 
though both factors are related in their associations, this is not absolute, 
and they are probably different substances. As a generalisation, L.A.T.S. 
was found to parallel the clinical state more closely than E.P.S. levels 
( this will be further shown in Chapter X) , and this may be the more inportant 
factor in the genesis of the puzzling synptom couplex of endocrine exophthalJOOs. 
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On the other hand, the relative failure to correla
te E.P.S. with the 
clinical status of the patients in this study may
 reflect on tre accuracy and 
sensitivity of the method, rather than on its act
ual presence in the plasma. 
It is possible that anterior pituitary E.P.S. lev
els may be more pertinent to 
the clinical picture as it is not unreasonable to
 postulate that it may mediate 
its effects by another hum:>ral ~chanism, possibl
y even L.A.T.S. 
SUl.iMARY OF L.A. T. S. ACTIVITY IN ENDOORINE DISORDE
RS: 
The assays for the presence of L.A. T.S. performed
 during this study are 
graphically represented below. The highest resu
lts are seen in pretibial 11\YXOedema. 
with exophthalm:>s, malignant exophthal.Ioos in euth
yroid subjects and "}zyperophthal-
mpathic" Graves' disease. Similarly elevated re
sponse ratios are seen in these 
states. This suggests a very strong association 
with exophtha.lln:>s. 
Two dose levels of thyrotrophin standard, as wel
l as plasma from an 
acromegalic and a IJ\YXOedematous subject showed a 
negative response ratio sugges-
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FIGURE 19: L.A.T.S. assays in endocrine disorde
rs, 
normal. subjects and thyrotrophin standard. 
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SUMMARY OF E.P. S. ACTIVITY lli mDOCRINE DI
SORDERS: 
Assqs for E.P.S. performed in this study
 are shown in Figure 20. 
Those results found in hyperthyroidism and
 uorxoedema have been excluded 
(see Fig. 17). Significant levels were found in
 pretibial uorxoedema and 
malignant exophthal100s in euthyroid subje
cts, though with nru.ch less consistency 
conpared to L.A.T.S. The other endocrinop
athies yielded insignificant results 
apart from the single positive assq in an
 a.cromegalic. This has been commented 
on already. 
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• Di ff US/l 0 Myxolldllma t issull 
0 Nodular X Control Fat 
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Serial Assays of E.P.S. and L.A.T.S. in relation
 to the therapy of 
h.vperth.yroidism and exophthalmJs 
As the correlation of the course and progression
 of' exophthalroos with 
E.P.S. and, roore especiaJ.ly, L.A.T.S. levels is a
 close one, serial assays of 
these substances would be valuable in the investi
gation of the effects of the 
various drugs used in the treatment of hyperthyro
idism and exophthalroos. Anti-
thyroid drugs are reported to precipitate or aggr
avate exophthalroos when used in 
the treatment of thyrotoxicosis ( ~33) , but this rema
ins a clinical inpression, 
rather than a scientific observation. 
The status of ni,dical treatment of severe exophth
alroos is likewise 
arbitrary. Claims have been ma.de in favour of oe
strogens(21 9) and f'or(
123,132) 
and against(
161 ) corticosteroids, while thyroxine remains the tr
aditional. treat-
ment; but adequately controlled trials are spars
ely reported, am. assessment in 
individual. cases is notoriously difficult, becaus
e of the great tendency for the 
disease to fluctuate spontaneously. 
As a correlation between the clinical. results of
 treatment and serial 
levels of 'L.A.T.S. and E.P.S. would make assessm
ent of these effects nx>re objec-
tive and less of a "clinical inpression", sooh es
timations were carried out under 
a variety of conditions, in an attempt to confirm
 or refute the therapeutic 
claims indicated above. 
Assays were seriaJ.ly performed under four sets o
f conditions:-
( 1 ) E. P. S. was assayed during the conventional t
reatment of a severely thyro-




(2) A patient suffering f'rom acute pretibial Ir(Y'XOedema. and severe progressive 
exophthalm:>s was given massive doses of dexamethasone. The progress was 
followed both clinically and by serial bioassays of L. A.T.S. and E.P.S. 
(3) L.A.T.S. and E.P.S. were assayed d\ll"ing the treatmmt of two thyrotoxic 
patients with methi.Dazole alone. 
(4) A thyrotoxic patient receiving methima.zole treatment and a eut}zyroid 
subject with eye signs of thyrotoxicosis, both of whom had significant 
L.A.T.S. levels were given thyroxine and followed serially. 
The results are reported below:-
(1) Effect of antithyroid drugs and thyroxine on E.P.S. activity in 
hyperthyroidism. 
A 42 year old female suffering from a severe hyperthyroid state with a 
marked degree of exophthalm:>s was treated with propylthiouracil 200 mg.tds., and 
thyroxine 0.1 ~· bd. E.P.S. activity was estimated weekly during a seven week 
course of treatment, and the results are ind.io ated in Figure 21. 
Treatment I 
+t++ 
+++ ~ T3 120 pg/day 
E.P.S. +t ~ Thyrox ine 0 -1 mg b.d. 
~ Propylthiouracil 200 mg t .d.s. 
+ 
± 
2 3 4 5 6 7 
Weeks 
R. D. Hypert hyroid - Marked Exophthalmos 
, FIGURE 21: E.P.S. assays during therapy for hyperthyroidism. 
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Comment: An E.P.S. level, which was extremely hi
gh, dropped progressively 
during this treatment until finally no activity w
as found. Unfortunately exoph-
thalmometry was not performed so that the inpressi
on of clinical iuprovement 
cannot be assessed objectively. However, the hyp
erthyroid.ism had considerably 
lessened, and at the end of the recorded period, 
all initial synptoms had 
abated, while a weight gain, drop in pulse rate a
nd disappearance of the tremor 
were noted. 
This response is somewhat difficult to assess. I
t is accepted by some 
that the exophthalmos of the usual case of Graves
' disease inproves as the 
thyroid overacti vi ty is brought under control, wh
ile in malignant exophthalmos 
with mild or no hyperthyroidism, eye signs may wo
rsen if treated by antithyroid 
drugs(
123). In this instance, the diminution of E.P.S. activit
y which paralleled 
inprovement in "toxicity" suggests that the case 
falls into the f'orner category. 
A diminution in E.P.S. activity may possibly be a
 prognostic pointer as to the 
direction in which a particular case of Graves' d
isease is moving. 
Although the explanation offered seems ioost likel
y in the case reported 
above, opinion Im.1st be guarded in the light of a 
single set of observations, 
and JIX)re especially as the patient received not o
nly antithyroid drugs but, 
in addition, thyroxine. 
(2) Effect of large doses of corticosteroids in 
progressive exophthalmos: 
A 42 year old male presented with a six week history o
f progressive 
swelling of both eyes. Examination revealed gros
s exophthalmos. (Right and 
left eyes 24 mm. as measured by a modification of the Lue
dde exophthalmometer) , 
warm, slightly tender pretibial Il\YXOedema and cla
ssical acropachy, with 
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radiological evidence of periostial reacti
on. Thyroid and red cell uptakes 
were in the eutbyroid range (23, 4'5% and 1~ respective
ly), and the pretibial 
JitYXOedema. was con:f'irned histologically. 
After a single baseline plasma assay of E
.P.S. and L.A.T.S., a heavy dose 
of dexamethasone was comnenced. Serial as
says were performed during two weeks 
of therapy,and the results are graphically
 shown:-
Treatment ~] 
DEXAMETHASONE 1 j 
mg / doy 
350 
" L.A.T.S " 300 
Act ivity 
'1. of In i t i a l 
P la ,ma 250 


















J.S. Pret ib iol Myxoedemo with Exop
hthalmo s 
FIGURE 22: Treatment of severe exophthalnvs with
 corticosteroids. 
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Conunent: The response to dexamethosone is striking. Obje
ctively, great reduc-
tion in exophthalmos was coupled with a marked subjective 
inprovement, and an 
associated drop in plasma L.A. T.S. activity. 
The correlation between L.A.T.S. levels and exophthalmos h
as been notable, 
whereas E.P.S. has shown an inconsistent relationship. Th
is confirms the 
inpression recorded in the previous chapter, and suggests 
that L.A.T.S. assay 
may be a useful laboratory confirmation of the clinical tre
nd in an exophthalmic 
patient. 
Of greater interest has been the response to corticosteroi
ds. The 
. (59 123 131132161) 
reported results have been di verse ' ' ' ' , bu
t some workers have 
felt that failure to elicit an inprovement reflects on the 
inadequacy of the 
dose rather than that of the drug(
123). 
Although one !Illst be cautious in interpreting the results 
of a single 
case, this eppears to support the reports favouring cortic
osteroids in large 
doses as treatment of exophthalms ( 
123, 131 ) and would suggest further controlled 
trials of this drug. 
(3) Effect of methima.zole in L.A.T.S. and E.P.S. activity: 
Two patients with classical hyperthyroidism and mild exoph
thalmos, and 
who had significant levels of L.A,T.S. activity, received 
methimazole 20 mg. tds. 
therapeutically, and serial assays for E.P.S. and L.A.T.S. 
activities were 
conducted weekly. There was subjective inprovemmt in the
 general condition 
and degree of hyperthyroidism in response to treatment in 
both cases. 
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One patient, L.G., aged 35, had thyroid I 
131 uptakes of 73, 80}& which 
did not suppress after T3, and red cell uptake of 22.6
%. The second subject, 
L.A., aged 36, had similarly raised thyroid uptakes o
f 75, 87%, which also did 
not diminish after T3, with red cell uptake of 27.6%.
 
The results of the serial assays are shown in the foll
owing two figures:-
Thy r"ox1n~ O 1 mg bd I 
Tr eatm ent 
M•th1mo rohi 20 mg t ds. 
"L.A.T.S . " 
01. o f ln it ia I 
Pla sm a 





E P S. 
Ac t iv it y ·:=]~~ ...... ~~~ ~~~[] 
1 2 3 4 5 6 7 8 Weeks 
L.G. Hype rthy r o id with Mild Exopht halm os 
FIGURE 23: Eff'ect of irethima.zole on L.A. T.S. and 
E. P.S. activity in hyperthyroidism. 
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Treatment 
Mothimozol• 20 mg. tds . 
L . A. T. S 
0 /o of Initial 
Pla sma 
Radioactivity 





++++I +++ .i D 
T 
' 
2 3 4 5 
Weeks 
J. A. Hyperthyroid - no Exophthalmos 
FIGURE 24-: Effect of rrethimazole on L.A.T.S. and 
E.P.S. activity in hyperthyroidism. 
Couunent: In both cases, a striking rise in the level of L.A
.T.S. is evident. 
Routine exophthalnx:>metry was not carried out, but no subject
ive or objective 
evidence of exacerbation of exophthalm:>s was noted. 
The inplications, on the basis of two cases, nrust be cautiou
sl.y inter-
preted. The clinical inpression that anti thyroid drugs exac
erbate exophthalm:>s 
has long been held (s3), but has never been put onto a scientific foo
ting. The 
observation that L.A.T.S. levels are increased by these agen
ts, suggest that 
some basis may exist for the above view. The effects 'IIJB3", h
owever, be transient 
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only, as in Case 1, L.A.T.S. levels were beginning to drop sharply before the 
therapy had been al.tered and Case 2 appears to be following the sam
e course. 
During these periods of increased L.A.T.S. activity, no obvious deterio
ration 
in exophthal.mos was evident. 
Once again, E.P.S. assays yielded results which did not paral.lel L.A
.T.S. 
activity and is further evidence for their independent identities. 
However, 
at the point of peak L.A.T.S. activity, E.P.S. was present in the pl
asma of 
Case 1, but its presence was confined to that single occasion. Con
versely, 
E.P.S. was maximal at the commencement of therapy in Case 2, and dis
appeared 
subsequently. This is very sindlar to the first case reported in this ch
apter. 
(4) Effect of thyroxine on L.A.T.S. and E.P.S. 
In L.G., the thyrotoxic patient on methimazole just described, and i
n 
another subject, E.R., considered to be eutlzyroid but with the eye s
igns of 
hyperthyroidism, thyroxine was given in an attempt to assess the ef
fect of 
this drug on the high levels of L.A.T.S. present in these two cases.
 In 
addition, E.P.S. was assayed serial.l.y. 
The results in L.G. have been indicated in Figure 23, while those in
 
the second subject are shown graphical.ly in Figure 25: 
Treatment 
hyrox1ne2 01 mg td s. 
" L. A.TS ." 
°lo of Init ial 
P lasma 
Radioactivity 













2 3 4 5 6 7 
Weeks 
E .R. Euthyroid with Eyes igns 
n 
8 
FIGURE 25: L.A.T.S. assays in a euthyroid subject with severe eye 
signs of hyperthyroidism, treated with thyroxine. 
Comnent: The effect of thyroxine administration in the two cases studied is 
inpossible to assess. L.A.T.s. activity was already beginning to drop in the 
plasma of L. G. while she was on methimazole only, a.nd the subsequent disappear a.nee 
of this activity mey have reflected the natural course of the treated eyper-
thyroidism, rather than a. specific effect of thyroxine added at a. late stage. 
Wide fluctuations in L.A.T.S. activity occurred in the case of E.R., and 
the initial rise, and subsequent drop in L.A.T.S. levels ca.n only be interpreted 
in the light of such fluctuations. 
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In actual fact, no definite trend was found in either case following 
thyroxine, though lower levels of L.A.T.S. tended to occur • .Although adequa
te 
explanations can be found to account for this phenomenon, further studies are
 in 
progress to clarify this inportant point. 
High values for L.A.T.S. have been reported in patients on thyroxine 
therap/ 
160) and L.A. T.S. has actually been shown to rise when assayed in a 
thyrotoxic patient before and after thyroxine(S). In addition, the highest a
ssa;y 
values in this study were found in the plasma of a patient with pretibial II\YX
-
oedema. on maintainance thyroxine therapy. 
It would appear, therefore, that thyroxine in the dosage enployed, has 
not been conclusively shown to affect the levels of L.A.T.S. It would be 
inportant in the assessment of this drug to use it in higher dosage in the 
treatment of rapidly progressive exophthel.ros and to follow such cases with 
serial assays of the hor:m:>ne. 
thyroxine nu.st remain reserved. 
Until this is done, judgement on the status of 
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CHAPTER XI 
The effects of tri-iodothyronine (TJ) on teyrotrophic, 
L.A. T.S. and E.P.S. activity in human plasma 
An investigation of the mechanism of the T3 suPpression test of th
yroid function 
The d.enx>nstration of an increased thyroidal uptake of radioactive 
iodine 
was a useful collaborative laboratory test in the diagnosis of Gra
ves' disease, 
but confusion arose as euthyroid patients with goitre were not infr
equently 
found to have high uptakes. The introduction of thyroid hornx>ne, 
and, later, 
tri-iodothyronine (T}) solved this difficulty as these hormones su
ppressed r131 
uptakes in euteyroid states but failed to do so in Graves' disease(
1121 225). 
The pathways by which this suppression normally occurs are well docu-
mented ( 
168) but the reason why suppression is not demonstrable in Graves 
I disease 
is unknovm.. Werner(
224) postulated the concept of autononx>us thyroid activity 
to explain this. Suppressibility has been shown to return with the euthyroid 
state, whether induced by radio-iodine, thyroid.ectOJJ\Y or antithyro
id d.rugs(
116), 
even though th~ abnormal metabolism of thyroxine ( 
124) and T/ 11 5) persists. 
This, too, has been taken to suggest that the resistance to suppre
ssion in 
Graves' disease may be directly related to the hyperftmctioning th
yroid gland, 
as suppressibility has returned after treatment which has cured the
 hyperthyroid 
state by apparently exerting an effect only on the thyroid gland a
nd its pro-
duction of hormone<
116). Werner's concept has been criticised by Russell 
Fraser(




the pituitary-thyroid homeostatic mechanism and not of necessity primaril
y 
a thyroid dysfunction. 
The assay of thyrotrophin and L.A.T.S. provides an excellent opportunity 
for testing these hypotheses in euthyroid subjects with high 24 hour thyr
oidal 
I 131 uptakes in whom suppression is induced by T3, and hyperthyroid patie
nts 
with high uptakes in whom this does not occur. This is of particular int
erest 
as L.A.T.S. has been postulated as the aetiological factor responsible fo
r 
Graves' disease, mediating its effect presumably via its thyrotrophin-lik
e 
action. It is even possible that the high thyroidal I 
131 uptakes in Graves' 
disease are a resul. t of the action of this substance. 
For these reasons thyrotrophic and L.A.T.S. activities were assayed 
before and after a T3 suppression test in euthyroid and hyperthyroid subj
ects. 
All had high 6 and 24 hour r
131 uptakes following 25 Po• oral r
131 
and received 
120 pg· T3 daily for 7 days, when the 6 and 24 hour uptakes were repeated. 
On the day of both uptakes, blood was sanpled and thyrotrophin or L.A.T.S
. 
was assayed. 
(1) Effect of tri-iodothyronine administration on thyrotrophic activity 
in euthyroid subjects with high thyroidal I131 uptakes. 
Seven persons presented with diff'use goitre but no synptoms or signs 
of hyperthyroidism. All had high thyroidal I 
131 uptakes which were suppressed 
by T3. Thyrotrophic activity was estimated before and after T3 suppressi
on 
as indicated above. Results are tabulated and graphically shown in Table
 XIX 
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L.S P.P. J.K. L.V. DH EF D M FF G
.D. RB JH BR 
Euthyroid with Goit r e Hyperthyr
oid 
FIGURE 26: Thyrotrophic activity in euthyroid and hyper
thyroid 
subjects before and after tri-iodothyronine. This is 
Post T3 
conpared to the 24 hour uptake Pre T3
, expressed as 
a percentage. 
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Comments: In Oases 1 - 4, thyroidal I 
131 uptakes were effectively suppressed 
by tri-iod.othyronine in the dose stated earlier. In ea.ch case, this appears 
clearly to be related to an effective suppression of plasma thyrotrophic 
activity. This confirms results obtained in a di:f'terent type of study, where 
the effects of exogenous thyrotrophin were suppressed by administered thyroid 
honoone(168) with resultant lowering of thyroidal I 
131 uptake. The mechanism 
of this test in euthyroid individuals seems clear, therefore. Thyrotrophic 
activity was within normal limits initially and. it is unlikely to have been 
directly responsible for the increased I 
131 uptakes. This phenomenon is more 
probably related to the status of the thyroid. gland in these goitrous subjects. 
Cases 5 - 7 showed increased I 
131 uptakes, but only partial suppression 
by T3 administration was achieved. This, too, was paralleled by the absence 
of the usual drop in thyrotrophic activity, which appears to confirm the close 
relationship between thyrotrophin levels and thyroidal I 
131 uptake in the 
euthyroid subject. The evidence is based on a very small nuni:>er of cases 
however, and until a larger series is completed, the results must remain an 
interesting, though probably correct, speculation. Bottari has reported 
similar results in a few cases he studied, but no details have be~ quoted(48) 
(2) Effect of tri-iod.oth.yronine administration on thyrotrophic activity 
in h.yperth.yroid subjects: 
Thyrotrophic activity was estimated in five subjects with classical 
Graves' disease who had the typical high thyroidal r131 uptakes, not suppressed. 
by T3. Assays were done at the commencement and the end of T3 administration, 

















































































































































































































































































































































































































































































CoIDIOOnt: It is quite clear from these results that thyrotrophic activity does 
not alter significantly or consistently in any one direction following the 
administration of T3. This is paralleled by a lack of suppression of the high 
thyroidal I 131 uptakes. 
It was pointed out earlier that assa,ys for "thyrotrophin" in hyper-
thyroidism must have limited, if arzy-, significance when carried out by the 
methods used in this study. Such activity possibly represents L.A.T.S. which 
can exert part of its effect as early as two hours after administration. The 
great majority of the cases with high levels of L.A.T.S. assa,yed in this study 
had significant activity at that time. 
As these results have a very limited meaning, and as they might be 
taken as evidence that L.A.T.S., rather than thyrotrophin, was the active 
substance unresponsive to T3, this substance was assayed in three cases of 
Graves' disease before and after T3 administration in the usual "suppressive" 
dosage. 
(3) Effect of tri-iodothyronine administration on L.A.T.S. activity 
in hyperthyroid subjects: 
The results of L.A.T.S. assays in three subjects are shown in the 
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°lo of Initial 
200 I / 
/ / ~71 
Radioactivity , / 
100 1 ./ 
M.N. J.P M.M. 
Hyperthyroid 
~ 7hr. 
---} 2 hr. 
FIGURE 27: L.A.T.S. activity in hyperthyroid subjects before 
and after tri-iodothyronine. This is conpared to 
thyroidal 24 hour uptakes post T3/pre T3, expressed 
as a percentage. 
Comment: A delayed rise in activity and positive response ratio characteris-
tic of L.A.T.S. occurred in every case, even though the responses at 7 hours 
were not very significantly increased over those at 2 hours. In all three 
instances, these values rose after the administration of T3, which in this smel.l. 
series of cases appears to have no suppressive effect either on L.A.T.S. or 
the thyroida11131 uptake in hyperthyroidism. 
This is not a surprising finding, as McKenzie in fact obtained many of 
his positive assay results in patients either taking thyroid horoone, or under-
. . t t(160) going a suppression es • 
-
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As the results seem to show a d.ef'ini te trend, it is tempting to speculate 
on the implications of these findings. 
L.A.T.S. is found in the great majority of patients suffering from Graves' 
d.isease(5, 155,160, 162). It has a thyrotrop~like action in that it stim..tl.ates 
not only the discharge of r131 (used as an assay method), but increases thyroid.al 
uptake of r131 with histologic evidence of' thyroid byperplasia(144-, 158). Its mde 
of effect therefore is compatible with it being the agent responsible for main-
taining the high I 131 uptake levels in hyperthyroidism. 
Werner• s suggestion that all farms of endocrine exophthalms, whether in 
hyperthyroid subjects or not, are associated with a raised thyroid.al r
131 uptake 
which T3 does not suppress<224(a)), may be linked with the observation, :mentioned 
earlier, that L.A.T.S. levels correlate well with exophthalms, even when it is 
not necessarily part of Graves' disease. 
Thus L.A.T.S. and raised thyroidal 1
131 uptakes have a conm:>n denominator 
both as regards their broad clinical association with exophthalioos, and also the 
absence of a suppressive effect of T3, as suggested by this small study. The 
implication that L.A.T.S. is in fact the agent responsible for the pathologica.lly 
raised r131 uptakes in the hyperthyroid.ism-exophthalms complex is very tempting, 
but f'urther studies will be needed to confirm this point. 
The non-response of L.A.T.S. levels to T3 administration is not supprising 
as its origin is not in the pituitary(
160, 163) and it has probably no direct 
bearing on the anterior pituitary-thyroid homsostatic system in health. As such, 
it could hardl.y be expected to depress after T3 which exerts its effects, as 
shown earlier, by depressing thyrotrophin. If L.A.T.S. is indeed the agent 
responsible for the high I
131 uptake in hyperthyroidism, the reason for the absence 
of suppression by T3 becomes self-evident. 
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There are, however, two main objections to this hypothesis. Firstly, 
not all thyrotoxic patients have a raised L.A.T.S. level, yet failure to suppress 
I 131 uptakes by T3 is a constant finding. It is possible that every thyrotoxic 
patient may, in fact, have increased aIWunts of L.A.T.S., but that the assay 
methods available may be too crude for its detection at lower, and yet abnormal, 
levels. 
The second objection concerns the observation that suppressibility by 
T3 returns after successful therapy of Graves' disease(116), therapy which is 
directed at the thyroid gland and its excessive production of hormone, rather 
than the primary, but unknown, cause. The inference that the agent responsible 
for the resistance to T3 suppression lies in the thyroid gland, is difficult 




Swmnary and Conclusions. 
In the presentation of this work, speculation on and discussion of 
individual results has, to a large extent, :followed inmediately on their 
recording and has been confined to the relevant chapters. As nuni>ers o:f topics, 
not directly related, were studied, it was thought that such a system would 
make for easier and :roore direct appraisal of findings. However, to conclude 
the thesis, some sort of integration is necessary. To achieve this, the stud.y 
will be reviewed with the enphasis on facts, rather than inplication or dis-
cussion, and with the exclusion of ref eremes to the literature unless they 
have not been mentioned in the earlier text. Such a review now follows. 
The development of an understanding of t}zyroid physiology and the regu-
lation of its horIIOnal secretion was traced until the ooncept of an anterior 
pituitary-thyroid homeostatic balance had been founded and the existence of a 
thyrotrophic hormone proven by crude biological assay. 
A review of such assay methods was presented, with special enphasis 
on the oore recent techniques involving the use of radio-isotopes. The limi-
tations of biological assays were stressed and oore essential prerequisites 
for the ideal assay, including objectivity, sensitivity, reproducibility, 
specificity and statistical validity were discussed in relation to newer 
methods. 
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An assay based on the discharge of radio-iodine from the thyroid glands 
of mice was adapted very slightly from that developed by McKenzie ( 154) and was 
used in this study. It appeared to fulfil the prerequisites outlined above. 
Weanling female mice received 8 pc• r131 intraperitoneally, followed by 
thyroxine subcutaneously to suppress endogenous thyrotrophin secretion. Four 
days later, they were used for the assay experiment when whole blood was counted 
for radioactivity before and two hours after the intravenous injection of three 
dose levels of thyrotrophin standard, a saline control and the "unknown" plasma 
sa.nples or tissue homogenates. The increase in radioactivity of the "unknown" 
substances, plotted in relation to the standard dose response line, was translated 
into an absolute value for thyrotrophin and finally expressed in milliunits (~. )/ 
100 ml. plasma.. The technique enabled detection of 0.05 to o.08 nu. thyrotrophin/ 
100 ml. plasma., a sensitivity enough to detect normal thyrotrophic activity. 
Although this assay end point constitutes what is probably the JOOst inportant 
parameter of thyrotrophin function, the quantitative measurement of such function 
does not necessarily inply an equivalent quantitation of thyrotrophin. Such 
biological methods of determination cannot, for instance, distinguish negative 
effects due to antihormones or other circulating antagonists. What was measured 
then, was thyrotrophin-like activity, and all results are best considered in 
this light. 
Evidence for the existence of a circulating e:xophthalmos producing sub-
stance (E.P.S.) as distinct from thyrotrophin, was reviewed. Its nature and 
mode of action were discussed am. the existing assays used to determine its 
presence in the serum of exophthalmic patients were outlined. The only currently 
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used assay depends on the induction of measurable degrees of proptosis in fish, 
either by anterior pituitary extracts or sera and such a technique was conse-
quently euployed in this study, with the goldfish as test animal. The inter-
corneal distance was nee.sured before and three hours after the intracoelomic 
injection of plasma, anterior pituitary extract or saline. No standard reference 
substance exists for E.P.S. assay-s, but an anterior pituitary extract with high 
E.P.S. activity was used consistently at a single dose level throughout this 
study. .An atteupt was ma.de to standardise an otherwise crude procedure and 
conpensate for seasonal and other fluctuations by expressing the increase in 
intercorneal distance (I.C.D.) invoked by the unknown substance as a percentage 
of that invoked by the fixed dose of standard. Such percentages were graded 
0 - ++++, in which terms E.P.S. activity was ultimately expressed. An ad.equate 
dose response relationship was established though great fluctuations from fish 
to fish ma.de it difficult to evaluate results statistically, and this was not 
atteupted. In spite of this, reported assay- results have tended to parallel 
the degree and progression of exophthalm:>s. 
The association of a circulating substance with both Graves' disease and 
exophthalmic states has been reported recently. This substance has a slow and 
very sustained thyrotrophin-like action and has been named "long-acting thyroid 
stim.il.ator" or L.A.T.S. This property has enabled its assay to be undertaken 
by the same method used for "true" thyrotrophin, but as the release of radio-
iodine occurs nuch later, muse blood radioactivity is counted seven to twelve 
hours after injection. The statistical interpretation of such "late" activity 
is not easy as no valid standard for conparison exists. As "true" thyrotrophic 
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activity had aloost invariably dropped at seven hours, any increase as conpared 
to the two hour reading was considered suggestive and a statistically significant 
rise was regarded as conclusive. A "response ratio" was evaluated, being the 
ratio of the seven hour to the two hour response in each unknown assa,y. 
Using the techniques outlined, assa,ys :for the presence of these sub-
stances, either singly or as a collaborative assa,y for all three, were performed 
on aliquots of plasma.. 
Thyrotrophic and E.P.S. activity was investigated in plasma from normal 
volunteers. Mean thyrotrophin levels of 22 I!ll. and 24 Iml../100 ml. were found 
in males and females respectively, while E.P.S. activity was detected in only 
one of the subjects. The recent suggestion that serum thyrotrophin levels may 
be considerably lower(32) has to be interpreted cautiously in view of the com-
plicated extraction procedures used before such ievels could be convincingly 
shown. 
Serial estimations of' thyrotrophin levels in a normal subject revealed 
virtually no fluctuations from week to week. 
In hypothyroid states-great extremes of thyrotrophic activity were 
assayed ranging :from O to 310 mu./100 ml. in eight patients. With the anticipated 
disturbance in pituitary-thyroid balance, thyrotrophin values are usually raised, 
often considerably. Low levels have been explained by a secondarily induced 
bypopituitary function as a result of' subnormal cellular metabolism in the 
JI\YXOedematous state. E.P.S. activity was assa,yed and found generally to be 
absent, in spite of' these high levels, con:firming the dif'f'erent identities of 
E.P.S. and thyrotrophin. However, two patients who had undergone total 
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thyroidectomies for carcinoma had detectable E.P.S. A hypothetical. E.P.S. 
inhibitor, originating in the thyroid glam., was postulated to account for the 
unusuaJ. :findings, though a teclmicaJ. faJ.se positive effect was IOOre likely. 
In hyperthyroid states, thyrotrophin estima.tiona adhered closely to the 
normal distribution range. As these readings may have represented merely a facet 
of L.A.T.S. activity, their significance is doubtful. L.A.T.S. assays were 
performed on nine thyrotoxic patients, in only two of whom was activity unequi-
vocaJ.ly absent. It was highest in the single subject who could be termed hyper-
ophthaJ.IOOpathic. E.P.S. was assayed IOOre consistently than in hypothyroidism, 
and at higher levels. Though the greatest response was in the severely exoph-
tha.lmic patient, E.P.S. was found in subjects with mild eye signs. It has been 
suggested that such patients may ultimately develop exophthaJ.mos. 
In 22 euthyroid subjects with various types of goitre t?Y1"otrophic 
activity was generaJ.ly normal. The thyrotrophin level appeared to bear no 
relationship to the thyroidaJ. I 131 uptakes, as the high and low uptake groups 
had very similar activity. The cause of raised thyroidaJ. I 
131 uptakes in goitre 
remains obscure, therefore, but appears to be independent of raised plasma. 
thyrotrophin levels. E.P.S. activity was not increased in the few patients on 
whom assays were perforned. 
In proven lzypopituitarism no thyrotrophic activity was detected, while 
in two cases of thyroid carcinoma, it was within the normal range. Levels of 
thyrotrophin, two to three times those of normal, were found in a single case 
of subacute thyroiditis. The significance of this single vaJ.ue is doubtful. 
Of' three patients with HashiIOOto' s disease, two had absent thyrotrophic activity. 
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The inportance of' such results in a small number of' cases when normal. blood 
may on occasion have no detectable thyrotrophic activity, is doubtful. The 
result may, however, be related to the presence of a cytotoxic factor in the 
sera of many patients with this disease. E.P.S. was absent in all three cases. 
In three cases of untreated acromegal.y, thyrotrophin was normal, but 
one case had L.A.T.S. activity which was probably significant. This patient 
also had increased levels of E.P.S. and rather high thyroidal and REC I 131 
uptakes. This is interesting in view of the association between acromegaly 
and both hyperthyroidism and goitre. 
Three euthyroid patients with marked lid lag, lid retraction and slight 
exophthalmos were shown to have L.A.T.S. activity. This syndrome has been 
considered to occupy one end of' the spectrum of hyperthyroidism(224,b), and the 
results reported may strengthen this concept. E.P.S. was present in one of two 
such cases tested. 
Two patients presented with malignant exophthalmos following repeated 
thyroidectomies. One had definite, and the other suggestive, L.A.T.S. activity. 
Again, E.P.S. assS3"s yielded inconsistent values, being raised in the one ease 
only. 
Striking results were obtained when plasma of three subjects with pre-
tibial nzyxoedema and exophthalmos was assS3"ed. In two, enorm:>us amounts of 
L.A.T.S. were present. lioIOC>genates of the pretibial norxoedematous tissue 
appeared to have L.A.T.S. activity too, this being significantly increased as 
conpared to control suspensions of subcutaneous fat. The significance of these 
findings is obscure, but the presence of L.A.T.S. in very high concentration in 
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plasma and pretibial tissues of such patients may point to a direct aetiological 
association between L.A.T.S. and this very interesting syndrome. 
The results of aJ.l the collaborative asseys for E.P.S. and L.A.T.S. were 
correlated and though both substances were found to parallel exophthalmos to a 
certain extent, L.A.T.S. was shown to be IID.J.Ch more consistent in this respect. 
Furthermore, plasma with extreirely high L.A.T.S. activity failed to elicit an 
exophthalmic response in the test animals. If one excludes the possibility of 
false negative assays due to non-responsiveness of the fish, it v.ould appear 
that L.A.T.S. and E.P.S. are different substances although both are clearly 
related to the pathogenesis of exopbthalmos. Pituitary E.P.S. levels rather 
than plasma values, IIl83'" be mre inportant in this respect, and it is not inpos-
sible that E.P.S. mediates its action via other substances, possibly even L.A.T.S. 
In summary, the highest responses in the L.A.T.S. assays performed in 
this study were obtained in the pretibial icyxoedema. syndrome, malignant exoph-
thalms in euthyroid subjects and "hyperophthalmopathic" Graves' disease. This 
suggests a very strong relationship to exophthalmos. Thyrotrophin standard, and 
plasma from JqyXoedema.tous and acromegalic subjects showed a considerably reduced 
"late" response, that is, no L.A.T.S. was found. 
E.P.S. was assayed most consistently and at highest levels in patients 
with hyperthyroidism but activity was also found in the plasma of euthyroid 
patients both with malignant exophthalmos and with the eye signs of hyperthy-
roidism and those with pretibial JI\YXOedema.. The occasional false positive 
result was noted with this assay. 
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Serial assays for E.P.S. and L.A.T.S. were perfonned on a number of 
patients to investigate the effects of various forms of therapy in hyper-
thyroidism or exophthalioos. 
In one thyrotoxic patient with exophthalloos, an elevated E.P.s. value 
diminished progressively dlilring therapy with propylthiouracil and thyroxine 
and this result may represent the counterpart to the clinical response ot 
exophthalIOOs to antithyroid therppy which is claimed to occur ins:>ne cases 
of hyperthyroidism. 
The progression of exophthalmos in a patient with pretibial JlO'XOed.ema 
was dramatically reversed by the exhibition of large doses of dexanethasone. 
This effect was followed by exophthalIIX>metry and a concomitant drop in L.A.T.S. 
levels was d.eIIX>nstrated. E.P.S. appeared inconsistently in the plasma however, 
and did not parallel the clinical state at s:ny tine. The close link between 
L.A.T.S. levels and exophthalmos was well illustrated as was the striking thera-
peutic response to d.examethasone in large doses. 
In each of two cases studied, methimuole appeared to elevate plasma 
L.A.T.S. levels markedly, but the effect may have been a transient one. No 
conclusions are warranted on such meagre results, but if this is confirmed in 
a larger series, a basis may have been provided for the reputed averse effects 
of antithyroid drugs on the exophthalmos in son:e patients with Graves' disease. 
However, in one of these cases, E.P.S. actually disappeared from the plasma. 
during therapy. Again, E.P.S. and L.A.T.S. values have been found to be 
contradictory. 
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The effect of thyroxine on L.A.T.S. was inconclusive in the two cases 
studied. One patient had levels which fluctuated greatly, and L.A.T.S. appeared 
to be subsiding before thyroxine administration in the second.. No clear-cut 
effect was noted, but it was thought that this would be unlikely in view of the 
high aJOOunts of L.A. T.S. reported in sera from thyrotoxic patients on thyroxine 
or during a tri-iod.otbyronine suppression test. 
The suppressive effect of tri-iodothyronine (T3) on the high thyroidal 
I 131 uptakes in euthyroid subjects with goitre was shown to be due probably to 
a depression of endogenous thyrotrophin secretion, as plasma thyrotrophic 
activity disappeared in fcnm such patients after the a.dministration of T3. 
In three, in whom partial suppression of r131 uptakes occurred, depression of 
thyrotrophic activity was not recorded. 
In hyperthyroidism, lack of a suppressive effect of T3 on the elevated 
I 131 uptakes correlated with the persistence of thyrotrophic activity in five 
cases studied. As thyrotrophin estimations are of doubtful significance in the 
presence of L.A.T.S., the latter substance was assayed in three cases, before 
and after T3. No effect was noted. This result is not surprising, as L.A.T.S. 
does not appear to originate in the anterior pituitary gland and would not be 
expected to participate in the homeostatic effects of thyroxine. L.A.T.S. has 
been shown to stimulate thyroidal I 
131 uptake, and it is speculated that the 
presence of this substance in the plasma of thyrotoxic patients is responsible 
for both the elevated thyroidal r131 uptakes and the lack of suppression by T3, 
so typical of that condition. That the presence of L.A.T.S. is by no means 
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as universal in hyperthyroidism as the abnormal. r131 uptakes, must constitute 
a major objection to this attractive theory. 1't remains to be assessed 
whether the return to normal of the r131 uptakes with the euthyroid state 




Recommendations for future work. 
11 •••••••• 0ne cannot fly through the air on a broomstick. 
It must at least have a machine on it. But as yet there 
is no such ma.chine. Perhaps there will never be, for man 
is too heavy. But, of course, one cannot tell. We don't 
know nearly enough, Giuseppe. We are really only at the 
beginning." 
Bertolt Brecht. - The Life of Galileo. 
When new or uncommon techniques are developed, they may either be used 
to study a limi. ted project extensively, or be enployed in a. probing fashion to 
so\.llld out a number of problems, as has been done in this work. The resulting 
thesis may be circumscribed and con:plete or discursive and provocative. Dis-
cursive methods often raise questions rather than answer them, and in this 
concluding chapter, some of these questions will be considered, and the attempts 
being made to pursue them will be outlined. 
(1) One of the most in:portant facets of this study concerned the suggestion 
that L.A.T.S. may be the agent responsible for the elevated thyroidal I 131 
uptakes and the associated resistance to T3 suppression so characteristic of 
hyperthyroidism. While it was shown that T3 did not suppress L.A.T.S. activity 
in a small series of thyrotoxic patients, the rest of the theory was supplied 
by analogy and supposition, but it may well be correct. It is being pursued in 
two ways:-
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(a) the number of thyrotoxic subjects who are being subjected to L.A.T.S. assays 
during a T3 suppression test, is being increased. (b) Patients are being 
followed up, and the return of suppressibility following T3 which is said to 
parallel clinical in:provement, will be con:pared to serial L.A.T.S. levels. If 
a close correlation is shown to exist, the circumstantial evidence for the 
above asswiption will be strong. 
( 2) The abnormal thyrotrophin levels found in ·Hashimoto' s disease and 
suba.cute thyroiditis, and the L.A.T.S. assayed in acromegaly, all await con-
firmation in larger series of cases. These studies will continue until enough 
material is obtained to warrant a more conclusive statement. 
(3) Collaborative assays have led to the suggestion that E.P.S. and L.A.T.S. 
are different substances. This finding will be :further investigated by frac-
tionating plasma. and assaying each :fraction for both substances. Should they 
differ in their mobility either on electrophoresis or on a DEAE column, their 
non-id.entity will be conclusively proven. L.A. T. S. however, apparently migrates 
with no specific serum fraction when eluted from a starch block after electro-
phoresis(160,162), or when fractionated on a DEAE column(160). The establish-
ment of such differential mobility may therefore be difficult, or even in:possible. 
(4) L.A.T.S. has been found in truly remarkable aIOOunts in the plasma of 
a patient suf:f ering from pretibial ieyxoedema. and exophthalmos. The presence of 
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this substance in such high concentration may allow its chemical extraction and 
perhaps even purification. Such possibilities are at present under investigation. 
(5) Serial plasma assays for E.P.S. and L.A.T.S. in thyrotoxic and exoph-
thalmic patients under therapy are being continued. Of particular inportance 
using these techniques, is the evaluation of the possible effect of antithyroid 
drugs in raising the L.A.T.S. level and the clinical parallel of this effect 
with exophthalm:>s. 
The effect of thyroxine on L.A.T.S. and exophthal!oos is likewise under 
further scrutiny, both at conventional and at much higher dosages. 
The field of both endocrine exophthalm:>s and hyperthyroidism has always 
been an open one. Exciting recent researches, while shed.ding new light, have 
sometimes obscured the old. It was an attempt to explore some of the shadows 
which led to this study. That much darlmess has been dispelled cannot be 
claimed; perhaps more has been added. Fundamental difficulties remain, and 
until more refined tools are available for hormone research and assay, many 







STATISTICAL METHODS USED IN THIS STUDY. 
Mean value x =Zx where n x = single observation and 
n = number of observations • 
Standard deviations 
or more conveniently expressed when large numbers of 
observations are used 
s = 
Standard error of the mean e 
Limits for the variation of 
(Z x) 2 
n - 1 
s - -- ,In 
n 
X were decided on the 
distribution of t ' for the corresponding numbers of degrees 
of freedom (n - 1 = f) • At a "probability" value of 
0·05 (95°/0 confidence limits) , the variation of x would 
be calculated as x ± e.t
0 • 05 
• 
(5) Significance of difference between x and y was estimated 
by the students 11 t 11 test , where 
t = X - V e and e represent the 
X y 
standard errors of x and 
Using statistical tables, significance was read in 
"probability" ln the corresponding number of degrees of 
y. 
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freedom (n + n - 2 = f) • :x: . y A difference was regarded 
as significant if p < 0·05 • The statistical difficulties 
regarding the significance of L.A.T.S. assays have been 
alluded to. In these instances, the result was regarded 
as probably significant if p < O•l 
(6) The slope of the log.-dose response line was calculated by 
regression analysts , made by the method of least squares. 
The regression line in a given range was regarded as 
straight, and corresponded to the formula y = mx + c, 
where x and y are variables (the logarithm of the dose 






= . z (x-x) (y-y) 
Z (x-x) 2 
= mean of y 
= mean of X 
was derived by 
in the equation 
or 
'Z xy _ 'ZxZ y 
n 
2 (Z x) 2 






y = mx + C 
' 
and 
the response line crosses the y 
and m 
is the point 
axls . 
1. Adams A.E. (1946) 
- 155 -
BIBLIOGRAPHY: 
Variations in potency of thyrotrophic hormone of 
pituitary in animals. Quart. Rev. Biol. 21, 1. 
2. Adams A.E. and Jensen D. (1944) The effect of thyroxin injections on the 
3. Adams D.D. (1956) 
4. Adams D.D. (1958) 
5. Adams D.D. (1958) 
6. Adams D.D. (1960) 
7. Adams D.D. (1961) 
8. Ada.ms D.D. (1961) 
thyrotDophin content of the anterior pituitary of the 
male albino roouse. Endocrinology .22., 296 
The clinical status of patients whose sera have given 
the abnormal response when assayed for thyrotrophin. 
Proc. Univ. Otago Med.School. ~, 29 
Detection of the abnormal thyrotrophin by a IIX)USe 
assay method. Proc. Univ. Otago Med. School • .i§., 10 
The presence of an abnormal thyroid-stimulating hornx>ne 
in the serum of sore thyrotoxic patients. J .Olin. 
Endocrinol. & Metab • .1§., 699 
A conparison of the rates at which thyrotrophin and the 
human abnormal thyroid stinulator disappear from the 
circulating blood of the rat. Endocrinology 66, 658 
Bioaasq of long-acting thyroid stinulator (L.A. T. S.); 
I 
the dose-response relationship. J .Olin. Endocrinol. & 
Metab. £1., 799 
Personal communication. 
9. A.dams D.D. and Purves H.D. (1953) A method of assay for th7rotrophic horn:one. 
Proc. Univ. Otago Med. School ..2.1, 38 
10. Adams D.D. and Purves H.D. (1955) A new method of assay for thyrotrophic horm::>ne. 
Endocrinology 21.., 17 
11. Adams D.D. and Purves H.D. (1956) Abnormal responses in the assay of thyrotrophin. 
Proc. Univ. Otago Med. School ~' 11 
12. Adams D.D. and Purves H.D. (1957) Thyrotrophin assay by plasma 1131 measurements. 
Can. J. Biochem. & Physiol • .22., 993 
- 156 -
13. Adams D.D. and Purves H.D. (1957) The role of thyrotrophin in hyperthyroidism 
and exophthalmos. Metabolism.§., 26 
14. Adams D.D. and Purves H.D. (1958) Effective treatment of a case of meta-
static thyroid carcinoma by I 131 and desiccated thyroid. 
Austral as. Ann. Med. 1, 306 
15. Adams D.D. and Purves H.D. and Sirett N.E. (1961) The response of hypo-
physectomised mice to injections of human serum containing 
long-acting thyroid stimulator. Endocrinology 68, 154 
16. Aird R.B. (1940) Experimental exophthalmos and associated nwopathy induced 
by thyrotrophic extract. Arch. Ophth. 24, 1167 
17. Aird R. B. ( 1941) ExperinentaJ.. exophthal100s and associated II\YOpathy induced 
by thyrotrophic hormone. Ann. Int. Med • ..12., 564 
18. Albert A. ( 1945) The experirrentaJ.. prod.ootion of exophthaJ..mos in Fundulus 
by means of anterior pituitary extracts. Endocrinology 
XL, 389 
19. Albert A. ( 1949) The biochemistry of the thyrotropic horm:me. Ann. New 
York Acad. Sci. .2,Q, 460 
20. Albert A. , Rawson R. W. , Merrill P. , Lennon B. and Riddell C. ( 1946) 
Reversible inactivation of thyrotropic hor100ne by 
elemental iodine. J. Biol. Chem. 166, 637 
21. Allen B.l{. ( 1916) The result of extirpation of the anterior lobe of the 
hypophysis and of the thyroid of the rana pipiens larvae. 
Science 44, 755 
22. Allen B.M. (1920) Experimmts in transplantation of the hypophysis of adult 
ran.a pipiens to tadpoles. Science jg, 274 
23. Anderson E.M. and Collip J.B. (1933) Thyreotropic hormone of anterior 
pituitary. Proc. Soc. Exper. Biol. 1Q, 680 
24. Anderson E. M. and Collip J.B. (1934) Studies on the physiology of the 
thyreotropic hormone of the anterior pituitary. 
J. Physiol. 82, 11 
' 
25. Aron M. (1929) 
- 157 -
Action de la preh;ypophyse sur la thyroide chez le cob83'e. 
Conpt. rend. Soc. Biol. - Paris. 102, 682 
26 • .Asboe-Hansen G. and Iversen K. (1951) Influence of thyrotrophic hormone on 
connective tissue; pathogenic significance of muco-
polysaccharides in experimental exophthaJ.xoos. Acta 
endocrinol. 8, 90 
27. .Asboe-Hansen G., Iversen K. and Wichmann R. ( 1952) Malignant exophthaJ.xoos; 
muscular changes and thyrotrophin content in serum. 
Acta endocrinol • .!1, 376 
28. Aterman K. (1954) ExophthaJ.xoos; its relation to adrenocorticaJ. function. 
Acta endocrinol. Suppl. 20 
29. Aterma.n K. and Greenberg S.M. (1953) Experimental exophthalmos in rats 
produced by cortisone. Endocrinology .2.f,, 510 
30. Bakke J.L. and Lawrence N. (1956) The effect of thyroid stimulating horxoone 
upon the iodide collecting mechanism of thyroid tissue 
slices. Endocrinology~' 531 
31. Bakke J.L., Heidemann L. Jr., Lawrence N.L. and Wiburg C. (1957) Bioass83' of 
thyrotropic hormone by weight response of bovine thyroid 
slices. Endocrinology 61, 352 
32. Bakke J.L, Lawrence N., Arneltt F. and MacFadden W. { 1961) The fractionation 
of exogenous and endogenous thyroid-stimulating horlIX)ne 
from human and rat plasma and tissues. J. Olin. Endocrinol. 
& Metab. £1, 1280 
33. BaJ.me H.W. (1954) Metastatic carcinoma of the thyroid successfully treated 
with thyroxine. Lancet i, 812 
34. Barett H.G., Byerly T.C. and Pringle E.M. (1936) Energy and gaseous metabolism 
of normal and deutectomised chicks between 10 hours and 
100 hours of age. J. Nutrition 11, 191 
35. Bates R.W. (1961) The chick method of thyrotropin assay; clinical results. 
presented at the N.I.H. T.S.H. conference, Arden House, N.Y. 
February 20th-23rd 1961 • (Proceedings to be published by 
Charles C.Thomas, Publisher Springfield, Ill.) Quoted by 
Bakke J.L., Lawrence N., Arneltt F. and MacFadden w. ( 1961) 
J.Clin.Endocrinol. & Metab. £1, 1280 
- 158 -
36. Bates R.W., Albert A. and Condliffe P.G. (1959) Absence of an exophthalroo-
genic substance in transplantable thyrotrophin-producing 
tumours of the pituitary of mice. Endocrinology .2,2., 860 
37. Bates R. W. and Condliffe P.G. (1960) Studies on the chemistry and bioassay of 
thyrotropins from bovine pituitaries, transplantable 
pituitary tumors of mice and blood plasma. Rec.Frog. 
Horroone Res. .1§., 309 
38. Bates R. W. and Cornfield J. (1957) An irrproved assay method for thyrotropin 
using depletion of I 131 from the thyroid of day-old chicks. 
Endocrinology 60, 225 
39. Bates, R. W., Garrison M.M. and Boward T.B. ( 1959) Extraction of thyrotrophin 
from pituitary glands, roouse pituitary twnours and blood 
plasma by percolation. Endocrinology .£2,, 7 
40. Becker D. v., Rall J.E., Peacock W.C. and Rawson R. W. ( 1953) Effect of thyro-
trophic hormone preparation on metabolism of radio-iodine in 
euthyroid, hyperthyroid and acromegalic individuals. 
J. Clin. Invest. E, 149 
41. Bergman A.J. and Turner C.W. (1939) Corrparison of guinea pig and chick thyroid 
in assay of thyrotropic hormone. Endocrinology 24, 656 
42. Besford H., Crooke A.O. and Matthews J.D. (1952) Chick assay for thyrotrophic 
horirone using 32p. J. Endocrinol. 8, Proc. p.xv 
43. Bj8rkman S.E., Denneberg T. and Hedenskog I. (1961) Clinical evaluation of 
the thyroid stimulating hormone activity in exophthalmos. 
Acta endocrinol. ...2§, 577 
4,4.. Bliss C.I. ( 1952) The statistics of bioassay. pp.475, 492. Academic Press Inc. 
N. Y. 
45. Borell U. (1945) On transport route of thyrotropic hormone, occurrence of 
latter in different parts of brain and its effect on 
thyroidea; investigations of utility of various methods for 
proving small quantities of thyrotropic horm:me. Acta Med. 
Scandina.v. Supplem. 161 
- 159 -
46. Borell U. and Holmgr,en H. (1949) Determination of thyrotrophin by means of 
radioactive phosphorus. Acta endocrinol. 1, 331 
47. Bottari P. M. ( 1957) The concentration of thyrotrophic hornone in the blood 
of the rabbit under different experimental conditions. 
Ciba Fndn. Colloq. Endocrinology !.:! , 52 
48. Bottari P. M. (1960) Blood concentration of thyrotropic horm:)ne in normal 
subjects and in patients with thyroid disease". Ciba 
Fndn. Colloq. Endocrinol. .12., 275 
49. Bottari P. M. and Donovan B.T. (1958) A sensitive in vitro technique for the 
assay of thyrotrophic horm:me. J. Physiol. ~' 36P 
50. Bowers C.Y., Gordon D.L. and Segaloff A. (1959) The IJ\YXedema reflex in 
inf ants and children with hypothyroidism. J. Paediat. 
~' 46 
51. Brimblecombe R., Haigh C.P., Halkerston I.D.K., Reiss M. and Warledge J.(1952) 
Studies on biological assay of thyrotrophic hormone. 
J. End.ocrinol. .§., proc. p.v 
52. Brown J.R. (1959) The measurement of thyroid stimulating hormone (T.S.H.) 
in bod;y fluids: A critical review. Acta endocrinol. jg, 289 
53. Brown J.R. and Dodd J.M. (1956) Measurement of thyrotrophic horirone (T.S.H.) 




• J .En.docrinol. 14, xxix 
54. Brunish R. ( 19 58) The production of experimental exophthaliros. Endocrinology 
62, 437 
55. Cameron A.T. and Carmichael J. (1921) Contributions to the biochemistry of 
iodine. IV. The effect of thyrotoxin on growth in white 
rats and in rabbi ts. J. Biol. Chem. 46, 35 
56. Canad.ell J.M. and Barraquer J. (1956) Le facteur exophtalzoogene du serwn; 
sa determination et utilite pratique • .Ann. endocrinol. Par. 
11, 369 
- 160 -
57. Canad.ell J.M. and Barraquer J. (1959) Enhancing ef'fect of corticotrophin 
on thyrotrophin produced exophthalmos in fish. Endocrinology 
64, 1017 
58. Chaikoff I.L. and Taurog A. (1949) Studies on the formation of organically-
bound iodine con:pounds in the thyroid gland and their 
appearance in plasma as shown by the use of radioactive 
iodine. Ann. N. Y. Acad.. Sci. .22, 377 
59 . Chandler G. N. and Hartfall S.J. (1952) Cortisone and A.C.T.H. in exophthalmic 
ophthal:rooplegia. Lancet.!• , 847 
60. Closs K., Loeb L. and MacKay E.M. (1932) The effect of acid extract of the · 
anterior pituitary on the iodine concentration of the blood 
and thyroid gland. J. Biol . Chem. .2§., 585 
61. Cohn E.J., Strong E.L., Hughes W.L. Jr., Mulfii>rd D.J., Ashworth J.N., Melin M. 
and Taylor H. L. (1946) Preparation and properties of serum 
and plasma. proteins. J. Am. Chem. Soc. 68, 459 
62. Colla.rd H.B., Mills F.H. Rundle F.F. and Sharpey-Shafer E.P. (1940) 
Thyrotropic hormone in the blood. Clin. Sci. !!;, 323 
63. Condliffe P.G. and Bates R.W. (1956) Chromatography of' thyroid-stimulating 
horxoone on ca.rboxymet.hylcellulose. J. Biol. Chem. 223, 843 
64. Cope C.L. (1938) Anterior pit uitary lobe in Graves' disease and i~ ieyxoedema. 
Qua.rt. J. Med. 1, 151 
65. Cope C.L. (1938) The young chick as test for the thyrotropic horllX>ne. 
J. Physiol . ~' 358 
66. Cortell R. and Rawson R. W. (1944) Effect of thyroxin on response of thyroid 
gland to thyrotropic horxoone. Endocrinology 12., 488 
67. Crew F.A.E. and Wiesner B.P. (1930) On the existence of fourth hormone, 
thyreotropic in nature, of anterior pituitary. Brit.Med.J. 
i, 777 
68. Crooke A.C. and Matthews J.D. (1953) Chick assay of thyrotrophic horm:me 
using 32p. Ciba Fndn. Colloq. Endocrinol. 2., 25 
- 161 -








J .B.Lippincott Philadelphia. Pa. 
Cuyl.er W.K., Stimmel B. F. and McCullagh D.R. ( 1936) Quantitative studies 
with the thyrotropic horm:me. J. Pharm. & Exp. Therap. 
~' 286 
D'Angelo S.A. (1951) The disappea ranee rate of exogenous thyrotrophin from 
the blood of normal and hypophysectomised rats. 
Endocrinology~' 249 
D'Angelo S.A. (1955) The matabolism of thyrotrophic hormone in the rat. 
Endocrinology 2.§., 37 
D'Angelo S.A., Gordon A.S. and Charipper H.A. (1942) Thyrotropic hormone 
assay in tad.pole. Endocrinology .i!, 217 
D'Angelo S.A. and Gordon A. S. (1950) The sinw.taneous detection of thyroid 
and thyrotrophic horoones in vertebrate sera. Endocrinology 
46, 39 
D' Angelo S.A., Paschkis K.E., Gordon A.S. and Cantarow A. (1951) Thyroid-
thyrotropic horoone balance in the blood of normal and 
endocrinopathic ind.i v:i.duaJ.s. J. Clin. Endocrinol. .11, 1237 
76. Davis A. C. ( 1941 ) The thyroid gland in 166 cases of acronegaly. J. Clin. 
Endocrinol. 1, 445 
77. Di George A.M., D'Angelo S.A. and Paschkis K.E. (1957) Thyro-pituitary 
relationships in children with cretinism and hypothyroidism. 
J .Clin.Endocrinol. and Metab • .!I, 842 
78. Dobyns B. M. (1945) The influence of thyroidectonzy" on the prominence of the 
eyes in the guinea-pig and in man. Surg. Gynec. & Obstet. 
80, 526 
79. Dobyns B.M. (1946) Studies on exophthalmos produced by thyrotropic hormone; 
11. Changes indooed in various tissues and organs (including 
the orbit) by thyrotropic horoone and their relationship 
to exophthalmos. Surg., Gynec. & Obstet. 82, 609 
- 162 -
80. Dobyns B. M. (1946) Studies in exophthalmos produced by thyrotropic hormone. 
1 • A study of exophthaJ.mos produced by various thyrotropic 
hormones and the influence of the testes on the exophthalmos. 
Surg., Gynec. & Obstet. 82, 290 
81. Dobyns B.M. ( 1946) Studies on exophthaJ.mos produced by thyrotropic horirone; 
III. Further study of changes indu::ed in fat by thyrotropic 
horirone ( tissue reactions associated with exophthaJ.mos) 
Surg., Gynec. & Obstet. 82, 717 
82. Dobyns B.M. (1956) Physiologic concepts in the diagnosis and treatment of 
Graves' disease. Am. J. :V;ed. 20, 684 
83. Dobyns B. M. and Haines S. F. (1946) Changes in the prominence of the eyes in 
various thyroid states. J. Clin. Endocrinol • .§., 633 
84. Dobyns B.M. and Steelman S.L. (1953) The thyroid stinulating hormone of the 
anterior pituitary as distinct from the exophthaJ.mos 
producing substance. Endocrinology~' 705 
85. Dobyns B. M. and Wilson L.A. (1954) An exophthalmos-producing substance in the 
serum of patients suff ering from progressive exophthaJ.mos. 
J. Clin. End.ocrinol. ~, 1393 
86. Dobyns B. M., Wright A., and Wilson L. ( 1961) Assay of the exophthaJ.oos-
producing substance in the serum of patients with progressive 
exophthaJ.mos. J. Clin. :Endocrinol. & Met ab. gi, 648 
87. Dott N. M. (1923) An investigation into the functions of the pituitary and 
thyroid glands. Part I. Technique of their experilll3ntal 
surgery and summary of results. Quart. J. Exp. Physiol. 12., 2.lt-1 
88. Dvoskin S. ( 1947) Intracellular colloid droplets as a basis for thyrotrophic 
hormone assay in the chick. Endocrinology ~, 220 
89. Dvoskin S. ( 1947) The spontaneous formation of intracellular colloid dropl,ets 
in surviving chick thyroid tissue. Endocrinology 41, 403 
90. Dvoskin S. (1948) The effects of pituitary and non-pituitary gland factors on 
the formation of intracellular colloid droplets in the thyroid 
epithelium of lzypophysectomised rats. Endocrinology l:tl, 52 
- 163 -
91. Emerson K. Jr. (1937) On specificity of thyreotropic action of anterior pituitary 
gland. Bull. Johns Hopkins Hosp. 60, 358 
92. Enerson K. Jr., and Cutting W.C. (1938) Urinary thyrotropic hormne. 
Endocrinology El., 439 
93. Faires R.A. and Parks B.H. Radioisotope Laboratory Techniques. p.168 1st Ed. 
(1958) George Newnes Ltd., London. 
94. Faires R.A. and Parks B.H. Radioisotope Laboratory Techniques. p.155 1st Ed. 
( 19 58) George N ewnes Ltd. , London. 
95. Fellinger K. ( 1936) Klinische und e.xperimentelle Untersuchungen uber das 
Verhalten und die Bedentung des thyreotropen Hormons in 
Blute. Wien. Arch. inn. Med. E2., 375 
96. Florsheim W.H., Moskowitz N. , Schwartz J .R. and Morton M.E. ( 1957) A new assay 
for thyrotropic horrrone based upon thyroidal phospholipid 
turnover in vitro. Endocrinology 60, 683 
97. Foster G.L., Gutman A.B. and Gutman E.B. ( 1933) Total and thyroxine iodine 
content of thyroid gland after injection of saline anterior 
pituitary extracts. Pree. Soc. E.xper. Biol. & Med. l.Q, 1028 
98. Fraenkel-Conrat J., Fraenkel-Conrat H., Sinpson M. E. and Evans H.:M. (1940) 
Purification of thyrotropic hormone of the anterior pituitary. 
J. Biol. Chem • .!.12., 199 
99. Fraser, Russell T. (1960) in discussion following paper by Bottari P.M. (1960) 
Fndn. Coloq. Endocrinol. .ll, 295 
100. Fraser, Russell T. and '. Sonenberg M. ( 1960) in discussion following paper by 
Bottari P.M. Ciba Fndn. Coloq. Endocrinol. .ll, 295 and 299 
101. Fregola G. and Ferrara G.C. (1958) Sulla tirotropinernia nel gozzo endernico. 
Arch.Sc.Med • .1.Q.2, 211. As reported by McKenzie J.M.(1960) 
Physiol .Rev. 40, 398 
102. Frey H. M. and Albert A. (1959) A modification of the Bates-Cornfield bio-
assay for thyrotropin. Endocrinology 64, 304 
- 164- -
103. Gaddum J.H. (1953) Sinplified mathematics for bioassays. J.Pharm. and Ph8.I'llll:Col. 
2, 345 
104. Ghosh B.N., Woodbury D.M. and Sayers G. (1951) Quantitative effects of 
thyrotrophic horm:me on I 131 accum.tl.ation in thyroid and 
plasma proteins of hypophysectomised rats. Endocrinology 
li:s!, 631 
105. Gilliland r.c. and Fraser T.R. (1953) Assay of thyrotrophic horroone by 
I 131 discharge. Ciba Fndn. Coloq. Endocrinol. 2, 20 
106. Gilliland I.C. and Strudwick J.I. (1953) The assay of thyrotrophic horroone 
by the discharge of r131 from the thyroid of day-old chicks. 
Olin. Sci • .lg, 265 
107. Gilliland I. C. and Strudwick J. I. ( 19 56) Clinical application of assay of 
thyroid-stimulating horm::,ne in relation to exophthalmos. 
Brit. M.J. i, 378 
108. Gley E. (1910) De l' exophtal.mie consecutive a la thyroidectomie. 
Presentation d'animaux. Coup. Rend. Soc. Biol. 68, 858 
109. Graubuer W. (1924/25) Die hypophysare Kachexie. (Sirranondssche Krankheit) 
z. Kl.in. Med. 101, 249 
110. Greenspan F.S., Krise J.P., Moses L.E. and Lew W. ( 1956) An inproved bioassey 
method for thyrotropic horroone using thyroid uptake of 
radiophosphorus. Endocrinology~' 767 
111. Greenspan F.S. and Lew W. (1959) Limitations of the chick rad.iophosphorus 
uptake assay and the chick radio-iodine depletion assay for 
thyrotropic horroone when applied to blood and urine. 
Endocrinology 64, 160 
112. Greer M.A. and Smith G.E. (1954) Method for increasing the accuracy of the 
radio-iodine uptake as a test for thyroid function by the 
use of desiccated thyroid. J. Olin. Endocrinol. 14, 1374 
113. Griesbach W.E. and Purves H.D. (1943) Assay of thyrotropic activity by cell 
height response in guinea-pigs. Brit. J. Exper. Path. 24, 185 
- 165 -
114. Griffith J . Q. and Jeffers W.A. in "The Rat in Laboratory Investigation" 
Ed. by E.J. Farris and J.(f. Griffith. page 290, 2nd ed.(1949) 
J .B.Lippincott Co., Philadelphia, U.S . .&. 
115. Hales I.B. and Dobyns B.M. (1960) The xretabolism of triodothyronine in 
Graves' disease. J .Clin.Endocrinol. & Metab. 20, 68 
116. Hales I.B., Myhill J., Oddie T.H. and Rundle F.F. (1961) Thyroid suppressi-
bility after therapy :for thyrotoxicosis. J .Clin.Endocrinol. 
& Metab. 21, 569 
117. Hays E.E. and Steelman S.L. Chemistry of the anterior pituitary horm:>nes. 
In "The Hormones"; edited by G.Pincus and K.V. Thimann. 
New York Acad. Press (1955) Vol.3 p.201 
118. Heideman M. L. Jr., Bakke J. L. , and Lawrence N. L. ( 1959) Separation of human 
thyrotropin from plasma by ion exchange chromatography. 
J.Clin.Endocrinol. & Metab. 12., 831 
119. Hertz S. and Oastler E.G. (1936) Assay of blood and urine for thyreotropic 
hornnne in thyrotoxicosis and II\YXOedema. Endocrinology 
20, 520 
120. He~tz S. and Roberts A. (1941) Radioactive iodine as indicator in thyroid 
physiology; iodine collection as criterion of thyroid 
function in rabbits injected with thyrotropic horm::ine. 
Endocrinology £2., 82 
121. Hertz S., Roberts A. and Evans R.D. (1938) Radioactive iodine as indicator 
in atudy of thyroid physiology. Proc.Soc.Exper.Biol. & Med • 
..2£!, 510 
122. Heyl J.G. and Laqueur E. (1935) Zur quantitativen Bestinu:nung der thyreotropen 
Wirkung von Hypophysenvorderlappenpraparaten und die Einheit 
des thyreotropen Hormone. Arch. internat. de pharmacodyn. 
et de therap. ~' 338 
123. Hof'fenberg R. and Jackson W.B.U. (1958) Adrenocortical steriods in malignant 
exophthalmos. Lancet i, 693 
/ 
- 166 -
1 24. Ingbar S. H. and Freinkel N. ( 1958) Studies of thyroid function and the 
peripheral rootabolism of I 131 labelled thyroxine in patients 
with treated Graves' disease. J.Clin.Invest. 21., 1603 
125. Jefferies W. M. (1949) Studies of relationship of thyrotropic, exophthalmic 
/ and fat-mobilizing principles of pituitary extract; effect 
of various dosages of pituitary extract upon production of 
exophthalnos and mobilization of fat in intact and thyroidec-
tomised guinea-pigs. J.Clin.Endocrinol. 2, 913 
126. Jefferies W.M. (1949) Studies of relationship of thyrotropic, exophthalmic 
& fat-mobilizing principles of pituitary extr~t; effect 
of iodination of pituitary extract upon these 3 principles. 
J.Clin.Endocrinol. 2, 927 
127. Jensen H. and Gratton J.F. (1940) Identity of glycotropic (anti-insulin) 
substance of anterior pituitary gland. Am.J.Physiol.128,270 
,, 
128. Junkmann K. and Schoeller W. (1932) Uber das thyreotrope Hornon des Hypo-
physenvorderlappens. Ia.in. Wchnschr. 11, 11·76 
129. Keating F.R. Jr., Rawson R. W., Peacock W. and Evans R.D. (1945) The collection 
and loss of radioactive iodine conpared with the anatomic 
changes induced in the thyroid of the chick by the injection 
of thyrotropic horirone. Endocrinology 1§., 137 
130. Kinderen der P.J., Houtstra-Lanz M. and Schwarz F. (1960) Exophthalmos 
· producing substance in human serum. J .Clin.Endocrinol. 
& Metab. 20, 712 
131. Kinsell L. W., Partridge J. W. and Foreman N. ( 1953) The use of A.C. T.H. and 
cortisone in the treatment and in the differential diagnosis 
of malignant exophthalioos: A preliminary report. Ann.Int. 
16:,d. l§., 91 3 
132. Kirkeby K. (1954) Cortisone and A.C.T.H. in the treatment of localized thyro-
toxic nzyxoed.ema.. Report of a case. J.Clin.Endocrinol.14,561 
- 167 -
133. Laniberg B.A. (1953) Radioactive phosphorus as indicator in a chick assay 
of' thyrotropic hormone • .Acta Med. Scandinav. Suppl. 279 
134,. Lamberg B. A. ( 1955) Assay of' thyrotropin with radioactive indicators. Acta 
endocrinol • .1§., 405 
135. Laniberg B.A., Wegelius O. and Harjanne A. ( 1956) Uptake of radioactive 
sulphate by retrobuJ.bar connective tissue and Harder's 
gland in guinea-pigs treated with thyrotrophin. Acta 
endoorinol. 22, 407 
136. Levey H.A., Cheever E. and Roberts S. (1956) Bioassay of thyrotropin. 
137. Loeb L. (1932) 
138. Loeb L. (1932) 
Endocrinology ..2§., 420 
Specificity in action of anterior pituitary of different 
mammaJ.s as well as of urine of pregnant women on sex organs 
and thyroid glands of immature female guinea-pigs. 
Endocrinology 1§., 129 
Effects of anterior pituitary from various species on sex 
and thyroid of inunature guinea pigs . Proc.Soc.Exper.Biol. 
& Med. ~' 1128 
139. Loeb L. and Basset R.B. (1929) Effect of hornones of anterior pituitary on 
thyroid gland in the guinea-pig. Proc. Soc.Ex.per.Biol. & Med. 
26, 860 
140. Loeb L. Bassett R.B. and Fried.man H. (1930) Further investigations concerning 
the stimulating effect of anterior pituitary gland preparation 
on the thyroid gland. Proc.Soc.Exper.Biol. & Med. 28, 209 
141. Loeb L. and Friedman H. ( 1931) Exophthalmos produced by injections of acid 
extract of anterior pituitary gland of cattle. Proo.Soc. 
Exp er. Biol. & Med. ~' 648 
142. Loeser A. ( 19 34) Die schilddrusen wirksame Substanz des Hypophysenvorder-
lappens. Arch. f. ex.per. Path. u. Pha.rma.kol • ..11§., 697 
143. Ludwig K.S. (1950) Das Zellkernvolumen in der Schilddruse nonnaler sowie 
mi t Thiouracil und Thyroxin behandel ter Ratten. Acta anat. 
11, 146 
- 168 -
1411-• Major P. W. and Munro D.S. (1960) Thyroid stimulating activity in human sera. 
J.Endocrinol. 20 xix (Proceedings) 
145. Maloof F. Vickery A. O. and Rapp B. (1956) An evaluation of various factors 
influencing the treatment of metastatic thyroid carcinoma 
with r131 • J.Clin.Endocrinol. & Metab. 16, 1 
146. Marine D. and Rosen S. A. ( 19 3 3) Exophthalzoos in thyroidectomised guinea-pigs 
by thyrotropic substance of anterior pituitary and the 
mechanism involved. Proc.Soc.Exper.Biol.& Med. lQ., 901 
147. Marine D. & Rosen S.A . (1934) The exophthalmos of Graves' disease. Its 
experimental production and significance. Am.J. Med.Sci. 
188 , 565 
148. Marine D. and Ro-sen S. A. (1934) Effect of thyrotropic hornone on auto- and 
homeo-transplants of thyroid and its bearing on question 
of secretory nerves. Am. J. Physiol. 107, 677 
149. McCullagh E.P. and Brandon J. M. (1960) In "Clinical Endocrinology". p.43 
Ed. by E. B. Astwood. Grune and Stratton, N. Y. 
150. McGill D. A. ( 1960) Some investigations into endocrine exophthalmos. 
Quart. J. Med. ~, 423 
151. McGinty D.A. and McCullough N. B. (1936) Thyrotropic horzoone in non-pituitary 
tissue. Proc.Soc.Exper.Biol. & Med • ...22, 24 
152. McKenzie J. M. (1957) Association of thyrotropin with gamma-globulin in 
IJ\YXOedema. Proc.Soc.E.xper. Biol. & Med • .22., 736 
153. McKenzie J. M. ( 1957) A bioassay of' thyrotropin. Fed.Proo. 1§., 87 
154. McKenzie J. M. (1958) The bioassay of' thyrotropin in serum. Endocrinology 
.§1, 372 
155. McKenzie J. M. ( 1958) Delayed thyroid response to serum from thyrotoxic 
patients. Endocrinology 62, 865 
156. McKenzie J. M. (1959) The thyroid activator of hyperthyroidism. Tr.A.Am. 
Physicians. E, 122 
1 57. McKenzie J. M. ( 1960) Bio assay of thyrotropin in man. Physiol. Rev. !±Q, 398 
- 169 -
158. McKenzie J.M. (1960) Further evidence for a thyroid activator in hyper-
thyroidism. J .Clin.Endocrinol. & Metab. 20, 380 
159. McKenzie J.M. (1961) Personal communication. 
160. McKenzie J.M. (1961) Studies on the thyroid-activator of hyperthyroidism. 
J.Clin.Endocrinol. & Metab. 21, 635 
161. Medical Research Council (1955) Cortisone in exophthalnos. Lancet i, 6 
162. Munro D.S. (1959) Observations on the discharge of radio-iodine from the 
thyroid glands of mice injected with human sera. 
J .Endocrinol. .1.2., 64 
163. Munro D.S., Kilpatrick R., Major P. and Wilson G.M. (1960) Thyroid stim..llating 
horIIX)ne in human sera. Abstract No. 599, First International 
Congress of Endocrinology, Copenhagen, 1960 
164. Mussett M. V. and Perry W. L. M. ( 19 55) International Standard for thyrotDophin. 
Bull. World Health Organ • ..12., 917 
165. Niepce B. (1851) Traite du goitre et du cretinisme. Paris . Quoted by 
McKenzie J.M. (1960). Physiol. Rev. JtQ, 398 
166. Parry C.H. (1825) Collections from the unpublished Medical writings of the late 
Caleb Hillier Parry. Vol.2. Quoted by Iason, A.H. p.63 in 
The thyroid gland in medical history. Froben Press, N. Y. (1946) 
167. Paulson D.L. (1937) Experimental exophthalmos in guinea pig. Proc.Soc.Exper. 
Biol. & Med. 1.§., 604 
168. Perlmutter M., Weisenfeld S., Slater S., Wallace E.Z. and David M.M. (1952) 
A study of~ mechanism of the inhibition of the thyroid 
gland induced by ingestion of thyroid substance. J.Clin. 
Endocrinol. _g, 208 
169. Piotrowski L.J., Steelman S.L. and Koch F.C . (1953) Thyrotropin assay based 
on the depletion of iodine in chick thyroids. Endocrinology 
.2, 489 
- 170 -
170. Pechin E. E. ( 1952) The mechanism of experirental exophthalmos caused by 
pituitary extracts. Ciba Frum.. Colloq. Endocrinol. lJ:, 316 
171. Postel S. (1956) Zone electrophoresis in the preparation of serum and 
pituitary extracts for bioassay of thyroid stimulating 
horroone. Endocrinology~' 557 
172. Pulvertaf't R.J. v., ~oniach D., Roitt I. M. and Hudson R. V. ( 1959) Cytotoxic 
effects of Hashimoto serum on human cells in tissue culture. 
Lancet ii, 214 
173. · Puntriano G. and Meites J. (1951) Effects of continuous light or darkness 
on thyroid function in mice. Endocrinology 48, 217 
174. Pu.rl'es H.D. and Griesbach W.E. (1947) Studies on experimental goitre: 
Thyroid tumours in rats treated with thiourea. Brit.J.Exper. 
Path. 28, 46 
175. Purves H.D. and Griesbach W.E. (1949) Thyrotropic hormone in thyrotoxicosis, 
malignant exophthalmos and myxoedema. Brit. J. Exper. Path. 
lQ, 23 
176. Purves H.D., Griesbach W.E. and Kennedy T.H. (1951) Studies in experimental 
goitre: Malignant change in a transplantable rat thyroid 
t\llIX>ur. Brit.J.Cancer 2, 301 
177. Querido A. ( 1957) in "General Discussion''. Ciba Fndn. Colloq. Endocrinol. 
.11) 78 
178. Querido A., Kassenaar A.A.H. and Lameyer L.D. F. ( 1953) Assay of thyrotropic 
hormone by means of I 131 uptake in thyroid glands of 
iodocasein treated mice. Acta endocrinol. _!g, 335 
179. Querido A., and Lameyer L.D.F. (1956) Thyrotrophic hormone content of human 
sera in normals and patients with thyroid disease. 
Proc. Roy. Soc. Med. l±'2., 209 
- 171 -
180. Rawson, R. W. (1949) Physiological reactions of the thyroid-stimulating 
hormone. Ann. N. Y. Acad.. Sci • .22, 491 
181. Rawson R. W. and Salter W. T. ( 1940) Microhistometric assay of thyrotropic 
hormone in day-old chicks. Endocrinology Kl.., 155 
182. Rawson R. W. and Starr P. ( 19 38) Direct measurement of height of thyroid 
epithelium; method of assay of thyrotropic substance; 
clinical application. Arch. Int. Med. 61, 726 
183. Renon L. and DeLille A. (1908) Surles effets des extra.its d'h;ypophyse,de 
thyroide, de surrenale, d'ovaire enployes en injections 
intra-peri tone ales chez le lapin (injections sinples et 
combinees). Conpt. rend. Soc. Biol. 64, 1037 
184. Renon L. and DeLille A. (1908) Sur les eff ets des extra.its d'h;ypophyse, de 
thyroide, de surrenale, d'ovaire enployes en injections 
intra-peritoneales .chez le lapin (injections sinples et 
combinees). (Deuxieme note). Conpt. rend. Soc. Biol • 
.§2, 499 
185. Robertis de E. ( 1948) Assay of thyrotropic hormone in human blood. J .Olin. 
Endocrinol • .§., 956 
186. Rogowitsch N. (1889) Beitr. z. path. Anat. u. allq. Path. 4:453 
Quoted by Bottari P. M. (1957). Ciba Fndn. Colloq. 
Endocrinol. .11, 52 · 
187. Raitt I. M. and Doniach D. (1960) Thyroid auto-inmmity. Brit.Med.Bull • ..1§.,152 
188. Rowlands I. W. and Parkes A.S. ( 1934) Quantitative study of the thyrotropic 
activity of anterior pituitary extracts. Biochem J.28,1829 
189. Schittenhelm A. and Eisler B. (1932) Untersuchungen der Wirkung des thyreo-
tropen Hormons auf' die Tatigkei t der Schild.ruse. Ia.in. 
Wschr. 11., 1092 
- 172 -
1 90. Schockaert J. A. ( 19 31 ) Enlargement and hyperplasia of thyroid and exophthalms 
from treatment with anterior pituitary in young ducks. 
Proc.Soc.Exper.Biol. & Med. £2., 306 
191. Schockaert J .A. ( 1932) Enlargement and hyperplasia of thyroids in young 
duck from injection of anterior pituitary • .Am.J.Anat.~,37 
192. Segaloff A. (1953) Requirements for clinically useful endocrine bioassays. 
Ciba Fndml. Ofil.oq. Endocrinol. 2, 1 
193. Seidlin S.M. (1940) Metabolism of thyrotrophic and gonadotrophic horm::>nes. 
Endocrinology 26, 696 
194. Siebert W.J. and Smith R.S. (1930) Effect of various anterior pituitary 
preparations upon basal netabolism in partially thyroidec-
tomised and in conpletely thyroidectomised guinea-pigs. 
Am.J.Physiol. 22_, 396 
195. Simkin B.Starr P. and Hancock C. (1952) Serum thyrotropic hormone bioasseys 
in patients exhibiting various thyroid states. J.Clin. 
End.ocrinol. jg, 940 
196. Smelser G.K. (1937) A conparative study of experimental and clinical exoph-
thalmos. Am. J. Ophthal. 20, 1189 
197. Smelser G.K. (1938) Chick thyroid responses as a basis for thyrotropic 
horm:me assay. Endocrinology n_, 429 
198. Smelser G.K. ( 1943) Reaction of orbital tissues in experimental exophthal:ioos 
following rem::>val of Harder' s gland. Anat. Rec • .§2, 245 
199. Smelser G.K. (1943) Water and fat content of orbital tissues of guinea-pigs 
with experimental exophthalmos produced by extracts of 
anterior pituitary gland. Am.J.Physiol. 140, 308 
200. Srelser G.K. (1943) Changes induced in Harderian gland of guinea-pig by 
injection of hypophyseal extracts. Anat. Rec. 86, 41 
201. Smelser G.K. and Ozanics V. (1949) Reaction of various types of fat trans-
planted into orbit of guinea-pigs prior to development of 
exophthalmos. Am. J. Opth. .,g, 1557 
- 173 -
202. Smith P.E. (1916) The effect of hypophysectOJI\Y in the early embryo upon 
the growth and development of the frog. Anat.Rec • .11, 57 
203. Smith P.E. (1930) HypophysectoJI\Y and replacement therapy in rat. Am.J.Anat. 
~' 205 
204. Smith P.E. and Smith I.P. ( 1922) The repair and activation of the thyroid in 
the hypophysectomised tadpole by the parenteral admini-
stration of fresh anterior lobe of the bovine hypophysis. 
m. Med. Res • .!t.2,, 267 
205. Spaul E.A. (1930) Activity of the anterior lobe pituitary. J.Exper.Biol.1,49 
2o6. Stimmel B.F. and McCullagh D.R. (1936) A note concerning the determination 
of iodine. J. Biol. Chem 116, 21 
207. Stimrel B.F., McCullagh D.R. and Picha V. (1936) The thyrotropic horm:>ne 
of the pituitary gland and iodine metabolism. J .Pharm. 
& Exp. Therap. 21., 49 
208. Tala P. (1952) 
209. Tala P. (1953) 
Histoquantative studies on the effect of thyrotropin and 
thyroxin on the morphology of the thyroid gland, with 
special reference to the standardisation of the thyrotropic 
hormone. Acta endocrinol. Suppl. 9 
Conparison of the epithelial percentage and nuclear volume 
determinations as indicators of thyroid activity following 
stinrulation by thyrotropin. Endocrinology 22, 474 
210. Tala P., Kuusisto A. N. and Perasalo O. (1956) Assay of thyrotropic hormone 
in human blood in sorre cases of thyroid disease. 
Ann. med. int. Fenniae ~' 219 
211. Tala P. , Laniberg B. A. and Uotila U. ( 1955) The effect of a single dose of 
thyrotrophin on uptake of p32 by the guinea-pig thyroid. 
Acta endocrinol. 12., 255 
212. Thomas C.G. Jr. (1957) Hormonal treatment of thyroid cancer. 
J .C1in. Endocrinol. & Met ab. 17, 232 
- 174 -
213. Uhlenhuth E. and Schwartzbach S. (1927) Morphology and physiology of sala-
mander thyroid gland; anterior lobe of h;ypophysis as 
control mechanism of function of thyroid gland. 
Brit. J. Exper. Biol • .2, 1 
214. Uhlenhuth E. (1937) The thyreoactivator hormone; its isolation from the 
anterior lobe of the bovine pituitary gland and its 
effects on the thyroid gland. Ann. _Int. Med • ..1Q, 1459 
215. Uhlenhuth E. and Schwartzbach S. ( 1926) Control of the thyroid function by 
the anterior lobe of the h;ypophysis. Anat.Rec. ~' 119 
216. Uhlenhuth E. and Schwartzbach S. (1928) Anterior lobe substance, the thyroid 
stinrulator. III. Effect of anterior lobe substance on 
thyroid gland. Proc. Soc. Exper. Biol. & Med. 26, 152 
217. Uotila U. (1939) On role of pituitary stalk in regulation of anterior 
pituitary, with special reference to thyrotropic 
hormone. Endocrinology ~' 605 
218. Uotila U. and Kannas O. (1952) Quantitative histological method of deter-
mining proportions of principal corrponents of thyroid 
tissue. Acts endocrinol. 11, 49 
219. Vilanova X. and Canadell J. M. ( 1949) Myxoedema circumscripta thyrotoxicum. 
J.Clin.Endocrinol. 2, 883 
220. Vincent S. and Jolly W.A. (1904) Some observations upon the functions of the 
thyroid and parathyroid glands. J. Physiol. E, 65 
221. Wahlberg P. (1955) The effect of thyrotropic honnone on thyroid function; 
corrparative study on chicks with radioactive indica-
tors. Acta endocrinol. Suppl. 23 
222. Wegelius O. and Lamberg B.A. (1958) Quoted by Wegelius O., Neumann J. and 
Brunish R. (1959). Acta endocrinol. lQ, 53. 
- 175 -
223. Wegelius o. , Neumann J. and Brunish R. ( 1959) Uptake of' 35s-labelled sulphate 
in the Hard.erian and ventral lachrymal glands of' the 
guinea-pig during stinulation with ophthalmotrophic 
pituitary agents; a new assay f'or ophthalmotropic 
activity in thyrotrophic preparations. Acta endo-
crinol. l.Q, 53 
224. Werner S.C. (1954) 
224(a). Werner S.C. (1960) 
224(b). Werner S.C. (1953) 
The pituitary-thyroid relationship in Graves' disease. 
J.Clin.Endocrinol • .11!:, 1260 
The ophthalmopathy of' thyroid disease. In Clinical 
Endocrinology 1. Ed. E.B.Astwood. p. 212. Grune and 
Stratton, Ltd. N.Y., 1960 
Euthyroid patients with early eye signs of Graves' 
disease. Am. J. Med. 18: 608 
225. Werner s.c., Hamilton H. and Nemeth M. (1952) Graves' disease: hyperthyroidism 
or hyperpituitarism? J.Clin.Endocrinol. 12, 1561 
226. Wolf'f J. (1951) Some f'actors that inf'luence release of' iodine from 
the thyroid gland. Endocrinology 48, 284 
227. Yamazaki E., Noguchi A. , Sato S. and Slingerland D. W. ( 1961) Thyrotropic 
activity in the serum of' euthyroid, treated hyper-
thyroid and. postoperative hypothyroid patients. 
J. Clin. Endocrinol. & Meta.b. _gj_, 1127 
